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Genetic studies of schizophrenia have often been frustrated by the aetiological and 
pathological complexity of the disorder. One research strategy to address this issue is the use 
of endophenotype markers. 
The aim of this PhD thesis is to explore the validity of selected candidate endophenotype 
markers for schizophrenia by establishing the evidence that they may have some or indeed 
any relationship with the genetic risk for the disorder. 
I have studied a unique twin and family population, to describe the distribution of a variety of 
deficits as candidate markers in patients, their unaffected co-twins and relatives, and healthy 
controls, to explore the evidence for genetic and environmental influences on their 
distribution. 
I selected neurological soft signs, personality and social development, grey and white matter 
cerebral volumes, and regional neural activity during a phonological verbal fluency task. 
The results were most compelling for the developmental and verbal fluency markers, 
supporting their role as endophenotype markers. In comparative terms, this may relate more 
to methodological factors, than the markers inherent properties. All of the markers 
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Chapter 1 
1. An Introduction to Schizophrenia and Endophenotypes 
 
1.1. Abstract 
1.1.1. In this introductory chapter I will describe schizophrenia and introduce the 
concept of endophenotypes. 
 
1.2. What is schizophrenia? 
1.2.1. ‘Schizophrenia’ is a psychiatric disorder and falls within the scope of 
psychotic illnesses. This in simple terms means that the patient at some point develops 
symptoms that lead them to misinterpret reality. More specifically schizophrenia is 
characterised by the presence of certain symptoms and signs, in particular delusions and 
hallucinations, and thought disorganisation. 
1.2.2. The name schizophrenia was derived from the early observation that the 
illness is typified by ‘the disconnection or splitting of the psychic functions’ (Bleuler 
1911). Unfortunately, this has lead to the widespread common misconception that the 
illness is somehow characterised by a split personality. 
 
1.3. How Has the Concept of Schizophrenia Evolved? 
1.3.1. In the early 1800s many believed in a single psychotic illness 
’Einheitpsychose’, though by the early 1850s two French psychiatrists Falret and Morel 
had distinguished ‘folie circulaire’ what we now think of as manic depressive psychosis 
from ‘demence precoce’ (Morel 1860; Falret 1878), a progressive disorder, characterised 
by social withdrawl, self neglect and bizarre behaviour. In Germany Hecker later 
employed the term ’hebephrenia’ to describe a very similar clinical concept to ’demence 
precoce’(Hecker 1871), while his mentor Kahlbaum proposed ’catatonia’ to describe a 
presentation of psychosis but dominated by episodes of abnormal movement and posture 
(Kahlbaum 1863). 
1.3.2. Emil Kraepelin subsequently united the concepts of ’hebephrenia’ and 
‘catatonia’ with ’paranoia’ into a single disorder ‘dementia praecox’ (Kraepelin 1913). 
Kraepelin too believed that this was a progressive disorder beginning in early adult life, 
and characterised by delusions and hallucinations, disordered thought, loss of interest in 
the outside world and loss of emotional reactions. Bleuler, a Swiss psychiatrist proposed 
in 1911 that there was not one illness ‘dementia praecox’ but rather ‘a group of 
schizophrenias’ and identified what he felt were the primary and secondary symptoms of 
these disorders (Bleuler 1911). He suggested the primary symptoms were ambivalence, 
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autism, (loss of interest in the outside world), affective blunting (loss of emotional 
responses) and altered associations (thought fragmentation). In contrast he felt the 
secondary symptoms, delusions and hallucinations while often present were not specific 
to schizophrenia. 
1.3.3. Perhaps the most significant subsequent attempt to clarify the clinical 
definition of schizophrenia was that proposed by Kurt Schneider in 1950 and reflected a 
shift in emphasis from Bleuler’s position. Schneider also regarded certain symptoms as 
particularly indicative of the disorder, for example particular types of auditory 
hallucinations and labelled these ‘first rank symptoms’. The Schneiderian concept of 
schizophrenia has remained dominant into early 21st century diagnostic thinking, though 
it is not without its weaknesses, in particular Schneider’s first rank symptoms are neither 
present in every patients with schizophrenia nor necessarily prove the presence of the 
disorder(Nordgaard, Arnfred et al. 2008). 
 
1.4. Criticisms of the Concept of Schizophrenia. 
1.4.1. The very concept of schizophrenia has remained contentious, perhaps 
reaching its zenith with the anti-psychiatry movement of the 1960s. Writers such as 
Thomas Szasz (Szasz 1976; Szasz 1996; Szasz 2008) and R.D. Laing (Laing 1964) 
viewed schizophrenia as a medical fallacy and more a handy sociological construct 
serving relatives and the public rather than the needs of the patient. Laing emphasised the 
role of schizophrenia as a reaction to the demands of modern life and a process that of 
itself served a therapeutic purpose (Laing 1983). Others postulated that many of the 
negative features of the illness are in fact a consequence of being labelled with such a 
stigmatising condition rather than any inherent facet of the disorder itself. 
 
1.5. Symptoms and Signs: How is Schizophrenia Clinically Defined? 
1.5.1. Positive Symptoms 
1.5.1.1. One of the commonest symptoms (Sartorius, Shapiro et al. 1974) in 
schizophrenia is hearing sounds or voices, ‘auditory hallucinations’ . A hallucination is 
defined as a perception without a stimulus causing it (Oyebode 2008). Hallucinations 
can occur in any sensory modality though in schizophrenia they are usually auditory. 
Very often the voices are experienced as personally critical or abusive (Nayani and 
David 1996). 
1.5.1.2. The other major group of positive symptoms are unusual beliefs or 
‘delusions’. A delusion is a fixedly held, usually false belief not shared by others from 
the patient’s cultural or social group. The core facet of a delusion is that it is a belief 
held onto rigidly but without evidence to support it or in the face of evidence to the 
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contrary. Delusions often develop along very personal themes in schizophrenia, such as 
persecution, the patient may believe that they are the victim of some form of threat or 
conspiracy, or of passivity, that their thoughts or actions are being controlled by an 
external force, though they can develop along any theme, for instance grandiose, sexual, 
or religious. 
1.5.1.3. Many patients also develop ’thought disorder’ manifesting as distorted or 
illogical speech due to a failure to generate and use language in a logical and coherent 
fashion. It is typified by a variety of descriptive medical signs including loosening of 
associations, derailment, tangentiality and knights-move thinking. 
 
1.5.2. Negative Symptoms. 
1.5.2.1. ‘Negative symptoms’ such as social withdrawal, self-neglect, loss of 
motivation and initiative, emotional blunting and paucity of speech may seem less 
troubling to the patient, but often cause families and carers the most distress. 
 
1.5.3. Cognitive Deficits. 
1.5.3.1. While not a diagnostic feature of the illness it has been recognised for some 
time that the majority of patients with schizophrenia experience a variety of cognitive or 
intellectual difficulties (Reichenberg and Harvey 2007). These range from impaired 
intelligence to quite specific deficits in for example working memory and executive 
function. These deficits are often not immediately apparent and their impact on daily 
living skills or the suitability of psychological or occupational therapy programmes such 
as cognitive behavioural therapy, can be easily underestimated. 
 
1.5.4. Clinical Subtypes of Schizophrenia 
1.5.4.1. Psychiatrists have traditionally recognised several subtypes of schizophrenia 
depending upon the balance of symptoms present. ‘Paranoid’ schizophrenia is typified 
by the presence of prominent positive symptoms specifically delusions or hallucinations 
often accompanied by fears of persecution, while the ‘Hebephrenic’ subtype is typified 
by a flattened or incongruous mood, a lack of goal directed behaviour and prominent 
thought disorder. ‘Catatonic’ schizophrenia, now rarely seen in the West is 
characterised by sustained evidence of abnormal motor behaviour including stupor, 
excitement, posturing or rigidity. Finally ‘Simple’ schizophrenia was said to be 
associated with a significant loss of personal drive, progressive deepening of negative 




1.5.5. Operationalised Diagnosis of Schizophrenia. 
1.5.5.1. Two similar international systems are in use to standardise the diagnostic 
criteria of schizophrenia. 
1.5.5.2. The International Statistical Classification of Diseases and Related Health 
Problems Tenth Revision http://www.who.int/classifications/icd/en/ (World Health 
Organisation, Geneva (1993)). Its diagnostic criteria for schizophrenia are: 
1.5.5.2.1. At least one of the following present most of the time for a month: 
• Thought echo, insertion or withdrawal, or thought broadcast; 
• Delusions of control referred to body parts, actions or sensations; 
• Delusional perception; 
• Hallucinatory voices giving a running commentary or discussing the patient or coming 
from some part of the body; 
• Persistent bizarre or culturally inappropriate delusions 
1.5.5.2.2. Or at least two of the following present most of the time for a month 
• Persistent daily hallucinations accompanied by delusions 
• Incoherent or irrelevant speech 
• Catatonic behaviour such as stupor or posturing 
• Negative symptoms such as marked apathy blunted or incongruous mood 
1.5.5.3. The Diagnostic and Statistical Manual Fourth Revision 
[http://www.dsmivtr.org/ DSM-IV] (American Psychiatric Association) criteria for 
schizophrenia are: 
1.5.5.3.1. Two or more of the following characteristic symptoms present for a 
significant portion of the time for a month 
• Delusions 
• Hallucinations 
• Disorganised speech 
• Disorganised or catatonic behaviour 
• Negative symptoms 
• Social or occupational decline 
1.5.5.3.2. Continuous signs of disturbance for at least six months, but at least one 
month for the symptoms in criterion A unless treated. 
1.5.5.4. By way of contrast, the most commonly reported symptoms of schizophrenia 
are (Sartorius, Shapiro et al. 1974): 
• Lack of insight   97% 
• Auditory hallucinations  74% 
• Ideas of reference   70% 
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• Delusions of reference  67% 
• Suspiciousness   66% 
• Flatness of affect   66% 
• Delusional mood   64% 
• Delusions of persecution  64% 
• Thought alienation   52% 
• Thoughts spoken aloud  50% 
 
1.6. Epidemiology & Risk Factors for Schizophrenia. 
1.6.1. In spite of schizophrenia’s relatively low incidence (15.2 per 
100,000)(McGrath, Saha et al. 2004), its prevalence is relatively high (7.2 per 
1000)(Saha, Chant et al. 2005), reflecting its tendency to start early in adult life and 
become chronic. 
1.6.2. Schizophrenia typically presents in early adulthood and is rare in 
childhood(McGrath, Saha et al. 2004). Men are at modestly greater risk of the disorder, 
have an earlier age of onset than women, and also tend to experience a more severe form 
of the illness with more negative symptoms, less chance of a full recovery, and a 
generally worse outcome (Jablensky 2000). Studies have also shown that it is more 
common in those born in cities, and that the larger the city and the longer the person has 
lived there, the greater the risk (Pedersen and Mortensen 2001). It seems to be more 
common in migrants (McGrath 2006; Selten, Blom et al. 2008) despite cultural 
considerations, though this remains contentious(Selten and Cantor-Graae 2010; Zandi, 
Havenaar et al. 2010). Some of the most dramatic increases are seen in African and 
Caribbean people living in the United Kingdom, whose rates are up to 6 times those of 
the native white population (Fearon, Kirkbride et al. 2006). The rates remain elevated in 
the children of migrants, but are not reflected in increased rates in their home country 
(Mahy, Mallett et al. 1999). Environmental and social factors have been particularly 
implicated in this increased risk, acting through racism and loss of social and family 
support(Veling, Selten et al. 2007). The risk of schizophrenia in migrants is greatest 
when they represent a smaller proportion of their local community (Boydell, van Os et al. 
2004; Veling, Susser et al. 2008). 
 
1.7. The Causes of Schizophrenia: Genetic and Environmental Factors. 
1.7.1. Genetics. 
1.7.1.1. Schizophrenia is an aetiologically complex clinical disorder. Its single 
greatest risk factor is a positive family history(Waddington, Corvin et al. 2007). While 
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the lifetime risk in the general population in just below 1%, it is 6.5% in the first-degree 
relatives of patients (Kendler, McGuire et al. 1993), and rises to over 40% in the 
monozygotic (genetically identical) co-twins of affected patients(Cardno, Marshall et al. 
1999). This pattern suggests a link between the genetic proximity of the relative and 
patient and the risk of developing the illness (Figure 1.1). Furthermore a small but 
landmark study has suggested that the risk is transmitted equally to the offspring of the 
well and ill twins from monozygotic discordant pairs, in a manner independent of 
whether the parent was affected by the illness or not (Fischer 1971). 
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Lifetime risk of developing schizophrenia and relationship to proband. 
Adapted from: Gottesman II. Schizophrenia Genesis. New York: WH Freeman and 
Company, 1991. 
 
1.7.1.2. After many years of failure and a multitude of studies, there has been some 
recent success identifying genes that increase the risk for schizophrenia. In 2002, an 
Icelandic group identified a haplotype in the Neuregulin 1 (NRG1) gene (Stefansson, 
Sigurdsson et al. 2002) which appeared to double the risk of illness, a result later 
replicated in Scotland and Wales, South Africa and China. Other susceptibility genes 
that have recently emerged include Dysbindin (DTNBP1)(Williams, Preece et al. 2004; 
Bray, Preece et al. 2005), and DISC1(Porteous, Thomson et al. 2006). 
1.7.1.3. It is generally believed that there are many risk genes each of small effect and 
each relatively common in the general population(Straub and Weinberger 2006; 
Tandon, Keshavan et al. 2008). Patients probably inherit several risk genes which 
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interact with each other and the environment to cause schizophrenia once a critical 
liability threshold has been crossed. In contrast, Crow (Crow 2000) has proposed a 
genetic model based on a single genetic mutation directly linked to the speciation event 
that gave rise to Homo Sapiens, cerebral asymmetry and our capacity for language. 
 
1.7.2. The Environment. 
1.7.2.1. While concordance rates (the likelihood that both twins are affected) 
approach 50% in monozygotic twins the fact that they are not 100% implicates 
environmental factors. A meta analysis has shown that patients with schizophrenia are 
more likely to have experienced obstetric complications, in particular premature birth, 
low birth weight and perinatal hypoxia (Canon, Jones et al. 2002). They are also more 
likely to have been born in late winter and early spring, possibly reflecting intra-uterine 
viral exposure. These early environmental hazards could act to subtly deviate early brain 
development. 
1.7.2.2. In adulthood different environmental stressors act; associations are seen with 
social isolation, migrant status, substance misuse and urban life(Boydell, van Os et al. 
2004), this remains the case even when life events attributable to the incipient psychosis 
itself are excluded. 
1.7.2.3. Historically certain parenting styles were considered to increase the risk of 
the illness in children(Frommreichmann 1954; Cheek 1964), however it seems that the 
way parents raise their children does not have a major impact on future vulnerability. 
However families do have an important role to play in the course of the illness once it 
develops(Goulding, Leiner et al. 2008; Seeman 2009); patients with supportive parents 
have fewer and less severe relapses than those with critical or hostile relatives. 
1.7.2.4. Stimulants like cocaine and amphetamines are capable of inducing a picture 
clinically identical to paranoid schizophrenia, and more recent reports have also 
implicated cannabis. There is overwhelming evidence that patients with established 
schizophrenia smoke more cannabis than the general population. Now, well conducted 
cohort studies like that from Dunedin in New Zealand (Arseneault, Cannon et al. 2002) 
specifically indicate that early cannabis use, long predating the psychotic symptoms, 
increases the future risk of schizophrenia four fold while a meta-analysis of prospective 
studies reported a doubling of this risk. This effect is robust, even after controlling for 
any self medication effect, undermining the suggestion that this early cannabis use is 
primarily an attempt to alleviate anxiety or distress actually caused by the developing 
illness (Henquet, Murray et al. 2005). Of course, only a small proportion of people who 
use cannabis develop schizophrenia, just as only a proportion of those who misuse 
alcohol develop cirrhosis. This probably reflects a genetically determined vulnerability 
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to the environmental agent. Indeed, there have been suggestions that variations in the 
dopamine metabolising COMT gene influence the vulnerability to develop psychosis in 
people who use cannabis (Caspi, Moffitt et al. 2005). 
1.7.2.5. Collectively these risk factors point to an interaction between biological, 
psychological and social risk factors driving increasingly deviant development and 
finally frank psychosis (Howes, McDonald et al. 2004; Broome, Wooley et al. 2005). 
 
1.8. Endophenotypes 
1.8.1. Notwithstanding the observations in 1.7.1.2, and that the effects of some 
genes have been successfully replicated, and that with the advent of new genetic and 
statistical methods new risk variants are being discovered(O'Donovan, Craddock et al. 
2008; Stefansson, Ophoff et al. 2009) most genetic results remain inconsistent and with 
very small effect sizes(Sklar 2002). One possible explanation for this inconsistency is 
that the genetic studies have relied on the clinical description of the disorder to define 
their phenotype, a methodology that may be imperfect for several reasons. Firstly it is 
clear that even deploying operationalised criteria, the diagnostic margins for 
schizophrenia are both indistinct and unstable over time (Baca-Garcia, Perez-Rodriguez 
et al. 2007; Jakobsen, Hansen et al. 2007). Secondly the disorder or syndrome is likely to 
encompass considerable genetic aetiological and pathophysiological 
heterogeneity(Craddock, O'Donovan et al. 2007; McClellan, Susser et al. 2007). Thirdly 
the clinical phenotype is in all probability far removed from the genetic effects that 
underpin it (Kendler and Neale 2010). One research strategy to address these concerns is 
to identify and use endophenotypes for clinical schizophrenia, which is in this case the 
exophenotype. 
1.8.2. Endophenotypes are quantitative traits that are hypothesised to lie somewhere 
on the pathophysiological pathway between genes and illness. By virtue of their 
quantitative nature they avoid the dichotomy of diagnostic categorisation and 
hypothetically lie closer to the genetic effects than the disorder they index. Ideally, and 
hypothetically, they should both be aetiologically less complex and more straight forward 
to measure, though in practice this may not be the case (Prasad and Keshavan 2008). 
1.8.3. Two widely accepted and largely complimentary ‘definitions’ are given 
below. 
1.8.3.1. That an endophenotype is (Gottesman and Gould 2003): 
• associated with the illness in the population 
• heritable 
• primarily state independent 
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• co-segregates in families 
• found in unaffected family members at a higher rate than the general population 
1.8.3.2. An intermediate phenotype (often loosely referred to as an endophenotype) 
is: (Preston and Weinberger 2005) 
• a quantitative biological trait that is reliable and reasonably heritable 
• associated with variant alleles that distinguish patients and their unaffected siblings from 
healthy controls on quantitative measures 
• reflect a less complex genetic architecture than the disorder 
1.8.4. The two terms endophenotype and intermediate phenotype are often used 
interchangeably. This is in part a product of the relative lack of agreement about the 
precise definition of the terms and indeed the concept as a whole (see 7.3). To be precise 
an endophenotype should be reserved for a heritable trait that is not manifestly expressed, 
it is a mechanistically neutral term, implying no specific link between genes and 
disorder(Walters and Craddock 2007). By way of contrast an intermediate phenotype is 
also a heritable trait but with an implied position on the pathophysiological pathway 
between genes and illness. As will be shown in the course of this thesis the evidence to 
support this key function of an intermediate phenotype, while desirable, is hard to 
establish, and thus I will continue to use the more neutral term endophenotype. 
1.8.5. An assumption on the endopheotype approach is that the underlying genetic 
architecture of the endophenotype is less complex that the exophenotype. This too is 
based on the assumption that the exophenotype is the expression of neural dysfunction in 
numerous systems, each summarizing the influence of multiple genetic and 
environmental influences (Gottesman and Gould 2003; Cannon and Keller 2006). The 
task then is to break down the disorder into its constituent parts, or endophenotypes, that 





Levels of the phenotypic effect from genes to disorder. Candidate endophenotypes can 
exist at any level indicated. Adapted from Cannon and Keller, 2006. 
 
1.8.6. The primary method used to establish a candidate marker’s endophenotypic 
credentials is the family-study design. In this method patients and their unaffected 
relatives are contrasted with healthy control subjects to establish that a marker is 
associated with the disorder, is state independent and is detected at increased rates in the 
unaffected relatives. While in general the latter is interpreted as evidence of a genetic 
effect, in fact common environmental factors, shared within families can confound this 
interpretation. While adoption studies can address this point, in practice the twin method 
offers the best solution. 
1.9. It will be against these endophenotype criteria, particularly those of Gottesman and 
Gould that I propose to assess four selected candidate markers for schizophrenia in the 
Maudsely Twin and Family Study of schizophrenia. The selected markers are firstly 
neurological soft signs, secondly childhood social development and schizotypal 
personality traits, thirdly brain volume and finally neural function induced by verbal 
















2. A Selective Review of Twin Studies in Schizophrenia 
 
2.1. Introduction. 
2.1.1. Perhaps one of the few areas of agreement between proponents of the 
biological and psychodynamic origins of schizophrenia, is that its roots lie within the 
family (Rosenthal 1960). Indeed Kraepelin’s earliest observations of abnormalities in 
patients’ unaffected relatives (Kraepelin 1899) suggested a familial component to this 
disorder that has only grown in influence. 
2.1.2. Familiality however can arise from common (shared within the family) 
environmental factors, as much as genetic causes. Studies of unaffected relatives alone 
can not separate these influences. Twin studies offer the only experimental design to 
separate and quantify genetic from common and unique environmental influences acting 
on a complex trait. To achieve this and make the most of that opportunity, twin studies 
should adopt specific statistical techniques and recruit adequately powered samples, two 
common failings of twin studies in schizophrenia in the past. 
2.1.3. This review will explore the nature of twin birth and selectively summarise 
the results of the twin literature in schizophrenia. I will attempt to highlight where the 
findings are particularly relevant to the question of endophenotype criteria. 
2.1.4. I searched Web of Science and Medline using the terms ‘Twin*’, ‘Twins’, 
‘Multiple birth’, ‘Schizo*’ and ‘Schizophrenia’. I tried to access paper copies of papers if 
they were not available on-line and cross referenced citations as necessary. 
 
2.2. Twin Birth 
2.2.1. Twins are the commonest form of multiple births in humans. They are 
classified as monozygotic (MZ) and dizygotic (DZ), with implied differences in their 
degree of genetic similarity. The rates of live twin births, both for MZ and DZ twins have 
increased steadily over the last forty years (Bressers, Eriksson et al. 1987; Imaizumi 
2003; Chauhan, Scardo et al. 2010). 
2.2.2. DZ twins arise when two fertilised ova implant during a single menstrual 
cycle. The twins develop in the same pregnancy, but are no more genetically alike than 
any other sibling pair; thus genetically determined characteristics will vary in DZ pairs in 
a normal family wise fashion. DZ twins in general, but not exclusively, develop 
independent chorionic tissues (Fig 2.1), and can experience quite different intra-uterine 
environments (Denbow and Fisk 1996; Suzuki 2009). Dizygotic twinning rates vary 
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geographically, seasonally, with maternal age and with family history (Chauhan, Scardo 




The relationship between zygosity and chorionicity 
Reprinted from: Denbow, M. L. and N. M. Fisk (1996). "Chorionicity and twins." Current 
Obstetrics and Gynaecology 6: 212-219. With permission of Elsevier 
 
2.2.3. MZ twins arise from a single zygote and so share the same genome, as a 
consequence they tend towards concordance for genetically determined characteristics. 
The point in gestation at which MZ twinning occurs will determine the degree to which 
these twins share chorionic and amniotic tissues (Hall 1996) (Fig 2.2). Critically however 
this does not imply that such twins necessarily share common intra-uterine environments. 
The clearest example of this is twin-to-twin transfusion syndrome. In this disorder MZ 
twins, despite, and indeed because, they share a common chorion, can develop vascular 
anastomses between the two embryonic circulations (Machin, Still et al. 1996; Machin 
1996) (Fig 2.2). This leads to one twin being relatively starved of it’s vascular supply, 
while the co-twin is over supplied (Fig 2.3). Both are pathological but ‘opposite’ states, 
and act as sources of gross phenotypic discordance (Machin 1996; Slaghekke, Kist et al. 





The aetiology of monozygotic twins and their relationship with extra-embryonic 
membranes. 
A Split occurs during the late cleavage stage, giving rise to two genetically identical 
blastocysts. The two embryos each possess a distinct placenta, amniotic cavity and 
chorionic cavity (dichorionic and diamniotic). 
B Splitting of the embryo occurs after implantation, the embryo possesses two distinct 
inner cell masses. The two embryos share a common placenta, a common chorionic cavity,  
but have separate amniotic cavities (monochorionic and diamniotic). 
C Splitting of the embryo occurs at or shortly before the primitive streak stage. The 
embryos share a common placenta, a common chorionic cavity and a common amniotic 
cavity (monochorionic and monoamniotic). 
With kind permission from Springer Science+Business Media: Childs Nerv Syst, The 
embyology of conjoined twins , 20, 2004, 508–525, M.H. Kaufman, figure 1, Originally 






The physiological basis of twin-to-twin transfusion syndrome. 
A shift in the watershed area between twins within an arterio-arterial anastomosis. It 
results in the creation of a deep arterio-venous anastomosis. 
(Reproduced with permission from Multiple Pregnancy (Eds Humphry ward and Martin 
whittle) published by RCOG Press, 1995. Reprinted from: Denbow, M. L. and N. M. Fisk 
(1996). "Chorionicity and twins." Current Obstetrics and Gynaecology 6: 212-219. With 
permission of Elsevier 
 
2.2.4. The later in gestation that MZ twinning occurs, so the probability of tissue 
‘sharing’ between the two twins increases. The extreme event being a persistent somatic 
connection between the twins and the phenomenon of conjoining (Kulkarni, Sureshkumar 
et al. 1994; Kaufman 2004; Spitz 2005). 
2.2.5. MZ twinning is an almost uniquely human event and its aetiology is 
unknown. It is possible that genetic mechanisms, for instance skewed X inactivation 
(Hall 1996) may be a possible source of the female excess. The lack however of any 
familial aggregation for MZ twinning suggests that environmental events are more 
influential (Kaufman 2004). For example the recent increase in MZ twinning rates has 
been attributed to the increased use of oral contraceptives and assisted conception 
techniques, while increasing survival figures reflect improvements in obstetric and 
neonatal care (Chauhan, Scardo et al. 2010). 
2.2.6. DZ twinning, and other higher order multiple births, have increased even 
more dramatically over the same period (Chauhan, Scardo et al. 2010). This increase is 
principally due to the increased availability and success of assisted conception 
techniques, particularly hormone induction of ovulation, however other factors such as 
increasing parental age at conception (Raschka 2000; Malaspina, Harlap et al. 2001), and 
the increased use of hormonal contraception have probably also played a role. 
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2.3. Does the Environment Respond to or Create Similarities in Twins? 
2.3.1. A core assumption of twin studies is that aetiologically significant 
environmental factors will not vary systematically between MZ and DZ twins (Plomin, 
DeFries et al. 1997). The Equal Environments Assumption (EEA) has both its supporters 
(Kendler, Neale et al. 1993), and detractors (Joseph 1998). If invalid, then any 
differences in similarity between MZ and DZ twins cannot be attributed to genetic factors 
alone. While studies comparing the environmental experiences of MZ and DZ twins have 
reached a broad consensus in terms of their results the interpretations still differ. 
2.3.2. The environmental experiences of MZ twins are more similar than DZtwins. 
Parents report that their MZ twins are more alike on personality and behaviour scores 
than DZ twins (Jones 1955; Scarr 1968); thus their environment perceives, and indeed 
expects, them to be more similar. This distinction though is maintained even when 
parents are mistaken in their assessment of their own twins zygosity, and is consistent 
with the twins true zygosity. 
2.3.3. Subjective and objective ratings of social characteristics and experiences are 
more similar for MZ compared to DZ adolescent twins (Horwitz, Videon et al. 2003). 
However parental reports of behavioural, cognitive and personality similarities do not 
correlate with measures of the twins’ physical similarity (Matheny, Wilson et al. 1976; 
Plomin, Willerman et al. 1976). Furthermore while parental treatment of MZ twins is 
more similar than DZ twins (Lytton 1977; Kendler, Neale et al. 1994), it has been 
interpreted as principally determined by behaviours initiated by the twins themselves 
rather than by their parents. The possible implication of this is that the environmental 
response is actually an expression of the twins underlying genotype (Scarr and 
McCartney 1983; Scarr 1996). 
2.3.4. Several studies have explored the correlation between perceived zygosity 
(Kendler, Neale et al. 1993; Kendler, Neale et al. 1994), physical similarity (Hettema, 
Neale et al. 1995), and social treatment (Morris Yates, Andrews et al. 1990) and 
phenotypic concordance for major psychiatric illnesses. There was no evidence of a 
relationship. 
2.3.5. Thus while the available evidence shows that the social environment for MZ 
twins is more similar than DZs, the EEA can not be rejected as this environmental 
similarity appears itself to be a function of the shared genotype of MZ pairs (Lykken, 
McGue et al. 1990; Plomin and Bergeman 1991; Plomin and Bergeman 1991; Eaves, 





2.4. MZ Twins: Genetically Similar but Different 
2.4.1. The core assumption that MZ twins are genetically identical and that any 
within pair phenotypic differences can not be genetic in origin is a simplification, at least 
for some twins (Phillips 1993; Machin 1996; Gringras and Chen 2001; Zwijnenburg, 
Meijers-Heijboer et al. 2010). There are many examples of genetic discordance in MZ 
twins. The timing of MZ twinning can influence the degree of chorionic and somatic 
sharing between MZ twins (2.2.3). Equally the timing of the twinning event can influence 
the allocation of blastomeres and genetic material between the two developing embryos. 
These twins will only remain genetically identical if post zygotic genetic, and epi-genetic 
factors are equal. 
2.4.2. MZ twins can differ in their karyotype (Nieuwint, Van Zalen-Sprock et al. 
1999), most clearly illustrated by MZ twins discordant for trisomy 21, Down’s 
Syndrome, (Rogers, Voullaire et al. 1982) and Turner’s Syndrome, (Uchida, Desa et al. 
1983). Further chromosomal differences can occur through chimerism; the presence of 
genetic material in one individual originating from two. The origins for this lie in the 
vascular anastomoses between monochorionic MZ twins, which allow stem cell transfer 
in utero between twins. This also suggests that twin genotyping using non-blood tissue 
will produce the most accurate uncontaminated results. 
2.4.3. While genomic determinism is established at conception, genes are unstable 
throughout life (Petronis, Vincent et al. 1998). This instability can be expressed at a 
molecular level, with changes in DNA structure, for instance MZ twins discordant for 
Fragile X,(Kruyer, Mila et al. 1994), or with epigenetic changes (Petronis and Kennedy 
1995; Petronis, Paterson et al. 1999), through alterations in methylation status (Kruyer, 
Mila et al. 1994; Singh, Murphy et al. 2002), and skewed X inactivation (Orstavik, 
Tommerup et al. 1995). 
2.4.4. Few studies have examined this genetic ‘instability’ as a potential source of 
phenotypic discordance for schizophrenia within MZ twins and consequently what little 
data there is is mixed, reflecting the variety of techniques used and the genetic 
heterogeneity within the small samples studied. 
2.4.5. McDonald (McDonald, Lewis et al. 2003), found no evidence of either 
genomic or epigenetic discordance in a phenotypically discordant MZ twin pair, while 
Tsujita (Tsujita, Niikawa et al. 1998), detected differences in genomic DNA within one 
MZ discordant pair, and attributed this to a mutation in the genomic sequence or 
methylation status. Friedhoff (Friedhoff, Miller et al. 1995), used subtractive 
hybridisation to identify novel DNA sequences expressed in one member of an MZ 
discordant pair. The authors later reported an attempt at validation, detecting the 
expression of one of the clones in rat cortex and hippocampus, though could not then 
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replicate their own finding (Zumarraga, Andia et al. 2004). In a similar study, Deb-
Rinker et al (Deb-Rinker, Klempan et al. 1999) identified differences in retro-viral 
related mammalian specific sequences between members of three MZ pairs discordant for 
schizophrenia and concluded that these sequences, principally expressed in placental 
tissue, could act as sources of future phenotypic discordance. Vincent et al (Vincent, 
Kalsi et al. 1998) found evidence of trinucleotide expansion, a possible mechanism of 
genetic instability, in concordant MZ pairs but not in discordant pairs. In the largest study 
of its type Nguyen (Lavrentieva, Broude et al. 1999; Nguyen, Bouchard et al. 2003) 
explored peak similarity scores in MZ discordant and concordant pairs and healthy 
controls, reporting reduced similarity in the phenotypically discordant pairs, while 
Polymeropoloulos (Polymeropoulos, Xiao et al. 1993) detected no differences in five MZ 
discordant pairs. 
 
2.5. Twin Studies of the Heritability of Schizophrenia 
2.5.1. Twin studies can only be more widely informative about schizophrenia if 
twins are not themselves at inherently greater risk of developing the disorder (Jackson 
1960; Lidz, Schafer et al. 1962). The majority of studies have found no evidence of this 
for schizophrenia (Rosenthal 1960; Tienari 1963; Kringlen 1967; Allen and Pollin 1970; 
Hoffer and Pollin 1970; Nathan and Guttman 1984; Sirugo, Ashenbrenner et al. 2004). 
However two large national surveys (Klaning, Mortensen et al. 1996; Klaning 1999) did 
report an increased risk of schizophrenia in DZ twins specifically. Hypothetical 
explanations for this link have included shared genetic factors, driving both DZ twinning 
and schizophrenia, though competing hypotheses suggest obstetric complications (Lewis 
1996) and increasing parental age could link the two (Crow 1999; Malaspina, Harlap et 
al. 2001). 
2.5.2. Concordance and Heritability 
2.5.2.1. Sullivan (Sullivan, Kendler et al. 2003) in a recent meta-analysis of the 12 
independent twin studies in schizophrenia, highlighted their methodological 
heterogeneity, but was still able to report a heritability estimate of over 80% for 
schizophrenia. They proposed that the most important aetiological influences were 
additive genetic and, more contentiously, common environmental factors. By way of 
contrast, two single centre but national studies, used the systematic Finnish twin 
cohortand the consecutive Maudsley Twin series (Cannon, Kaprio et al. 1998; Cardno, 
Marshall et al. 1999) and concluded that the most parsimonious, and indeed more 
widely accepted aetiological model incorporated principally genetic and unique 
environmental effects. 
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2.5.2.2. The heterogeneity of the old twin studies may in part reflect their 
methodological differences. They recruited differently, varying from national 
population surveys, to studies of psychiatric inpatients, to US Army recruits, each 
population with their own biases and morbidity levels (Sadrzadeh, Treloar et al. 2001). 
The diagnostic criteria the studies applied also varied conspicuously, with a potential 
impact on concordance rates both for schizophrenia (McGuffin, Farmer et al. 1984; 
Farmer, McGuffin et al. 1987; Franzek and Beckmann 1998) and other disorders (Gatz, 
Pedersen et al. 2000). 
2.5.2.3. Thus ‘how’ the studies defined schizophrenia had an impact on detected 
concordance rates. Of phenomenological schizophrenia subtypes, the hebephrenic and 
‘non-paranoid’ subtypes show the greatest genetic influences (Farmer, McGuffin et al. 
1984; McGuffin, Farmer et al. 1987; Onstad, Skre et al. 1991; Cardno, Sham et al. 
2001) and the strongest tendency to ‘breed true’, while prototypical Schneiderian 
schizophrenia (Cardno, Sham et al. 2002) has the lowest heritability and poorly predicts 
the risk of psychosis in patients’ relatives. Crucially, Cardno (Cardno, Sham et al. 2001; 
Cardno, Rijsdijk et al. 2002) was able to challenge the Kraepelinian dichotomy, in the 
national Maudsley Twin Series, a study of consecutive admissions to that hospital. The 
authors reported, for the first time, that schizophrenia, schizoaffective disorder and 
mania share genetic risk, and noted again that diagnostic criteria influenced 
concordance rates. They also concluded that the disorganised dimension, analogous to 
schizophrenia’s hebephrenic subtype, was the most genetically determined, with little 
evidence of a genetic contribution to the positive symptom dimension as a whole. 
2.5.3. What are the Other ‘Determinants’ of Concordance for Schizophrenia? 
2.5.3.1. Few studies have reliably identified what subject characteristics, other than 
zygosity and diagnostic criteria (Kringlen 1967; Kendler and Robinette 1983) influence 
concordance rates. Rosenthal’s (Rosenthal 1959) reanalysis of Slater’s original twin 
data (Slater 1953) suggested concordant pairs were more likely to come from multiply 
affected families, and speculated that concordant pairs had received a greater genetic 
load. This hypothesis lead others to suggest that discordant pairs actually harboured 
very little genetic risk (Luxenburger 1940). However the experimental data to address 
this is restricted to evidence that MZ discordant pairs are subject to greater 
environmental stress in the form of obstetric complications (Cantor-Graae, McNeil et al. 
1994; Cantor-Graae, McNeil et al. 1994; Van Oel and Kahn 1997; Kunugi, Tsukue et al. 
1999; Van Oel, Baare et al. 1999). Arguing against this point, there is no evidence that 
the offspring of discordant twins, whether from the patient or the unaffected co-twin, 
were at any less risk of developing schizophrenia than their concordant counterparts 
Kringlen (Kringlen and Cramer 1989). 
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2.5.3.2. There is some data to suggest that concordant pairs develop schizophrenia at 
a younger age, with age at onset highly correlated within pairs (Allan, Cardno et al. 
2009). They ,may have a more extreme symptom profile, reflecting a more severe form 
of the illness, though these findings are inconsistent (Slater 1953; Kringlen 1967; 
Fischer 1973; McGuffin, Asherson et al. 1994; Allan, Cardno et al. 2009). Finally it is 
possible that male gender might inflate concordance rates (Kringlen 1967; Samuels 
1978; Samuels 1979). 
 
2.6. Is the Familial Risk for Schizophrenia Specific? 
2.6.1. While twin and family studies suggest that an individual’s proximity to the 
proband determines their risk of developing schizophrenia, it remains to be seen whether 
this risk can manifest itself in other non-schizophrenia spectrum disorders. A question 
formalised as whether the genetic risk for schizophrenia leads to an increased liability to 
(Kendler and Diehl 1993): 
• schizophrenia alone 
• schizophrenia and all schizophrenia spectrum disorders 
• all non-affective psychoses 
• a broad liability to all psychiatric illness 
2.6.2. Two related reports from the Vietnam Era Twin Registry (Lyons, Toomey et 
al. 1997; Lyons, Bar et al. 2002) have shown that schizophrenia is associated with a 
greater risk of affective and anxiety disorders in probands, but that this does not extend to 
their well co-twins, in contrast to nicotine dependence which did. 
2.6.3. DiLalla (Dilalla and Gottesman 1995), in a highly selected discordant twin 
sample reported normal personality development in the well co-twins. 
2.6.4. By contrast many other studies have demonstrated increased rates of 
personality disorder (Kendler and Robinette 1983; Torgersen, Onstad et al. 1993), 
abnormal communication styles (Docherty and Gottesman 2000), anxiety symptoms 
(Kendler and Robinette 1983; Torgersen, Onstad et al. 1993; Argyropoulos, Landau et al. 
2008), and affective disorders (Argyropoulos, Landau et al. 2008), in the well co-twins of 
discordant MZ pairs, with some evidence of a risk gradient between MZ and DZ co-twins 
(Kendler and Robinette 1983). This if true, suggests that the familial risk for 
schizophrenia increases risk to a broad spectrum of other psychopathology in ‘unaffected 
family members’. This observation is consistent with the current concept of the At Risk 
Mental State (Yung, Phillips et al. 1998; Phillips, Yung et al. 2002; Yung, Phillips et al. 
2004; Nelson, Yung et al. 2008) and the often very non-specific early psychiatric 
presentation of psychosis and schizophrenia. Finally Reichenberg (Reichenberg, Weiser 
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et al. 1999; Reichenberg, Rabinowitz et al. 2000), in a unique but small sample assessed 
behavioural and psychological functioning in adolescent MZ twins, before one twin later 
developed schizophrenia. They detected the greatest deficits in the future probands, but 
noted that the well co-twins expressed deficits in social functioning, well in advance of 
their co-twin ever being ill. 
2.6.5. Thus it seems that the schizophrenia genotype does not exclusively breed 
true. This raises the possibility that some of the familial, and perhaps genetic, risk for 
schizophrenia increases vulnerability to a wider range of psychopathology, while perhaps 
others aspects of the risk are much more specific to the vulnerability for psychosis or 
schizophrenia itself. 
2.6.6. A complimentary research strategy focuses on exploring the vulnerability to 
non-schizophrenia psychopathology in the children of MZ discordant twins. The strength 
of this design is the assumption that the well co-twins represents the ‘purest’ form of 
unaffected obligate carrier, its weakness the limited statistical power of often incredibly 
small samples. Fisher’s landmark study (Fischer 1971), contentiously revisited 
(Gottesman and Bertelsen 1989; Torrey 1990), suggested that well co-twins were indeed 
at high genetic risk, and actively transmitted that risk to their own offspring, which in 
turn bred true. In contrast Kringlen (Kringlen and Cramer 1989), in a larger and 
methodologically superior but still limited study, detected statistically increased rates of 
broadly defined schizophrenia spectrum disorders in probands’ children compared to the 
well co-twins’ children. 
 
2.7. When do Discordant Pairs Diverge? 
2.7.1. Many studies (Arieti 1949; Pollin, Stabenau et al. 1965; Pollin, Stabenau et 
al. 1966; Kringlen 1967; Stabenau and Pollin 1967; Mosher, Pollin et al. 1971; Fischer 
1973; Kunugi, Urushibara et al. 2003) have demonstrated that probands from discordant 
pairs manifest abnormalities of personality and non-psychotic symptomatology in early 
childhood, and well before any psychotic symptoms emerge, with increased levels of 
passivity, dependence and anxiety. These abnormalities are maintained into adult life 
with increased emotionality, labile mood, paranoia and anxiety. 
2.7.2. Fuller Torrey (Fuller Torry, Bowler et al. 1994) has argued that 
developmental discordance is not a uniform phenomenon within MZ discordant twins, 
but rather that a subgroup of MZ discordant pairs diverge relatively early in life, around 
the age of 5, with a second peak of discordance later, and relatively closer to the onset of 
frank psychotic symptoms in the probands. While the early divergent group are 
subsequently no more severely affected by the illness, they do tend to be male, with more 
obvious risk hsitories, though this can be for family history or obstetric complications. In 
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perhaps the most methodologically robust study, van Oel et al retrospectively examined 
adult discordant twins’ school reports. They found that elementary school performance 
differentiated twins who only clinically diverged many years later (van Oel, Baare et al. 
2001). 
 
2.8. Environmental Mechanisms and Measures in Schizophrenia 
2.8.1. Dermatoglyphics 
2.8.1.1. Dermatoglyphic abnormalities hypothetically offer a time sensitive marker of 
ectodermal development. Studies in twins with schizophrenia have tended to be small 
and underpowered. 
2.8.1.2. Bracha (Bracha, Torrey et al. 1991) found evidence of abnormal development 
early in the second trimester of pregnancy in probands with schizophrenia, and 
concluded that this was evidence of an aetiologically important environmental agent 
acting at that developmental stage. All but one of several other studies (Bracha, Torrey 
et al. 1992; Davis and Bracha 1996; van Os, Fananas et al. 1997; van Oel, Baare et al. 
2001; Kelly, Cotter et al. 2004) reported reduced a-b ridge count correlations within 
discordant compared to control pairs, though only two (Davis and Bracha 1996; Kelly, 
Cotter et al. 2004) actually detected greater numbers of abnormalities in the probands 
themselves. Thus they could provided only limited evidence to support their specificity 
for schizophrenia. While the two of these studies that assessed finger ridge fluctuating 
asymmetry (FA) in psychotic twins reached strikingly different conclusions. The failure 
of these studies to detect significant differences between the probands and their well co-
twins appears to undermine their usefulness as an index of aetiologically relevant 
unique environmental insult. 
2.8.1.3. Two studies assessed ridge dissociation in twins, (van Os, Fananas et al. 
1997; Rosa, Fananas et al. 2000), both detected more abnormalities in the patients. 
However one (van Os, Fananas et al. 1997) detected greater rates in concordant 
compared to discordant pairs, while the other (Rosa, Fananas et al. 2000), detected more 
abnormalities in probands compared to their well co-twins in discordant pairs. 
2.8.1.4. The evidence from twin studies of ectodermal development in psychosis is 
thus mixed. There is some dermatoglyphic evidence to suggest the presence of early 
developmental divergence in MZ pairs who later become discordant for schizophrenia, 
and that this divergence may be present from as early as the first 15 weeks of life in 
utero. However the presence of these markers, albeit at attenuated levels in the well co-
twins as well, necessarily undermines their validity as markers of the unique 
environmental insult responsible for schizophrenia. It seems more likely that these 
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markers reflect abnormal ectodermal development in utero, but that they give little 
indication of the underlying aetiology. 
 
2.8.2. Obstetric Complications 
2.8.2.1. Obstetric complications (OCs), in particular perinatal hypoxia, are themselves 
the environmental risk factors. Notwithstanding that they are almost always 
retrospectively assessed, frequently ‘shared’ within twin pairs, and that twins, as with all 
multiple pregnancies are inherently at greater risk of OCs, including prematurity and 
low birth weight (Chauhan, Scardo et al. 2010), several attempts have been made to 
explore their association with schizophrenia in twins. 
2.8.2.2. Early evidence suggested that OCs were over-represented in discordant twins. 
Two small highly selected cohorts (Lewis, Chitkara et al. 1987; Fuller Torry, Bowler et 
al. 1994) detected birth weight discordance in discordant pairs, with the lighter twin 
more likely to develop schizophrenia. Some (McNeil, Cantorgraae et al. 1994; McNeil, 
Cantorgraae et al. 1994) have reported a reducing gradient of peri and neonatal 
complications in MZ discordant through MZ concordant to MZ control pairs. However 
others (Kringlen 1967; Fischer 1973; Onstad, Skre et al. 1992) could not replicate these 
findings, nor detect any evidence of an increased risk of OCs in MZ discordant and 
concordant pairs at all. 
2.8.2.3. Gilmore (Gilmore, Perkins et al. 1996) used ultrasound and reported greater 
mean parietal diameter differences in MZ than DZ pairs, and suggested that 
environmental factors, acting through the placenta had caused divergent brain 
development, in a portion of the MZ twins. The same NIMH sample (Cantor-Graae, 
McNeil et al. 1994) demonstrated an association between early pregnancy complications 
and minor physical anomalies in the MZ discordant group, though these were detected 
both in the probands and the well co-twins. The study also used unvalidated makers of 
chorionicity to suggest that the environmental agent may have been infectious (Davis 
and Phelps 1995; Davis, Phelps et al. 1995). A related study (McNeil, Cantor-Graae et 
al. 2000) explored the link between obstetric complications and brain structure, 
reporting reduced hippocampal volume and increased lateral ventricular volume with 
increased OCs. However this was in the discordant group as a whole, not just the 
patients. It also reported that the length of labour predicted hippocampal volume, and 
raised the suggestion that a complicated delivery, through hypoxia, might cause brain 






2.9.1. More than any other field, with the exception perhaps of structural 
neuroimaging, twin neuropsychological studies have evolved from deficit detection, 
through estimation of their heritability, to the identification and quantification of shared 
genetic risk with schizophrenia, thereby establishing their endophenotypic credentials. 
2.9.2. Goldberg (Goldberg, Ragland et al. 1990; Goldberg, Torrey et al. 1993; 
Goldberg, Torrey et al. 1995) originally reported in the NIMH twins, that probands from 
MZ discordant pairs under-performed compared to their unaffected co-twins on 
vigilance, concept formation, learning and memory. They reported only limited genetic 
effects (Goldberg, Torrey et al. 1995) in executive function, implicating unique 
environmental factors in determining the patients’ deficits in that domain. Subsequently, 
Reichenberg (Reichenberg, Rabinowitz et al. 2000) examined premorbid cognitive 
function in a national twin cohort and detected evidence of familial deficits in some 
aspects of cognition related to schizophrenia. The twins who later developed 
schizophrenia scored worse than controls, with no significant differences in premorbid 
performance within the discordant pairs. 
2.9.3. Two studies contrasted MZ and DZ discordant pairs (Docherty and 
Gottesman 2000; Pardo, Knesevich et al. 2000) on specific cognitive tasks. They reported 
a genetic contribution to perseverative errors (Pardo, Knesevich et al. 2000) and intrusive 
missing information (Docherty and Gottesman 2000), finding evidence for genetic 
effects, with greater deficits in the unaffected co-twins from MZ than DZ pairs. 
2.9.4. Cannon (Cannon, Huttunen et al. 2000) in a large national cohort used a 
structured cognitive battery to establish the heritability of neuro-cognitive deficits in 
schizophrenia. They concluded that spatial working memory, divided attention, intrusions 
during recall and choice reaction time were linked to the genetic load for the illness, and 
that spatial working memory and recall intrusions were genetically determined. In 
contrast, verbal and visual episodic memory, more impaired in the ill than the well MZ 
twins, suggested unique environmental effects. The same group (Johnson, Huttunen et al. 
2003; Johnson, Tuulio-Henriksson et al. 2003) later reported that cognitive function was 
mediated in those at genetic risk by schizotypal traits, and that in the absence of 
schizotypy there were few cognitive deficits. The authors suggested that future genetic 
studies should adopt such a bivariate phenotype. 
2.9.5. Most recently Toulopoulou et al first in a large carefully phenotyped 
psychotic twin series (Toulopoulou, Picchioni et al. 2007), then in an international multi 
site collaboration(Toulopoulou, Goldberg et al. 2010) used full genetic modelling 
techniques to highlight the significant correlation between intelligence and working 
memory, and schizophrenia and most importantly that shared genetic variance accounted 
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for a large proportion of the covariance between the two. Recently selected executive 
function deficits, including verbal fluency performance showed similar results (Owens, 
Rijsdijk et al. In Press). 
2.9.6. Thus twin studies of cognition in schizophrenia have suggested that specific 
cognitive markers may be able to act as sensitive markers of the genetic risk for 
schizophrenia, with particular emphasis on intelligence, working memory and divided 
attention, executive function, intrusions during recall, and choice reaction time to visual 
targets, as the most likely targets for further investigation. 
 
2.10. Neuroimaging 
2.10.1. Whole Brain Volume 
2.10.1.1. Structural imaging studies of twins with schizophrenia have in the main been 
hampered by their relatively small sample sizes and limited statistical power. Only one 
has been sufficiently powered to implement full genetic modelling, and so to tease apart 
genetic and common environmental influences on the structures being investiged. 
2.10.1.2. Two qualitative studies (Suddath, Christison et al. 1990; Noga, Bartley et al. 
1996), used overlapping MZ discordant cohorts, but failed to agree on the presence of 
significant differences between patients and their well co-twins. Two later studies, in the 
same sample (Narr, Cannon et al. 2002; Narr, van Erp et al. 2002), reported no 
differences in intracranial, grey or white matter volume between patients and either their 
healthy co-twins or controls. 
2.10.1.3. In contrast, later larger studies, including up to 15 discordant pairs, have 
shown reduced whole brain volume (WBV) in discordant pairs compared to controls 
(Baare, van Oel et al. 2001; Hulshoff Pol, Brans et al. 2004), and that within these pairs, 
patients had lower WBV than their well co-twins (Noga, Bartley et al. 1996; van Haren, 
Picchioni et al. 2004). These results suggested in the main familial effects, acting 
through genetic or common environmental factors, with less compelling evidence for 
additional unique environmental effects driving further volume loss in the patients. This 
finding was developed further by Rijsdijk et al (Rijsdijk, Van Haren et al. 2005), who 
reported on a large combined Maudsley Family and Twin Schizophrenia sample. The 
authors used genetic model fitting and were able to report firstly that whole brain 
volume in schizophrenia was heritable, but secondly and perhaps more importantly in 
this context, that there was evidence of a significant genetic correlation with 
schizophrenia, thus that the genes that cause or are linked to schizophrenia, also reduce 
whole brain volume. 
2.10.1.4. When grey and white matter volumes are segmented (Hulshoff Pol, Brans et 
al. 2004), white matter reductions were detected in the discordant group as a whole, 
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suggesting genetic or common environmental effects, with the grey matter deficits 
appearing to be more specific to the probands, implying unique environmental effects 
on that tissue class. Intra-class correlation coefficients (ICCs) for whole brain, grey and 
white matter volumes (Baare, van Oel et al. 2001; Narr, Cannon et al. 2002; Hulshoff 
Pol, Brans et al. 2004; van Haren, Picchioni et al. 2004) have been consistently greater 
in MZ compared to DZ twins, surprisingly irrespective of their concordance for 
schizophrenia, and consistent with the data from healthy control twins, that prominent 
genetic effects act on all these volumes. 
2.10.1.5. The most sophisticated image analysis methods applied so far to cortical grey 
matter in discordant twins (Cannon, Thompson et al. 2002) used a novel mapping 
algorithm to produce estimates of the location and magnitude of illness/unshared 
environmental and genetically driven deficits over the entire cortical surface in 
schizophrenia. Non-genetic effects were found particularly in the dorso-lateral 
prefrontal cortex, superior and middle temporal gyrus, parietal association and motor 
cortex, with contrast genetic effects particularly localised to a region in frontal cortex. 
2.10.1.6. Brans et al (Brans, Van Haren et al. 2007) utilised a twin modelling approach 
in a unique longitudinal study that rescanned many of the original Utrecht twins (Baare, 
van Oel et al. 2001), approximately five years after their original scan. This rigorous 
approach has resulted in the only MRI follow up study in twins in schizophrenia and 
suggested that accelerated loss of brain volume was a feature both of schizophrenia and 
its genetic risk, and that the genetic correlation, for example with loss of whole brain 
volume, was over 60%. 
2.10.1.7. Taken as a whole, the majority of these results strongly suggest that brain 
volumes in health and in schizophrenia are highly heritable. Furthermore that familial 
mechanisms, central to schizophrenia have an impact reducing total cerebral, grey and 
possibly white matter volumes. More contentiously these factors, again acting through 
genetic risk, then contribute to accelerated loss of tissue volume over the lifespan. 
 
2.10.2. Region Of Interest 
2.10.2.1. Region of interest studies can help to address the anatomical specificity of the 
global tissue loss described above. 
2.10.2.2. In MZ discordant twin pairs, lateral ventricular volume is greater in patients 
than their healthy co-twins, controls (Reveley, Reveley et al. 1982; Reveley, Reveley et 
al. 1984; Ohara, Xu et al. 1998), and more tentatively than patients from concordant 
pairs, (van Haren, Picchioni et al. 2004), suggesting a greater sensitivity to 
environmental insult in the patients from those pairs. However Styner et al (Styner, 
Lieberman et al. 2005) have shown that despite the presence of the illness, lateral 
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ventricular volume and shape can remain highly conserved, even within MZ discordant 
pairs, suggesting that strong genetic or common environmental influences continue to 
act on this structure. 
2.10.2.3. Only two studies have assessed brain volumes in relation to environmental 
agents in twins with schizophrenia. The first (Reveley, Reveley et al. 1984) found a 
relationship between obstetric complications (environmental risk) and increased lateral 
ventricular volume, but only in healthy controls, and that a positive family history for 
schizophrenia (and so more ‘genetic’ risk) was associated with smaller lateral 
ventricular volumes in patients. The second (McNeil, Cantor-Graae et al. 2000) reported 
that perinatal complications were associated with smaller hippocampi and larger lateral 
ventricular volumes in patients. These results suggest that obstetric complications, and 
in particular perinatal hypoxia, may represent an environmental insult, that in 
genetically vulnerable individuals, could cause tissue loss, smaller hippocampi and 
ventricular enlargement, while genetic risk alone may lead to more subtle structural 
changes. 
2.10.2.4. Medial temporal lobe structural differences have been detected in both 
members of discordant pairs compared to controls (Baare, van Oel et al. 2001; Narr, van 
Erp et al. 2002), but with no additional deficits in the patients, while others (Suddath, 
Christison et al. 1990; McNeil, Cantor-Graae et al. 2000; van Erp, Saleh et al. 2004) 
have found further illness specific volume loss in the patients from MZ discordant pairs, 
and that these deficits were correlated with cognitive performance, including verbal 
working memory (Goldberg, Torrey et al. 1994). 
2.10.2.5. The only study so far that attempted to assess hippocampal sub-regions 
reported that volume loss was greatest posteriorly (Narr, van Erp et al. 2002). They also 
applied genetic model fitting techniques (van Erp, Saleh et al. 2004) and reported lower 
heritability estimates for hippocampal volume  in discordant twins (42%) than controls 
(71%). 
2.10.2.6. Two studies (Casanova, Sanders et al. 1990; Narr, Cannon et al. 2002) 
addressed the corpus callosum in MZ discordant pairs. Both reported no evidence of 
abnormalities in callosal length or area but found upwards displacement in probands. 
The later study though also reported this effect in the unaffected co-twins, and 
suggested a genetic or common environmental effect in schizophrenia, possibly driving 
or a response to changes in lateral ventricular volume or shape. 
2.10.2.7. Two studies focused on the thalamus. The first and smaller study (Bridle, 
Pantelis et al. 2002) reported no significant differences between controls and MZ 
discordant or concordant pairs for thalamic volume, while probands had larger caudate 
lobes than their co-twins, but not controls. In the second and larger study Ettinger et al 
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(Ettinger, Picchioni et al. 2007) detected reduced thalamic volume in MZ concordant 
pairs compared to controls, with a gradient from MZ healthy controls, through MZ 
discordant to the MZ concordant pairs. Contentiously this was interpreted as evidence of 
a sliding scale of genetically driven volume loss across these groups. 
 
2.10.3. Voxel Based Morphometry 
2.10.3.1. Only two studies have so far used a whole brain voxel based approach in 
twins with schizophrenia. Both the Utrecht and Maudsley studies examined samples that 
overlapped with their respective whole brain studies described above (Baare, van Oel et 
al. 2001; van Haren, Picchioni et al. 2004). Neither were sufficiently powered to 
implement full genetic modelling or estimate heritability, and were only able to use 
regression to detect group effects. 
2.10.3.2. In the first (Hulshoff Pol, Schnack et al. 2006) despite the earlier report of 
global grey matter volume deficits in patients, there were no regional deficits that 
discriminated patients from their unaffected co-twins. There were however significant 
difference in the left orbitofrontal gyrus between the discordant twins as a whole and 
controls. 
2.10.3.3. The second study (Borgwardt, Picchioni et al. In Press), did not include DZ 
twins but did include MZ concordant pairs. The authors detected no differences between 
twins with schizophrenia from concordant and discordant pairs. They also found no 
evidence of focal grey matter deficits between the MZ discordant well and the healthy 
control twins. However unique environmental differences were detected in the insula 
and the superior temporal gyrus, as well as the cingulate gyrus in the twins with 
schizophrenia. 
 
2.10.4. Functional Imaging 
2.10.4.1. Despite a wealth of functional imaging studies in schizophrenia very few 
have focused on twins. What few studies there are, are extremely heterogeneous, so that 
few firm conclusions can be drawn. 
2.10.4.2. One functional MRI study examined lateralisation for word tasks in MZ 
discordant and control twins (Sommer, Ramsey et al. 2004). It reported an increase in 
activity in right sided language regions, in both members of discordant pairs, and 
interpreted this as evidence of genetically determined abnormal language lateralisation. 
In contrast, a case report of a single MZ discordant pair (Spaniel, Hajek et al. 2003), 
highlighted the non-genetic nature of a very similar deficit detected only in the patient, 
with no impairment in the well co-twin. The authors linked the patient’s deficit to 
abnormal hippocampal function subsequently detected at spectroscopy. The same group 
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(Spaniel, Herynek et al. 2005) reported further illness specific deficits in the structural 
integrity of the globus pallidus detected using MR relaxometry. 
2.10.4.3. A larger study (Berman, Torrey et al. 1992) used radio labelled Xenon to 
measure regional cerebral blood flow and reported localised frontal, but no temporal, 
lobe deficits in patients from MZ discordant pairs, in response to a frontal lobe 
challenge. They detected no functional deficits in the well co-twins. These data suggest 
that the frontal lobe deficits were illness specific and reflected the impact of unique 
environmental factors. In a secondary analysis the same authors (Weinberger, Berman et 
al. 1992) demonstrated that within pair differences in hippocampal volume, measured 
using structural MRI predicted these frontal lobe blood flow deficits, and interpreted 
this as evidence of illness specific (environmental) abnormalities in a distributed 
cortical-subcortical network. 
2.10.4.4. In contrast a later study (Hirvonen, van Erp et al. 2005), examined only the 
well co-twins from MZ and DZ discordant pairs. It detected increases in caudate D2 
receptor density correlated with genetic risk. 
2.10.4.5. Finally one single proton magnetic resonance spectroscopy study in a modest 
mixed zygosity sub sample of the Finnish twin cohort (Lutkenhoff, van Erp et al. 2010), 
detected evidence of genetically determined prefrontal cortical glutamate reductions, 
with additional disease specific elevations in hippocampal N-acetylaspartate, creatine 
and glycerophosphocholine. This preliminary data supported a model of genetically 
determined glutamate dysfunction in schizophrenia.  
 
2.11. Other Biological Markers 
2.11.1. Electrophysiology 
2.11.1.1. To date five studies have examined electrophysiological function in MZ 
twins with schizophrenia (Stassen, Coppola et al. 1999; Weisbrod, Hill et al. 1999; 
Bachman, Kim et al. 2003; Weisbrod, Hill et al. 2004; Hall, Rijsdijk et al. 2007) all with 
modest sample sizes. 
2.11.1.2. Weisbrod (Weisbrod, Hill et al. 1999) reported reduced P300 amplitude in 
both patients and their well co-twins in MZ discordant pairs and concluded that this 
reflected the genetically determined vulnerability to schizophrenia. Two other studies 
though, one by the same group (Stassen, Coppola et al. 1999; Weisbrod, Hill et al. 
2004), produced contrasting results. The later studies noted that pairs with at least one 
ill member had lower within-pair EEG concordance, and concluded that this was driven 
by unique environmental effects. Furthermore both studies, identified EEG parameters 
that could reliably distinguish the patients from their unaffected co-twins, suggesting its 
possible use as a disease specific marker. 
 47 
2.11.1.3. Four other studies have used different cognitive tasks to manipulate the EEG 
signal in twins (Bachman, Kim et al. 2003; Ahveninen, Jaaskelainen et al. 2006; Hall, 
Rijsdijk et al. 2007; Bachman, Kim et al. 2008). They all elicited what they interpreted 
as electrophysiological correlates of the genetic risk for schizophrenia. However only 
the latter (Hall, Rijsdijk et al. 2007) was able to quantify the heritability, phenotypic and 
genetic correlation of its selected electrophysiological markers with schizophrenia, 
culminating, using those indeces in its claim that P50 suppression was the best 
candidate endophenotype marker for schizophrenia. 
2.11.1.4. Thus while much of the earlier work is mixed, the emerging evidence from 
the newest electrophysiological studies, that have included the largest, but still modest 
subject numbers, is that selected electrophysiological measures offer scope as candidate 
endophenotype markers, though this needs replication. 
 
2.11.2. Eye movements 
2.11.2.1. Two Scandinavian studies examined eye tracking abnormalities between MZ 
and DZ discordant pairs, though did not compare within twin pairs, nor include any 
control twins. They both detected smooth pursuit abnormalities in the well co-twins and 
noted that MZ pairs were more similar than DZ pairs whether assessed qualitatively 
(Holzman, Kringlen et al. 1978; Holzman, Kringlen et al. 1980), or quantitatively 
(Holzman, Kringlen et al. 1977; Holzman, Kringlen et al. 1980). The authors concluded 
that eye-tracking deficits could serve as genetic markers for schizophrenia as they were 
familial and probably genetically determined, finally suggesting also that these deficits 
were more ‘penetrant’ than schizophrenia’s clinical phenotype. 
2.11.2.2. Two studies (Torrey, Gottesman et al. 1994; Litman, Torrey et al. 1997) 
contentiously failed to reproduce these results (Holzman, Levy et al. 1997). The later in 
particular used more advanced recording techniques, but adopted a different statistical 
model, that could have contributed to this inconsistency. Both however found that the 
well co-twins were not significantly impaired compared to controls, and rejected a 
genetic model for smooth pursuit abnormalities in schizophrenia. 
2.11.2.3. Most recently, in the Maudsley cohort (Ettinger, Picchioni et al. 2006), 
contrasted relatively modest MZ discordant and control twin samples, and produced 
evidence of genetically determined deficits in antisaccade gain and latency that were 
consistent with familial effects.  
 
2.11.3. Neurological Soft Signs 
2.11.3.1. Mosher (Mosher, Pollin et al. 1971), studied MZ discordant pairs and 
detected an increase in neurological soft signs in probands but not in their co-twins, 
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while Kelly (Kelly, Cotter et al. 2004) could not detect any difference between probands 
and their well co-twins. In contrast two other studies (Rosenthal and Kety 1968; Torrey, 
Gottesman et al. 1994), reported that the well co-twins from MZ discordant pairs 
occupied a position between probands and healthy controls, suggesting both genetic and 
unique environmental effects driving the neurological soft signs. Obstetric 
complications have been suggested to be one possible source of this environmental risk 
in twins (Mosher, Pollin et al. 1971; Cantorgraae, McNeil et al. 1994). 
2.11.3.2. Three studies (Boklage 1977; Luchins, Pollin et al. 1980; Lewis, Chitkara et 
al. 1989) have explored laterality and handedness (Crow 1999) in twins with 
schizophrenia. The evidence is mixed but suggests that in twin pairs with at least one 
left handed member, the proband is more likely to be left handed, though none of the 
studies were able to explore the aetiology of this further. 
 
2.11.4. Other Markers 
2.11.4.1. One study (Torrey, Gottesman et al. 1994) assessed minor physical anomalies 
(MPAs) in MZ discordant, concordant and control twins but detected no significant 
increase in the patients with MPAs highly correlated even within discordant twin pairs. 
2.11.4.2. Very few studies have measured peripheral biological markers in twins with 
schizophrenia. Vander Putten (Vander Putten, Fuller Torry et al. 1996) detected 
significantly greater differences in plasma proteins in MZ discordant than control pairs, 
and concluded these reflected non-genetic factors. Two (Stabenau, Pollin et al. 1969; 
Poltorak, Wright et al. 1997) examined blood and CSF markers, and reported abnormal 
rates in the patients compared both to their well co-twins and controls. Again these were 
interpreted as evidence of unique environmental effects. 
2.11.4.3. Kopola (Kopala, Good et al. 1998) used a smell identification task in the 
NIMH twin sample. They reported that MZ discordant twins as a whole experienced 
deficits, but were insufficiently powered to detect differences between the well co-twins 
and either the patients or the controls. This suggested a familial defect in cerebral 
function, detected through impaired smell identification, but that additional illness 
specific effects, (unrelated to smoking) were also having an effect. 
 
2.11.5. Medication Response 
2.11.5.1. Two twin case reports have reported evidence supporting genetic 
determination of neurotransmitter systems predicting antipsychotic medication response 
in schizophrneia. They each reported on pairs of MZ twins concordant for schizophrenia 
who shared their clinical response to Clozapine (Vojvoda, Grimmell et al. 1996) and 
olanzapine (Mata, Madoz et al. 2001). Despite the obvious limitations of size, these case 
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2.12.1. Twin studies have over many years produced influential and significant 
results that have steered thought about the aetiology and pathophysiology of 
schizophrenia. From the early concordance studies to current advanced genetic modelling 
this remains the case. Over the last decade the methodology underpinning twin research 
in schizophrenia has advanced considerably and sample sizes have slowly increased. 
2.12.2. The early generally small and highly selected twin studies reliably established 
the presence of a multitude of deficits in the patients with schizophrenia and their co-
twins. This emphasised the familiarity of the disorder. Qualitatively similar but 
quantitatively less marked deficits, for many of these traits, were present in the MZ and 
DZ unaffected co-twins further supporting a familial effect. These familial influences 
though could arise from genetic and shared familial environmental influences. It is only a 
small number of these studies that tried to and were able to detect either a ‘gradient’ 
effect from the DZ to MZ unaffected co-twins or greater correlations in the MZ than DZ 
samples, that begin to establish specific evidence for genetic effects. Thus the majority of 
the published twin literature can only describe their markers on a limited number of the 
endophenotype criteria. 
2.12.3. Many of these studies can be criticised for: 
• often focussing exclusively on MZ discordant and MZ control samples 
• failing to deal appropriately with the familial nature of the data and the lack of 
independence of observations between members of the same twin pair. Many studies 
either ignored this statistical consideration, or dropped one member at random from each 
pair 
• failing to recruit samples with sufficient statistical power 
• failing to employ genetic modelling techniques to discriminate between and quantify the 
genetic and shared environmental effects on the traits underinvestigation. 
2.12.4. It is only relatively recently with the emergence of larger national and indeed 
international twins studies, that have recruited sufficiently large samples, and with the 
ability to deploy the most suitable statistical and genetic modelling techniques, that we 
have started to be able to quantify the genetic links between these familial deficits and 
schizophrenia. 
2.12.5. At present there are two linked international collaborations underway, the 
Schizophrenia Twin and Family (STaR) consortium involving centres in Utrecht, Jena, 
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Helsinki and London, and the EUTwins Network, sponsored by the European Union 
through a Marie Curie Training Network grant that extends to nine European centres. 
Such international collaborations offer the best means of evaluating the suitability and 
usefulness of candidate markers as endophenotypes of schizophrenia. It is only by 
applying the most suitable modelling techniques to these unique datasets that the full 




3. Neurological Abnormalities in Twins with Schizophrenia 
 
3.1. Abstract 
3.1.1. While neurological abnormalities (NAs) are well recognised in schizophrenia, 
their aetiology, and specifically their genetic and environmental determinants are poorly 
understood. Thus their utility as endophenotypes is unknown. 
3.1.2. 63 twin pairs, varying in their zygosity and concordance for schizophrenia, 
and 73 unaffected control twin pairs were examined for total, primary and integrative 
NAs using the Neurological Evaluation Scale. 
3.1.3. NAs were increased in probands with schizophrenia compared to non-
schizophrenic co-twins and to healthy control twins. There were no significant 
differences between patients, whether they were from concordant or discordant pairs. 
NAs in the non-psychotic co-twins from discordant pairs were increased compared to 
control twins. There were no significant differences in NAs between the non-
schizophrenic co-twins from monozygotic (MZ) and dizygotic (DZ) discordant pairs, 
though the within pair correlations were greater in the MZ compared to DZ pairs. NAs 
were modified in all groups by pre-morbid schizotypal traits, and in patients by anti-
psychotic medication. 
3.1.4. Thus NAs in schizophrenia are determined in part by genetic risk for the 
illness and the presence of premorbid schizotypal traits. However anti-psychotic 




3.2.1. Neurological abnormalities (NAs) are frequently noted in patients with 
schizophrenia (Kraepelin 1919; Buchanan and Heinrichs 1989; Keshavan, Sanders et al. 
2003; Chan, Xu et al. 2010) but their pathophysiological significance remains elusive. 
3.2.2. Family studies have consistently reported increased rates of NAs in the non-
schizophrenic relatives of probands, including parents (Rossi, Decataldo et al. 1990; 
Kinney, Yurgelun Todd et al. 1991; Flyckt, Sydow et al. 1999), siblings (Ismail, Cantor-
Graae et al. 1998; Egan, Hyde et al. 2001; Mechri, Bourdel et al. 2009; Mechri, Gassab et 
al. 2010), and offspring (Marcus, Hans et al. 1985; Schubert, Cantor-Graae et al. 2002; 
Schubert and McNeil 2004; Prasad, Sanders et al. 2009). NAs are highly correlated 
within families (Ismail, Cantor-Graae et al. 1998; Yazici, Demir et al. 2002) and there 
have been claims that they are determined by the degree of genetic loading for 
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schizophrenia within the family (Griffiths, Sigmundsson et al. 1998) and they are 
heritable and thus on the basis of this evidence that they could act as an endophenotype 
marker for the disorder (Hui, Wong et al. 2009). 
3.2.3. Some studies of MZ twins discordant for schizophrenia (Mosher, Pollin et al. 
1970; Cantor-Graae, McNeil et al. 1994; Niethammer, Weisbrod et al. 2000) have shown 
that the non-schizophrenic co-twins lie midway between probands and healthy controls in 
the extent of NAs detected. 
3.2.4. Cantor-Graae (Cantor-Graae, McNeil et al. 1994) observed an association 
between obstetric complications and NAs in both the probands and their well co-twins, 
replicating this finding in a later study of non-twin relatives (Cantor-Graae, Ismail et al. 
2000). They concluded that the NAs reflect the impact of environmental agents in 
genetically sensitised individuals, and additionally speculated that patients from MZ 
discordant pairs are subject to greater environmental effect than those from concordant 
pairs, who had a ‘more genetic’ form of the illness. 
3.2.5. Griffith et al (Griffiths, Sigmundsson et al. 1998) divided NAs into primary 
and integrative subscales. Primary NAs were postulated to reflect dysfunction that can be 
detected at routine neurological examination, and include cranial nerve signs, eye 
movement abnormalities, lateralising limb pyramidal and frontal release signs. 
Integrative NAs were thought to reflect dysfunction in the integration of activity within 
the sensory and motor systems, and include dysdiadokokinesia, and the sequencing of 
complex motor acts, such as the fist-edge-palm test. The authors found that primary NAs 
were over represented in non-familial, or sporadic, cases of schizophrenia, and were not 
elevated in their well relatives. In contrast, integrative NAs were increased both in 
probands and unaffected relatives from multiply affected families. This suggested that 
primary NAs were a reflection of environmentally induced neurological damage in ‘less 
familial and more environmental’ patients, while integrative NAs were determined by 
genetic loading for schizophrenia and were found in the ‘more familial’ cases and their 
relatives. 
3.2.6. Following this line of reasoning, I studied groups of twins varying in their 
zygosity and concordance for schizophrenia to test the following hypotheses: 
3.2.6.1. Total NAs would be greater in twins with schizophrenia than control twins. 
3.2.6.2. Twins with schizophrenia from concordant MZ pairs would have 
proportionally more integrative NAs, reflecting their greater genetic aetiological load, 
while those from discordant MZ pairs would have proportionally more primary NAs, 
reflecting their relatively greater environmental load. 
 53 
3.2.6.3. Non schizophrenic co-twins from discordant pairs would have greater NAs, 
principally integrative, than control twins, but fewer than their ill co-twins. This would 
reflect their genetic, but lack of environmental, risk. 
3.2.6.4. More NAs would be detected in non-schizophrenic co-twins from MZ 
discordant compared to DZ discordant pairs, reflecting their greater genetic proximity to 
their ill twin probands. This genetically determined effect would also be reflected in 




3.3.1.1. One hundred and thirty six twin pairs contributed data to this component of 
the Twin Study after Multi Centre Research Ethics Committee approval had been 
granted. 
3.3.1.2. Patients were referred by their treating psychiatrist. Control subjects were 
recruited from the Institute of Psychiatry Volunteer Twin Register and by advertisement 
in national media. 
3.3.1.3. Exclusion criteria applied to all groups were a history of neurological illness, 
or of systemic illness with known neurological complication, a history of head injury 
associated with loss of consciousness of more than one minute, and current substance 
misuse or dependence. 
3.3.1.4. All subjects gave written informed consent before participating. 
 
3.3.2. Clinical Assessment 
3.3.2.1. All subjects underwent the same extensive clinical assessment. Twin zygosity 
was determined by assessment of twelve highly polymorphic micro-satellite markers or 
standardised twin likeness questionnaire. Structured clinical interviews were performed 
by two trained psychiatrists using the Schedule for Affective Disorders and 
Schizophrenia-Lifetime version (Endicott and Spitzer 1978), augmented with further 
clinical information, from which DSM IV (American Psychiatric Association 1994) 
diagnoses were made. Current psychotic symptoms in the probands were assessed using 
the Scales for the Assessment of Positive and Negative Symptoms, SAPS (Andreasen 
1983) and SANS (Andreasen 1983). Premorbid traits were assessed in a subset of 
subjects (62 pairs) by maternal interview using the Premorbid Assessment of Schizoid 
and Schizotypal Traits (PSST) (Foerster, Lewis et al. 1991). Handedness was 
determined using the Annett scale (Annett 1970). Data on medication history was 
collected at the time of assessment and side effects were rated using the Targeting 
Abnormal Kinetic Effects (TAKE) scale (Wojcik, Gelenberg et al. 1980). 
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Table 3.1. 
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212 (7,136) <0.001 
Gender % Female 
 
29 41 41 49 46 46 52 3.55 (4) 0.48 
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74 (3,86) <0.001 
 
 
4.1 (6,61) 0.016 

























50 (3,131) <0.001 

















63 (3,88) <0.001 
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Legend Table 3.1 
MZ, Monozygotic; DZ, Dizygotic; SAPS, Scale for the Assessment of Positive Symptoms; 
SANS, Scale for the Assessment of Negative Symptoms; PSST, Premorbid Assessment of 
Schizoid and Schizotypal Traits; Cpz Equiv, Chlorpromazine Equivalents; TAKE, 
Targeting Abnormal Kinetic Movements; NA, Not Applicable 
 
3.3.3. Participants 
3.3.3.1. The final study groups consisted of 30 pairs of MZ twins concordant for 
schizophrenia or schizoaffective disorder; 21 pairs of MZ twins and 12 pairs of DZ 
twins discordant for schizophrenia, in which the co-twin was free of any psychotic 
illness. Finally 55 pairs of MZ and 18 pairs of DZ control twins with no personal or 
family history to second degree relative, of a psychotic or schizophrenia spectrum 
disorder. 
3.3.3.2. The probability that any of the discordant pairs would become concordant for 
schizophrenia in the future was low as an average of 10.24 (SD=8.82) years in the MZ, 
and 17.3 (SD=12.31) years in the DZ pairs, had elapsed since the onset of the illness in 
the probands (Belmaker, Pollin et al. 1974). 
3.3.3.3. All subjects with schizophrenia were clinically stable at the time of 
assessment, with no recent changes to their medication. 
3.3.3.4. Thirty nine of the non-schizophrenic co-twins from the discordant groups 
satisfied DSM IV criteria for a lifetime axis I disorder (Table 3.1). None were unwell at 
the time of testing nor taking any psychotropic medication. Within the MZ and DZ 
control groups 22 individuals satisfied DSM IV criteria for a lifetime axis I disorder, 
none were unwell at the time of testing and none were taking any psychotropic 
medication (Table 3.1). 
 
3.3.4. Neurological Examination 
3.3.4.1. The neurological examination was performed by one of two post Membership 
trained psychiatrists (MP and ND) blind to medication status, according to an expanded 
and previously validated version of the Neurological Evaluation Schedule (NES) 
(Buchanan and Heinrichs 1989; Griffiths, Sigmundsson et al. 1998) Table 3.2. This 
assessed thirty independent NAs; fifteen of the variables were assessed bilaterally 
giving a total of forty-five scored variables. This expanded version produced a Total 
score and scores on two subscales for Primary and Integrative NAs, hypothesised to 
reflect dysfunction in different CNS functional domains (Griffiths, Sigmundsson et al. 
1998). 
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3.3.4.2. Primary NAs are thought to reflect localised cerebral pathology while 
integrative NAs to reflect dysfunction in the integration of activity within and between 
the sensory and motor systems. 
3.3.4.3. The NES was administered in a standardised manner for each item and in a 
set order. 
3.3.4.4. The three subscales from the original NES (Buchanan and Heinrichs 1989), 
(sensory integration, motor co-ordination and motor sequencing) were left unchanged 
(items scored on an anchored three point scale from 0=no abnormality to 2=marked 
impairment, except for the snout and suck reflexes which were scored as either 0 or 2). 
For the additional items, in the primary subscale, we used scoring from Griffiths et al 
(Griffiths, Sigmundsson et al. 1998), using a three point scale 0=no abnormality to 
2=marked impairment according to the presence and severity of any abnormality. 
Conservative criteria for the determination of NAs were used. Scores for total, primary 
and integrative NA were calculated by producing the mean individual scores for the 
scales defined in Table 3.2. 
3.3.4.5. Both psychiatrists were trained using a standardised schedule and video 
teaching tool. Inter-rater reliability was calculated by both physicians rating a sub-
sample of twenty-six subjects randomly selected from the study group. Agreement rates 




Neurological Examination Schedule 
 
Total Score          
Primary Function    Integrative Function   
Cranial nerve palsy (right and left)  Audio-visual integration 
Smooth pursuit    Stereognosis (right and left) 
Saccade to target    Graphaesthesia (right and left) 
Saccade to command   Extinction 
Synkinesis     Right/left confusion 
Gaze impersistence    Tandem walk 
Convergence    Rapid alternating movements (right and left) 
Tone increase (right and left)   Finger thumb opposition test (right and left) 
Limb hypereflexia (right and left)  Finger-nose test (right and left) 
Babinski sign (right and left)   Fist-ring test (right and left) 
Romberg sign    Fist-edge-palm test (right and left) 
Chorea (right and left)   Oszeretski test 
Tremor (right and left)     
Mirror movements (right and left)    
Glabellar reflex      
Snout reflex      
Grasp reflex (right and left)    
Suck reflex     
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3.4. Data Analyses 
3.4.1. The main objective of the statistical analysis was to compare values on the 
three dependent variables (i) total NAs, (ii) primary NAs and (iii) integrative NAs 
between the groups (MZ concordant ill, MZ discordant ill, DZ discordant ill, MZ 
discordant well, DZ discordant well, MZ and DZ control twin pairs). 
3.4.2. The genetic relatedness of twin pairs and the likely within-pair correlations 
violate ANOVA’s assumption of independence. In addition, the dependent variables in 
some groups suffered from floor effects (see Figures 3.1-3.3). Consequently group 
differences on NA variables were analysed using a regression model with standard errors 
that are robust against correlations within twin pairs and departures from normality 
(Binder 1983). The model uses dummy variables for group as independent variables. The 
robust sandwich estimator provides robust standard errors (and therefore robust 
confidence intervals and p-values) which give accurate assessments of the sample-to-
sample variability of the parameter estimates even when the model is mis-specified, 
including when observations are non-independent, i.e. cluster-correlated as is the case in 
twins. Using robust regression the parameter estimate may be biased but the 95% 
confidence interval will be accurate, giving 95% confidence that the true parameter 
estimate lies within its range (Rogers 1993; Williams 2000). 
3.4.3. Overall group comparisons followed by post-hoc pair-wise comparisons were 
carried out. The choice of group comparisons was guided by the hypotheses (i)-(iv) listed 
in the introduction, thus we considered the following comparisons: 
• MZ Concordant Ill, MZ Discordant Ill, DZ Discordant Ill vs MZ & DZ Control 
• MZ Concordant Ill vs MZ Discordant Ill 
• MZ Discordant Ill vs MZ Discordant Well 
• DZ Discordant Ill vs DZ Discordant Well 
• MZ Discordant Well vs MZ Control 
• DZ Discordant Well vs DZ Control 
• MZ Discordant Well vs DZ Discordant Well 
3.4.4. To control for multiple testing, pairwise comparisons were carried out only 
when a significant overall difference was detected and the Bonferroni correction used to 
judge statistical significance throughout. 
3.4.5. Regression and logistic regression with robust standard errors were used to 
compare demographic and clinical variables between groups while taking account of twin 
clusters. Age, gender, social class of parents at subjects’ birth, and educational 
achievement were considered potential confounders of the group effects on NAs. 
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Whenever one of the terms contributed significantly to the prediction of the NA variable, 
it was included in the model to adjust group effects for confounder differences. 
3.4.6. Within the patient groups, the effects of patients’ age at onset, medication and 
psychotic symptoms were evaluated by adding the variables to the model for the NA 
outcomes after including group effects. To determine if schizotypal personality trait score 
affected NA either as an interaction with group or as a main effect, these terms were 
added to the model. 
3.4.7. Intraclass correlation coefficients (ICC) were calculated within the MZ 
control, MZ discordant and DZ discordant groups to further test hypothesis iv. The ICCs 
measure the degree of (positive) correlation between the scores of the members of each 
twin pair. A bootstrapping approach was used to compare the ICC in the MZ discordant 
group with each of the other two groups. The bootstrap algorithm allowed for effects of 
predictor variables on NAs and resampled twin pairs within each group to generate 
percentile confidence intervals for ICCs and tests for zero differences. 
3.4.8. All analyses were carried out in Stata 8 (Stata Corporation, 2003). 
 
3.5. Results 
3.5.1. Power Calculation 
3.5.1.1. Previous work (Cantor-Graae, McNeil et al. 1994) found a difference in mean 
NA score between schizophrenic and control groups of 3.7 and a within group standard 
deviation of 2.5. On this basis, I calculated that at least 11 unrelated subjects in each 
group would be needed to have 90% power to detect such an effect using a two sided 
independent samples t-test at the 5% significance level. 
 
3.5.2. Group Demographics 
3.5.2.1. The groups differed significantly in age and years spent in full time education 
(Table 3.1). Probands from both of the discordant groups were younger (p<0.001) at 
initial diagnosis than the MZ concordant pairs; they had statistically fewer positive 
(p<0.001), and in the case of the DZ pairs, fewer negative symptoms, and were on lower 
doses of antipsychotic medication, expressed in chlorpromazine equivalents (p<0.001). 
The DZ discordant probands experienced more side effects (TAKE) (p<0.001). 
3.5.2.2. Age (p<0.001) and educational achievement (p=0.002) significantly predicted 
NA scores, while gender (p=0.79), and parental social class (p=0.45) did not. 
3.5.2.3. The group comparisons for the NA scores were therefore adjusted for age and 
educational achievement to control for potential confounding effects. 
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Box plots demonstrating distribution of Total NA score within groups. 
Disc, Discordant; N, Number of subjects; Min, Minimum; Max, Maximum; NA, 
Neurological Abnormality. 
Reprinted from: Picchioni MM, Toulopoulou T, Landau S, Davies N, Ribchester N, 
Murray R.M. (2005)Neurological abnormalities in twins. Biological Psychiatry 59, 4 341-
348. 
 
3.5.3.1. The observed total NA scores are illustrated in Figure 3.1 and the results of 
the formal group comparisons in Table 3.3. 
3.5.3.2. An overall effect of group on total NA score was detected (p<0.0001). 
3.5.3.3. In accord with hypothesis i, patients with schizophrenia (all those from MZ 
concordant, MZ discordant and DZ discordant pairs) had more total NAs than control 
twins (p<0.001), while the MZ concordant and MZ discordant schizophrenic patients 
did not differ significantly from each other (p=0.82). 
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-0.14 to 0.19 
0.10 
0.0006 to 0.21 
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0.05 to 0.34 
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0.034 to 0.26 
0.13 
0.007 to 0.25 
0.086 
-0.06 to 0.23 
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0.28 to 0.46 
0.006 
-0.13 to 0.14 
0.24 
0.12 to 0.37 
0.19 
-0.06 to 0.45 
0.11 
-0005 to 0.23 
0.16 
-0.019 to 0.34 
0.033 
-0.16 to 0.23 
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Table 3.3. 
Neurological Abnormalities (NA) Test Results 
 
Legend Table 3.3 
** Significant at p<0.007 corrected for multiple comparisons, * Significant at 
p<0.05 uncorrected, all tests were adjusted for subject age and educational 
achievement. MZ, Monozygotic; DZ, Dizygotic; Conc, Concordant; Disc, 
Discordant 
 
3.5.3.4. Probands with schizophrenia from MZ discordant and DZ discordant pairs 
had more total NAs than their non-schizophrenic co-twins, (p<0.001 and p=0.027 
respectively), supporting hypothesis iii, but the DZ pair differences were not statistically 
significant after Bonferroni correction. 
3.5.3.5. The non-schizophrenic co-twins in discordant MZ pairs had more total NAs 
than control twins, (p=0.003), again supporting hypothesis iii, and while there was a 
similar trend in the DZ non-schizophrenic co-twins, it did not reach statistical 
significance (p=0.061). 
3.5.3.6. Contrary to hypothesis iv, the non-schizophrenic co-twins from MZ and DZ 
discordant pairs did not differ significantly in total NA score (p=0.28). 
 
3.5.4. Primary Neurological Abnormalities 
3.5.4.1. The observed Primary NA scores are illustrated in Figure 3.2 and the formal 
group comparisons are shown in Table 3.3. 
3.5.4.2. An overall effect of group on primary NA score was detected (p<0.0001). 
3.5.4.3. Patients with schizophrenia from MZ concordant, MZ discordant and DZ 
discordant pairs had more primary NA than control twins (p<0.001) but, contrary to 
hypothesis ii, probands from MZ discordant pairs did not have significantly more 
primary NA than those from MZ concordant pairs (p=0.79). 
3.5.4.4. As predicted in hypothesis iii, probands with schizophrenia from MZ 
discordant and DZ discordant pairs had more primary NA than their non-schizophrenic 
co-twins (p=0.048, p=0.007 respectively) though only the DZ pair differences remained 





Box plots demonstrating distribution of Primary NA score within groups. 
Disc, Discordant; N, Number of subjects; Min, Minimum; Max, Maximum; NA, 
Neurological Abnormality. 
Reprinted from: Picchioni MM, Toulopoulou T, Landau S, Davies N, Ribchester N, 
Murray R.M. (2005)Neurological abnormalities in twins. Biological Psychiatry 59, 4 341-
348. 
 
3.5.4.5. Contrary to hypothesis iii, there were trends for the non-schizophrenic co-
twins of both the MZ and DZ discordant pairs to have more primary NA than control 
twins (p=0.011 and p=0.037 respectively), though neither were significant after 
Bonferroni correction. 
3.5.4.6. The non-schizophrenic co-twins from MZ and DZ discordant pairs again did 
not differ significantly from each other on primary NA scores (p=0.25). 
 
3.5.5. Integrative Abnormalities 
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3.5.5.1. The observed integrative NA scores are illustrated in Figure 3.3 and the 
formal group comparisons are shown in Table 3.3. 
 
Figure 3.3. 
Box plots demonstrating distribution of Integration NA score within groups. 
Disc, Discordant; N, Number of subjects; Min, Minimum; Max, Maximum; NA, 
Neurological Abnormality. 
Reprinted from: Picchioni MM, Toulopoulou T, Landau S, Davies N, Ribchester N, 
Murray R.M. (2005)Neurological abnormalities in twins. Biological Psychiatry 59, 4 341-
348. 
 
3.5.5.2. An overall effect of group on integrative NA score was detected (p<0.0001). 
3.5.5.3. In accord with hypothesis i, patients with schizophrenia from MZ concordant, 
MZ discordant and DZ discordant pairs had more integrative NA than control twins 
(p<0.001), while, contrary to hypothesis ii, patients from MZ concordant and MZ 
discordant pairs did not differ significantly from each other (p=0.91). 
3.5.5.4. Contrary to hypothesis iii, probands from the MZ discordant group had more 
integrative NA than their non-schizophrenic co-twins (p<0.001). 
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3.5.5.5. Probands from DZ discordant pairs did not have significantly more 
integrative NA than their non-schizophrenic co-twins (p=0.14). 
3.5.5.6. We did not find a significant difference between the non-schizophrenic co-
twins from either the MZ or DZ discordant groups and control twins (p=0.061 and 
p=0.080) for integrative NA. 
3.5.5.7. Finally, and contrary to hypothesis iv, there was no significant difference 
between the non-schizophrenic co-twins from MZ and DZ discordant pairs for 
integrative abnormality scores (p=0.73). 
 
3.5.6. Intraclass Correlations 
3.5.6.1. The ICCs adjusted for age and educational achievement for the MZ control, 
MZ discordant and DZ discordant groups are shown in Table 3.4. 
 
Table 3.4. 
Intra-class correlations within twin pairs 
 Total Abnormalities Primary Abnormalities Integration Abnormalities 




















16.4% 0 to 89.9% 
DZ Discordant 
(n=12++) 
0% 0 to 64.7% 0% 0 to 65.5% 0.0% 0 to 65.0% 










MZ Control – 
MZ Discordant 
13.4% 0.51 3.8% 0.82 32.2% 0.38 
MZ Discordant – 
DZ Discordant 
52.3% 0.025 49.6% 0.038 16.4% 0.74 
 
Legend Table 3.4 
* Bootstrap percentile confidence interval CI based on 1999 bootstrap simulations 
+ Bootstrap test of constant intra-class correlation ICC in the two groups based on 1999 
bootstrap simulations 
++ Number of pairs 
 66 
3.5.6.2. The distribution of the ICC data was consistent with our a priori hypothesis 
iv. 
3.5.6.3. The ICCs for the MZ discordant pairs were significantly greater than the DZ 
discordant pairs for both total (p=0.025) and primary (p=0.038) NAs. 
3.5.6.4. However the ICCs for the MZ discordant twins did not differ significantly 
from the MZ control twins for any of the three NA scales. 
 
3.5.7. Antipsychotic Medication Effects 
3.5.7.1. Within the three patient groups, there was a significant effect of medication 
on total, primary and integrative NA score (t(128)=2.73, t(128)=2.85, t(128)=2.15 and 
p=0.007, p=0.005 and p=0.033, respectively). 
3.5.7.2. This effect was mirrored for side effect ratings on total, primary and 
integrative NAs, (t(88)=4.01, t(88)=4.19and t(88)=2.66 and p<0.0001, p<0.001 and 
p=0.009 respectively). 
3.5.7.3. These effects reflected greater medication doses and side effect scores being 
associated with increased NA scores. 
 
3.5.8. Psychotic State and Trait Effects 
3.5.8.1. Current psychotic symptoms did not have a significant effect on any of the 
three NA scores within patients from the three groups MZ concordant and MZ and DZ 
discordant, either as an interaction or main effect. 
3.5.8.2. However there was a trend towards increased negative symptoms being 
associated with increased total and primary NA (t(56)=1.80, t(56)=1.89, and p=0.078, 
p=0.064, respectively). 
3.5.8.3. Within the DZ discordant well group only 3 subjects scored non-zero on 
PSST rating, so I excluded this group from regression fitting and subsequent analysis of 
PSST effects. 
3.5.8.4. There was no significant interaction between PSST score and group on any of 
the three NA scores. However there was a main effect of PSST on both total (t(61)=54, 
p=0.039), and primary (t(61)=50, p=0.030) NA scores. Thus, increasingly abnormal 




3.6.1.1. The main findings are that NAs are, as predicted, increased both in probands 
with schizophrenia probands (hypothesis i) and their non-schizophrenic co-twins 
(hypothesis iii) compared to controls. 
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3.6.1.2. I confirmed that the non-schizophrenic co-twins occupy a position 
intermediate between their ill co-twins and healthy twins, but was unable to show from 
the comparison of means analysis, that the genetic proximity of the non-schizophrenic 
co-twins from discordant pairs to their respective probands determined their level of 
NA, i.e. MZ>DZ (hypothesis iv). However, the ICC data from these pairs give indirect 
support to this hypothesis. 
3.6.1.3. NAs of probands did not vary with their concordance for schizophrenia 
(contrary to hypothesis ii) nor psychotic symptomatology, but were influenced by 
antipsychotic medication. 
3.6.1.4. An effect was also detected across all groups between schizotypal personality 
traits and NAs. Chapter 4 will show that this further implicates a genetic role in their 
aetiology. 
3.6.1.5. Finally, the results do not support the division of NA into primary and 
integrative scores on aetiological grounds. 
3.6.1.6. These findings implicate familial, and more specifically genetic factors, in 
determining the level of NA detected in the well co-twins of patients with 
schizophrenia. However non-shared environmental, including illness specific factors 
must have had an additional effect as probands, particularly those from MZ discordant 
pairs, expressed significantly more NA than their genetically identical, but well, co-
twins. Antipsychotic medication played a part in this final effect. 
 
3.6.2. Non-Schizophrenic Co-twins 
3.6.2.1. Non-schizophrenic co-twins from MZ and DZ discordant pairs manifested 
elevated levels of NA compared to controls, suggesting that NAs reflect a familial factor 
related to schizophrenia. The ICC analysis, showing greater similarity within MZ than 
DZ discordant pairs, clarify that NA are determined in part by the co-twins’ genetic 
proximity to the proband, and consequently their genetic risk for the disorder. However, 
contrary to our hypothesis iii, we found significantly increased total and primary, rather 
than integrative, NA in the non-schizophrenic co-twins from the discordant pairs, 
suggesting that the division of NA into Primary and Integrative scales does not 
accurately reflect genetic risk as Griffith et al (1998) originally proposed. 
3.6.2.2. Cantor-Graae et al (Cantor-Graae, McNeil et al. 1994) speculated that MZ 
discordant compared to MZ concordant pairs, might represent a peculiarly 
environmental variant of the illness and consequently that the well co-twins of 
discordant pairs may have inherited relatively little genetic risk for schizophrenia. 
Evidence from a variety of other sources, epidemiological (Cardno, Marshall et al. 
1999; Sullivan, Kendler et al. 2003), neuro-cognitive (Cannon, Huttunen et al. 2000), 
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neuroimaging, (Cannon, Thompson et al. 2002; van Erp, Saleh et al. 2004; van Haren, 
Picchioni et al. 2004), together with data from this study, begins to suggest that on 
balance this is unlikely to the case. Non-schizophrenic co-twins from MZ and DZ 
discordant pairs consistently manifest deficits that place them in a position intermediate 
between controls and those with clinical schizophrenia. 
3.6.2.3. While the co-twins from MZ and DZ discordant pairs did not differ 
significantly in NA, the ICCs for MZ discordant pairs was more similar for Total and 
Primary NA than for DZ pairs. This suggests that Total and Primary, rather than 
Integrative NA, are influenced by genetic factors, and more specifically that their 
expression in well relatives reflects their genetic risk for the illness. This finding for 
Primary NA was not that hypothesised and could reflect the lack of specificity of the 
NA examination, coupled with aetiological and pathophysiological heterogeneity within 
the sample. 
3.6.2.4. The failure of the comparison of means approach to detect significant 
differences between the non-schizophrenic co-twins from MZ and DZ discordant pairs 
could reflect the limited power of the study to detect differences between two non-
schizophrenic groups, each of limited size, defined by their degree of genetic risk. 
Alternatively the NA may in fact be determined by shared environmental factors, and 
my failure to detect differences between the two groups would then be a genuine 
finding; however that would inconsistent with the ICC data if the equal environments 
assumption in twins is true. 
3.6.2.5. There have been no published studies that examined NAs in MZ and DZ 
discordant twins. However, previous neuro-imaging studies in twins (Cannon, 
Thompson et al. 2002) and multiply effected families (McDonald, Bullmore et al. 
2004), have used theoretical genetic loading scales to model the influence of the genetic 
risk for schizophrenia on cerebral volume. Results indicated that relatives demonstrate a 
similar distribution of deficits to probands, and that the magnitude of those deficits is 
determined at least in part by their degree of genetic risk; this could reflect the greater 
sensitivity for what ever reason, of structural MRI measures compared to NAs, to index 
the genetic risk of schizophrenia. 
 
3.6.3. Probands 
3.6.3.1. My findings imply that NAs are a robust finding in schizophrenia, determined 
in part by the inherited genetic risk for the disorder. However since MZ twins with 
schizophrenia express greater levels of NA, across all three scales, than their co-twins 
they must also be influenced by non-genetic factors. These are not related to positive 
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psychotic symptoms or other measures of illness severity (state), but the data do support 
the logical conclusion that NAs are increased by antipsychotic medication. 
3.6.3.2. Across the MZ patient groups (MZ concordant and MZ discordant ill), the 
distribution of total, primary and integrative NA abnormalities did not differ 
significantly. While the MZ discordant twins are unlikely to represent pairs of very low 
genetic load, a structural MRI study by our group (van Haren, Picchioni et al. 2004) has 
suggested that probands from discordant pairs may be more sensitive to environmental 
aetiological events, expressed as larger lateral ventricular volumes, or that the 
concordant twins have experienced a greater genetic load (Ettinger, Picchioni et al. 
2007). This we concluded is more likely to reflect a more subtle shift in the gene-
environment interaction in some discordant pairs than a more absolute model. The 
similar distribution of NA scores across the patient groups leads to the conclusion that 
while NAs do reflect this interaction between genetic and unshared environmental risk 
factors for schizophrenia, the pattern of expression is largely insensitive to the balance 
between the two. 
3.6.3.3. Within the patients in this specific sample, those from discordant pairs were 
younger at original diagnosis, but otherwise less symptomatic and on lower doses of 
medication. These clinical differences did not result in significant between group 
differences on the NA scores. Studies contrasting concordant and discordant MZ pairs 
on measures of clinical severity have produced mixed results. 
 
3.6.4. Antipsychotic Medication Effects 
3.6.4.1. The association between NAs and antipsychotic medication is plausible given 
their pharmacological properties and evidence that they cause brain changes (Dazzan, 
Morgan et al. 2004; Lieberman, Tollefson et al. 2005). While some studies have shown 
a link, as a statistical relationship, between NAs and antipsychotic medication (Gupta, 
Andreasen et al. 1995), the majority have failed to detect this. 
3.6.4.2. In this study, the effect in the probands was related both to current 
antipsychotic dose, and measured extra-pyramidal side effects. While scales for NAs 
and extra-pyramidal side effects may be measuring the same phenomena, I tried to 
guard against this by selecting the TAKE scale to directly assess extra-pyramidal side 
effects, this scale being less prone to contamination by NA variables than other side 
effect rating scales. 
3.6.4.3. It was not possible to covary for the effects of medication in the analysis 
model as neither the well co-twins nor controls were on any medication. One hypothesis 
might be that rather than being a direct consequence of antipsychotic medication, NAs 
may act as a marker of subjects who are more prone to experience extra-pyramidal side 
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effects to antipsychotics. Support for this comes from observations of ‘extra-pyramidal 
side effects’ in treatment naïve patient groups (Gupta, Rajaprabhakaran et al. 1995; 
Wolff and O'Driscoll 1999; Shibre, Kebede et al. 2002) and in those who later go on to 
develop symptoms (Leask, Done et al. 2002). 
 
3.6.5. Schizotypy 
3.6.5.1. NAs were associated with increased childhood schizotypal personality traits. 
The latter characteristics occur more commonly in those who later develop 
schizophrenia and correlate with familial risk for the disorder (Mata, Gilvarry et al. 
2003). 
3.6.5.2. In a recent study of neurocognitive deficits and schizotypal symptoms in 
schizophrenic twins, Johnson et al (Johnson, Tuulio-Henriksson et al. 2003) concluded 
that the presence of schizotypal symptoms alone did not confer risk for cognitive 
deficits without the additional presence of genetic risk for the illness. I have however 
shown in Chapter 4 of this thesis, that schizotypal traits correlate both genotypically and 
phenotypically with schizophrenia, that is that they share common risk genes. This 
finding is in agreement with Johnson’s suggestion that susceptibility loci for 
schizophrenia manifest themselves both as neurocognitive deficits and schizotypal 
symptoms, while my data support the conclusion that their effects also extend to NA 
expression. 
 
3.6.6. NAs as an Endophenotype 
3.6.6.1. Against the endopheotype criteria outlined in Chapter 1, I have confirmed in 
this study that NA’s are associated with schizophrenia. They are unrelated to the 
psychotic symptoms of the disorder, thus are state independent, but appear to be 
influenced by, or at least related to, its treatment with antipsychotic medication. NA’s 
are found at higher rates in the families of patients than the general population, with 
some evidence that they co-segregate in those families. When assessed using a 
standardised scale by trained clinicians, I have shown that they can be reliably 
quantified. Unfortunately I was not able to assess their heritability as the sample was too 
small for genetic modelling, though the distribution of deficits suggested that they were 







3.7. Strengths and Weakness 
3.7.1. Firstly, this study was hampered by a lack of blindness to diagnostic status. In 
preliminary assessments it was impossible to maintain blindness in the context of a 
clinical examination and so this was dropped as a feature of the study design. 
3.7.2. Secondly, NAs are by definition subjective and prone to rater error. I guarded 
against this by thoroughly training two raters, using a well validated structured rating 
instrument, and monitored inter-rater reliability. 
3.7.3. Thirdly, the subjects were not drawn from an epidemiological sample and 
consequently may have been prone to selection bias. This may have been compounded by 
the twin nature of this sample, since twins are more prone to obstetric complications, 
which can cause cerebral pathology manifesting as NAs (Pinborg, Loft et al. 2004). 
3.7.4. Both our control sample and well co-twins from discordant pairs, contained 
subjects with other lifetime axis I disorders. In order to maintain diagnostic consistency 
between all the non-schizophrenic subjects (MZ and DZ discordant co-twins, and MZ 
and DZ controls), we applied the same psychiatric exclusion criteria to all. Consequently 
these groups contained subjects who fulfilled criteria for other lifetime axis I disorders. 
None of these ‘well’ subjects was symptomatic at the time of testing or taking any 
psychotropic medication. We considered that to introduce additional exclusion criteria for 
the controls, specifically that any past illness be an exclusion criterion, would inflate 
differences with the controls by making the latter ‘super-well’ in comparison to the 
discordant well co-twins. I repeated the analyses excluding all control subjects with a 
past axis I disorder. As predicted this tended to increase group differences, particularly 
between DZ discordant co-twins and the controls. 
3.7.5. I made multiple statistical comparisons but only after a significant effect had 
been detected at the group level and post hoc results are quoted using the Bonferroni 
correction. 
3.7.6. The failure of the study to detect significant differences between the well co-
twins of discordant MZ and DZ pairs may well represent a type II error. This was the first 
study to directly compare MZ and DZ discordant groups on NA, the co-twins from these 
two groups differ only in their genetic proximity to the patient, and we can speculate 
consequently that the effect sizes will be small. 
3.7.7. Strengths of this study include the fact that this sample represents the largest 
examination of NA in twins with schizophrenia, and the only one to include both MZ and 
DZ discordant pairs, as well as compare patients from MZ concordant and discordant 
pairs, to assess their suitability as endophenotype markers for schizophrenia. Rigorous 
structured diagnostic and assessment criteria were applied throughout and improved 
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statistical methods utilised to capitalise on the strengths of the twin model while avoiding 








4.1.1. Abnormalities in early social development and personality are present in 
patients with schizophrenia and their unaffected relatives. In this study I aimed to 
establish both the degree to which these childhood and adolescent developmental 
abnormalities are genetically determined, and to what extent they share genetic risk with 
schizophrenia. 
4.1.2. I used a combined twin and family cohort (n=531) to assess childhood and 
adolescent social adjustment and schizotypal personality traits in 98 twin pairs (n=196) 
varying in their zygosity and concordance for schizophrenia and 156 sibling clusters 
(n=335) varying in their concordance for schizophrenia. 
4.1.3. Schizophrenia was significantly associated with childhood and adolescent 
deficits in social adjustment and schizotypal personality traits in adolescence. Additive 
genetic effects were the main source of these phenotypic correlations. 
4.1.4. Thus abnormalities of social adjustment and personality are present in 
children and adolescents who will later develop schizophrenia. These deficits share 




4.2.1. The neurodevelopmental model (Weinberger 1987; Murray, O'Callaghan et 
al. 1992) suggests that the origins of the illness lie in early life and that patients manifest 
signs of abnormal neural function well before overt psychotic symptoms. This theory is 
based in part, on the observation of premorbid abnormalities in a wide variety of domains 
including schizotypal personality and social competency (Gupta, Rajaprabhakaran et al. 
1995; Bailer, Brauer et al. 1996; Davidson, Reichenberg et al. 1999; Vourdas, Pipe et al. 
2003; Addington and Addington 2005; Johnstone, Ebmeier et al. 2005). These deficits 
predict those who go on to develop schizophrenia (Johnstone, Ebmeier et al. 2005), 
acting as markers of future illness severity (Gupta, Rajaprabhakaran et al. 1995; Vourdas, 
Pipe et al. 2003; Addington and Addington 2005) and prognosis (Bailer, Brauer et al. 
1996; Addington and Addington 2005). It is possible that these deficits could represent 
early facets of the illness, or alternatively risk factors for it. 
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4.2.2. Similar abnormalities accumulate in patients’ non-psychotic relatives 
(Cannon-Spoor, Potkin et al. 1982; Foerster, Lewis et al. 1991; Maxwell 1992; Walshe, 
Taylor et al. 2007; Shapiro, Marcenco et al. 2009), suggesting but not proving that they 
are genetic in origin. This question though remains unanswered, since the familial 
aggregation could result from shared familial environmental factors; by virtue of their 
design the earlier studies could not discriminate between these two competing influences. 
4.2.3. Combined twin and family studies utilising genetic modelling offer the 
optimal study design both to explore and quantify the extent to which genetic and 
environmental factors influence variation in, and covariation between traits. 
Developmental data in a schizophrenia twin and family sample can both establish the 
genetic and environmental influences on such traits, and quantify the genetic relationship 
between these facets and schizophrenia. A combined twin and family study design offers 
the additional advantages of increasing experimental sample size, reducing sample 
variance and offering a better approximation of the true population than a twin sample 
alone, while also increasing the study’s power to discriminate between additive and 
dominant genetic effects. Sibling pairs can model for dizygotic (DZ) twin pairs on the 
basis that they share the same degree of genetic similarity. 
4.2.4. I hypothesised: 
4.2.4.1. firstly that childhood and adolescent social adjustment and personality will be 
more abnormal in patients with schizophrenia compared both to their non-psychotic 
relatives and healthy controls 
4.2.4.2. secondly that their non-psychotic relatives will also be more abnormal than 
controls. 
4.2.4.3. thirdly that genetic model fitting would show that shared genetic factors 




4.3.1.1. The subjects for this study participated in the Maudsley Twin (Picchioni, 
Toulopoulou et al. 2006; Toulopoulou, Picchioni et al. 2007) and Family (McDonald, 
Marshall et al. 2006) Studies of Schizophrenia. 
4.3.1.2. A total of 531 individuals contributed to this study after Research Ethics 
Committee approval had been granted. 
4.3.1.3. Recruitment was as described in 3.3.1.2. Twin and singleton probands with 
schizophrenia, and their relatives, were recruited nationally through referral by treating 
National Health Service (NHS) psychiatrists and voluntary support groups. Control 
twins and families were recruited nationally. 
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4.3.1.4. Exclusion criteria were as in 3.3.1.3 with in addition lack of a suitable parent 
informant. 
4.3.1.5. All probands gave written informed consent for their parents to contribute 
after a detailed description of the study aims and method. 
 
4.3.2. Clinical Assessment 
4.3.2.1. All subjects directly assessed used the same methodology as 3.3.2.1. For 
sibling relatives not directly assessed, information regarding clinical status was obtained 
from the most reliable informant using the Family Interview for Genetic Studies 
(Maxwell 1992) with additional information from medical notes where available. Twin 
zygosity was determined from 12 highly polymorphic microsatellite markers (95%) or a 
twin likeness questionnaire (5%). 
4.3.2.2. Developmental Assessment 
4.3.2.2.1. Early social function and adjustment were assessed by parental 
interview (40%) and parental self-report questionnaire (60%) using a modified version 
of the Premorbid Social Adjustment scale PSA(Cannon-Spoor, Potkin et al. 1982; 
Foerster, Lewis et al. 1991). This assesses premorbid function on an eight point scale 
(0-7) of increasing deviance, over two developmental phases, childhood to the age of 
11, and adolescence from 12 to 16 years. It assesses function in four developmental 
areas, social interactions, peer relationships, school performance and adaptation, and 
general interests, as well as psychosexual function in the adolescent period only. It 
produces a sum score for each developmental age phase. 
4.3.2.2.2. Premorbid schizotypal personality traits were assessed using the 
Premorbid Assessment of Schizoid and Schizotypal Traits (PSST)(Foerster, Lewis et 
al. 1991). This is a seven item questionnaire, on which each item is rated on a four 
point scale (0-3) of increasing deviance using explicit anchor points, to produce a sum 
score. The items cover sociability, affect, suspiciousness and sensitivity, beliefs and 
behaviour, speech and isolated or peer group anti-social behaviour. 
 
4.3.3. Participants 
4.3.3.1. The final study group consisted of ninety-eight twin pairs (21 monozygotic 
(MZ) concordant for schizophrenia, 18 MZ discordant for schizophrenia in which the 
co-twin was free of any psychotic illness, 10 DZ discordant for schizophrenia and 29 
MZ and 20 DZ healthy control twin pairs (with no personal or family history of a 
psychotic or schizophrenia spectrum disorder), and one hundred and fifty six sibling 
family clusters(Walshe, Taylor et al. 2007) (128 schizophrenia patients, 21 of their 
concordant ill siblings, 122 of their discordant (i.e. free of any psychotic illness) 
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siblings, and 85 healthy control siblings from unaffected families, the largest family 
contained eight siblings. 
4.3.3.2. The probability that any of the discordant twin pairs would become 
concordant for schizophrenia was low as an average of 8.9 (SD=5.9) years in the MZ, 
and 16.5 (SD=11.2) years in the DZ pairs, had elapsed since the onset of the probands’ 
illness (Belmaker, Pollin et al. 1974). 16 of the non-schizophrenic co-twins from 
discordant pairs, 13 of the unaffected siblings and 21 of the healthy controls met DSM-
IV criteria for a lifetime axis I disorder, mainly major depressive disorder, though none 
were unwell at the time of testing. 
 
4.3.4. Regression Analysis 
4.3.4.1. The PSA and PSST scales generated three dependent variables, total 
childhood social adjustment (CSA), total adolescent social adjustment (ASA) and  total 
premorbid schizotypal personality traits (PSST). 
4.3.4.2. The main objective of this part of the statistical analysis was to compare 
values on these three dependent variables between the groups; MZ concordant ill, MZ 
discordant ill, MZ discordant well, siblings concordant ill, DZ twins & siblings 
discordant ill, DZ twins & siblings discordant well, with all the healthy control subjects. 
4.3.4.3. As before the genetic relatedness of twin and siblings and the likely within-
family correlations violate ANOVA’s assumption of independence. Furthermore, there 
were outlying points in the PSA distributions, while the PSST variables in some groups 
suffered from floor effects. Consequently, group differences were analysed using a 
regression model with standard errors that is robust against correlations within families, 
departures from normality, and heterogeneity of covariance matrices (Binder 1983). The 
model uses dummy variables for group as independent variables. 
4.3.4.4. I followed a similar analytical approach as in 3.4 and carried out overall 
group comparisons followed by post-hoc pair-wise comparisons. To control for multiple 
testing, pairwise comparisons were carried out only when there was a significant overall 
difference and Bonferroni correction used to judge statistical significance throughout. 
4.3.4.5. Regression and logistic regression with robust standard errors were used to 
compare demographic and clinical variables between groups while taking account of 
family clusters. Age and gender were considered potential confounders of the later 
group effects on the dependant variables. All analyses were carried out in Stata 10 
(StataCorp LP, Texas, USA, 2008). 
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Table 4.1 
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33.92 (8.88) 30.78 (5.52) 30.01 (9.23) 32.57 (7.62) 30.01 (9.23) 34.44 (8.15) 35.26 (10.62) 
424 (11, 253) 
<0.001 
Sex 




Mean (SD) 14.07 (3.16) 13.28 (3.53) 13.67 (3.07) 13.09 (2.45) 13.53 (2.65) 14.19 (2.94) 13.85 (10.76) 
540 (11, 242) 
<0.001 
Social Class 
Mean (SD) 2.29 (0.84) 2.33 (1.28) 2.28 (0.75) 2.47 (1.09) 2.28 (0.75) 2.46 (1.10) 2.55 (1.02) 
167 (8, 246) 
<0.001 
Legend Table 4.1 
Abbreviations: Cc, concordant; Dc, discordant; MZ, monozygotic; DZ, dizygotic 
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4.3.5. Model Fitting Analysis 
4.3.5.1. The Twin Model 
4.3.5.1.1. Data from identical (MZ) and non-identical (DZ) twins and siblings 
allows the decomposition of variation in, and covariation between, traits into latent 
genetic and environmental factors based on their hypothetical contributions to the 
correlation between different types of family relationships. 
4.3.5.1.2. MZ twins correlate 1 for additive genetic effects A (also known as 
narrow-sense heritability, h2), representing the combined effect of alleles at, and 
across, loci that ‘add up’ to affect a behaviour, while DZ twins and siblings correlate 
half (i.e. 0.5). Conversely, twins and siblings correlate equally (i.e. 1.0) for shared 
environmental effects (C or c2), while unique environmental effects (E or e2) are 
modelled as 0. Instead of C, a non-additive genetic or dominance component (D or d2) 
can be modelled, which correlates 1 for MZ twins and .25 for DZ twins and sibs and is 
consistent with DZ/sibling correlations that are smaller than half the MZ correlation. 
As a consequence of these different degrees of genetic correlations between MZ and 
DZ twins/siblings, but the same degree of correlation in environmental influences, a 
higher trait correlation in MZ than DZ twins/siblings, is assumed to represent the 
effects of genetic factors (Rijsdijk, van Haren et al. 2005). In addition, twin-specific 
environmental effects (S) were modelled, to account for the potential excess in 
correlation in twin pairs compared to sibling pairs. 
4.3.5.2. Bivariate Modelling 
4.3.5.2.1. Bivariate models estimate A, C or D, S and E of the individual variables 
through the MZ:DZ/sibling cross-member within-trait (Trait A or B in Subject 1 with 
that of their co-twin/sibling) correlations, partitioning the covariance between the two 
traits into A, C or D, S and E through the cross-member cross-trait (Trait A in Subject 
1 with Trait B of their co-twin/sibling) MZ:DZ/sibling correlation ratios. Significant 
cross-member within/cross traits covariance implies that common aetiological factors 
between two traits are familial. These familial effects are genetic in nature if the cross-
member cross-trait correlation is greater for MZ twins than for DZ/siblings and of the 
order 2 to 1, whereas a 1 to1 ratio suggests that shared-environmental effects (C) 
induce the correlation between the two traits. Non-significant cross-member cross-
trait correlations suggest that the shared aetiological influences on the two traits are 
non-familial, i.e. due to unique environmental effects, E. 
4.3.5.2.2. The partitioning of the covariation between schizophrenia and each 
developmental measure into genetic, shared and unique environmental sources of 
covariation, yields genetic (rg), common environmental (rc) and individual-specific 
environmental (re ) correlations: rg indicates the extent to which the same genetic 
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effects impact on both schizophrenia and development and personality, while the rc 
reflects the degree to which the environmental effects inducing a shared 
environmental correlation for one trait (e.g. abnormal childhood social development) 
are the same with those in the second trait (e.g. schizophrenia). The level to which the 
unique environmental influences are common in both traits is given by the re. 
4.3.5.2.3. As the rg, rc, and re correlations do not take into account the heritability 
of either trait, it is possible for a large genetic correlation to explain very little of the 
observed co-variation between two traits. Combining the information from the rg, rc, 
and re with the heritabilities, c2 and e2 of each trait allows us to establish the genetic 
(rph-a), common environmental (rph-c) and unique environmental (rph-e) contribution to 
the total phenotypic correlation (rph) between two traits. 
4.3.5.3. The Fixed Bivariate Threshold Liability Model 
4.3.5.3.1. In order to simultaneously analyse dichotomous diagnostic and 
continuous developmental data, the latter were ordinalized into five equal classes, 
after potential sources of variation and noise, age and gender, were partitioned out. 
The bivariate liability threshold model assumes a continuum of genetic risk that is 
normally distributed, the disorder occurring when it exceeds the liability threshold. All 
correlations between schizophrenia and social development and personality, both 
within and across individuals, were derived from the combined sample. In other 
words, both affected and unaffected individuals were assumed to be part of the same 
distribution of liability, with each individual below or above that threshold. As data 
were from twin pairs and siblings selected for schizophrenia rather than randomly, the 
sources of variance of the developmental/personality variables and their covariance 
with schizophrenia were estimated after ascertainment correction. This involved 
fixing the model parameters of the selection variable (schizophrenia) to values 
estimated by an earlier meta-analysis(Sullivan, Kendler et al. 2003) (h2=0.81, c2=0.11, 
e2=0.08) and set the threshold to the population life-time prevalence (1%). 
4.3.5.3.2. A goodness of model-fit index (χ2) was obtained by computing the 
difference in likelihoods and the degrees of freedom between the genetic AC/DSE 
model and a constrained correlational model in which the observed twin and sibling 
correlations are explained with a limited number of parameters given the complexity 
of the family data (Rijsdijk, van Haren et al. 2005). 
4.3.5.4. Polychoric Correlations 
4.3.5.4.1. To estimate the MZ and DZ/sibling correlations within and across each 
developmental and personality rating and schizophrenia, we fitted a constrained 
correlational model to the data to get: one within-member cross-trait correlation (e.g. 
childhood social development with liability to schizophrenia) equal across all 
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individuals in the sample regardless of their zygosity; one MZ, DZ and sibling cross-
member within-developmental-trait correlation; one MZ, DZ and sibling cross-
member cross-trait correlation. In line with the correction for selection described 
above, in each correlational model for schizophrenia the MZ and DZ/sibling cross-
member correlations were fixed according to the point estimates of the meta-analysis: 
rMZ = .92 and rDZ = .515. 
 
4.4. Results 
4.4.1. Group Differences-Comparison of Means 
4.4.1.1. The groups differed significantly in age, gender, years in full time education 
and social class (Table 4.1). Summary statistics for the developmental and personality 
scores are shown in Table 4.2.The subsequent group comparisons for the developmental 
and personality scores were adjusted for age and gender to control for potential 
confounding effects. 
4.4.1.2. There was an overall effect of group (Table 4.2) on both childhood and 
adolescent social development and premorbid schizotypal ratings. 
4.4.1.3. The post hoc group tests are shown in Table 4.3. There were no significant 
differences in the means between DZ twins and siblings for any of the developmental 
and personality variables. Since DZ twin pairs and sibling pairs share the same genetic 
relationship, we felt justified in collapsing them into single groups on the basis of 
concordance and diagnostic status. 
4.4.1.4. Irrespective of zygosity or concordance, patients with schizophrenia were 
rated to have experienced more abnormal childhood and adolescent social development 
and more abnormal childhood personality than healthy controls. 
4.4.1.5. The well co-twins from MZ discordant pairs, their co-twin had schizophrenia, 
were also more abnormal on all three developmental ratings compared to the healthy 
controls. In contrast, the well DZ co-twins and siblings from discordant pairs did not 
differ from controls for childhood social development and schizotypal ratings and only 
approached significance for adolescent social development. 
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F or χ2 (df) p 
CSA 2.35 (0.71) 2.80 (1.18) 2.51 (0.77) 2.73 (1.01) 2.31 (0.80) 2.04 (0.69) 1.71 (0.53) 41 (11, 236) <0.001 
ASA 2.75 (0.89) 3.22 (1.46) 3.06 (0.98) 3.10 (1.25) 2.65 (0.97) 2.08 (0.73) 1.78 (0.61) 33 (11, 236) <0.001 
PSST 1.64 (0.56) 1.47 (0.44) 1.47 (0.40) 1.41 (0.38) 1.43 (0.36) 1.13 (0.27) 1.11 (0.15) 60 (11, 247) <0.001 
 
Abbreviations: Cc, concordant; Dc, discordant; MZ, monozygotic; DZ, dizygotic ; CSA, childhood social adjustment ; ASA, adolescent 
social adjustment ; PSST Premorbid Schizotypal traits
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Table 4.3 Post hoc adjusted mean comparisons in twins and siblings 
 
MZ Cc ill 
vs  
All Controls 
MZ Dc ill 
vs 
All Controls 
MZ Dc well 
vs 
All Controls 
Siblings Cc ill 
vs 
All Controls 
DZ Dc ill & 
Siblings Dc ill 
vs 
All Controls 
DZ Dc well & 




t       p t      p t      p t      p t      p t      p 
CSA 3.61    <0.001** 4.16      <0.001** 3.03     0.003** 2.96     0.003** 6.74     <0.001** 2.14     0.033 
ASA 4.79     <0.001** 5.18     <0.001** 3.50     0.001** 3.22     0.001** 6.33    <0.001** 2.65     0.009 
PSST 4.00     <0.001** 3.12     0.002** 3.11     0.002** 2.85     0.005** 3.62     <0.001** 1.10     0.27 
 
Abbreviations: Cc, concordant; Dc, discordant; MZ, monozygotic; DZ, dizygotic ; CSA, childhood social adjustment ; ASA, adolescent 
social adjustment ; PSST Premorbid Schizotypal traits. **significant difference at p<0.0083 Bonferroni corrected
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Table 4.4 Cross-twin/sibling within trait and cross twin/sibling cross-trait correlations (r & 95% CI)  
 
Abbreviations: MZ, monozygotic; DZ, dizygotic ; CSA, childhood social adjustment ; ASA, adolescent social adjustment ; PSST 
Premorbid Schizotypal traits. 
Note: The schizophrenia cross-twin correlation (SZtw1–SZtw2) is constrained to be .92 in MZ twins and .515 in DZ twins based on the 
point estimates of meta-analysis results, and the thresholds on the liabilities are fixed to a prevalence of 1%. Intervals including 0 
indicate non-significance.  
 Correlation of developmental and personality score within 
members of twin and sibling pairs 
Correlation of  developmental and personality  score with 
schizophrenia across members of twin and sibling pairs 
 MZ DZ Siblings DZ & Sibs 
combined 



















































Table 4.5. Additive genetic, dominant genetic, shared and specific environmental estimates (with 95% CI) of the AD/CE genetic model 








Abbreviations: CSA, childhood social adjustment ; ASA, adolescent social adjustment ; PSST Premorbid Schizotypal traits. 
Note: a2, d2, c2 and e2: broad heritability, dominant genetic, shared and non-shared environmental. Confidence intervals including zero 
indicate non-significance. 
Parameters for schizophrenia are fixed based on a prevalence of 1% and the following genetic model: h2=.81, c2=.11, e2=.08  
 a2 d2 c2 e2 
CSA 0.17 ( 0.09/ 0.60) 0.63 (0.16/ 0.76 ) - 0.20 (0.12/ 0.35 ) 
ASA 0.46 ( 0.06/ 0.67 ) - 0.16 (0.08/ 0.40) 0.39 (0.24/ 0.60) 
PSST 0.13( 0.065/ 0.45 ) 0.53 (0.17/ 0.67 ) - 0.34 (0.23/ 0.51) 
 85 
Table 4.6 The phenotypic correlations between schizophrenia and the developmental and personality scores (rph), the decomposed 
sources of the correlations (rph-a, rph-c, rph-e) predicted by the AC/DE models and correlation estimates (with 95% CI)    
 
 rph-a rph-c rph-e rph ra rc re 





















Abbreviations: rph: total phenotypic correlation; rph-a, rph-c, rph-e, phenotypic correlation due to additive genetic, shared and unique 
environmental influences. ra, re, re, correlation between additive genetic, shared and specific environmental factors. Confidence 
intervals including zero indicate non-significance. Fixed genetic model for Schizophrenia used: h2=.81, c2=.11, e2=.08 
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4.4.2. Genetic Model Fitting 
4.4.2.1. Table 4.4 shows the maximum likelihood polychoric correlations for the MZ 
and DZ twin pairs and siblings. A sub-model of the constrained correlational model 
showed no significant difference in DZ twins and siblings for any of the variables 
(∆χ(df=2): 4.99, 1.83 and 1.75; p-values: 0.08, 0.40 and 0.42 for CSA, ASA and PSST, 
respectively) For CSA and PSST the pattern of MZ and DZ/sibling correlations 
suggested non-additive genetic effects (consequently an ADE model was fitted), 
whereas for ASA an ACE model was indicated, both included twin-specific 
environmental effects (S). Since these twin-specific effects were non-significant for all 
three variables (∆χ(df=1): 0.66, 0 and 3.8; p-values: 0.41, 1 and 0.05 for CSA, ASA and 
PSST, respectively), we evaluated the estimates from the full AD/CE models. 
4.4.2.2. Table 4.5 shows that significant additive genetic heritability (a2) effects were 
found for all three variables. There was further evidence of dominant genetic (d2) effects 
for childhood social development and schizoid/schizotypal personality and shared 
environmental effects for adolescent social development. The remainder of the variance 
was explained by unique environmental influences (e2), including measurement error. 
4.4.2.3. Table 4.6 shows that an increased liability for schizophrenia was associated 
with greater abnormalities in each of the developmental variables (rph). All three 
abnormal developmental markers had significant additive genetic correlations with 
schizophrenia (ra),. whereas specific environmental correlations (re) and the shared 
environmental correlation in ASA (rc) were not significant. Therefore, additive genetic 
factors were the main source of the phenotypic correlation between all three of the 
developmental variables and schizophrenia (rph-a). 
 
4.5. Discussion 
4.5.1. This studyconfirmed that both social development and schizotypal 
personality traits are abnormal in children and adolescents who subsequently develop 
schizophrenia, while unaffected relatives demonstrate qualitatively similar abnormalities 
suggesting a familial effect. Our model fitting analyses allowed us to extend this 
interpretation, supporting the notion that abnormal early social development and 
schizotypal personality traits are related to schizophrenia through common genetic 
influences. 
4.5.2. Premorbid social behaviour abnormalities are well replicated in schizophrenia 
(Done, Crow et al. 1994; Malmberg, Lewis et al. 1998; Cannon, Caspi et al. 2002; 
Addington and Addington 2005), with little effect of gender(Olin and Mednick 1996; 
Cannon, Jones et al. 1997; Addington and Addington 2005). They deteriorate from 
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childhood through adolescence(Davidson, Reichenberg et al. 1999; Tarbox and Pogue-
Geile 2008). 
4.5.3. The aetiology of these deficits has in the past been unclear with genetic and 
environmental origins proposed(Sobel 1961; Ragins, Schachter et al. 1975; Hans, 
Auerbach et al. 2000; Hans, Auerbach et al. 2005; Shim, Kang et al. 2008). The core of 
these pre-schizophrenia social deficits centre on the quality of peer relations(Lewine, 
Watt et al. 1980), especially with people of the opposite sex(Dworkin, Lewis et al. 1994; 
Malmberg, Lewis et al. 1998), through social immaturity and peer rejection(Hans, 
Auerbach et al. 2000). Furthermore, the more extreme the difficulties in establishing and 
maintaining peer relationships, the greater the future risk for schizophrenia(Malmberg, 
Lewis et al. 1998). 
4.5.4. Social adjustment abnormalities both in childhood (a2=0.17) and adolescence 
(a2=0.46) were heritable. The additive genetic correlations for childhood (ra=1.0) and 
adolescent (ra=0.55) social development with schizophrenia indicate that the same genetic 
effects contribute to variance in abnormal social development at both ages and to the 
liability for schizophrenia. For both childhood and adolescent social development much 
of this phenotypic correlation was attributable to shared additive genetic effects, 
environmental effects were insignificant. Correlations however do not prove causality 
and this study is still unable to determine if the liability to schizophrenia impairs early 
social development or if, from the endophenotype perspective, impaired early social 
development causes schizophrenia. Equally they could be linked by another common 
patho-physiological process. 
4.5.5. Broad heritability of schizotypal traits in twin studies range between 27 and 
60%, depending on the measures used, with considerable overlap of confidence intervals 
(Kendler and Hewitt 1992; Hay, Martin et al. 2001; MacDonald, Pogue-Geile et al. 
2001). Schizotypal personality traits are, phenomenologically at least intricately linked to 
schizophrenia(Liddle 1987; Bentall, Claridge et al. 1988; Liddle and Barnes 1990; 
Bergman, Silverman et al. 2000), more prominent in men(Kremen, Faraone et al. 1998), 
linked with minor psychotic symptoms in childhood(Poulton, Caspi et al. 2000) and are 
associated with an increased future risk of schizophrenia(Vourdas, Pipe et al. 2003). They 
hypothetically lie on a population based continuum of psychosis(van Os, Verdoux et al. 
1999); indeed the modest phenotypic correlation with schizophrenia (rph=0.33) in this 
study was perhaps surprising. Despite some inconsistency, studies in relatives and twins 
(Baron, Gruen et al. 1985; Grove, Lebow et al. 1991; Kendler, McGuire et al. 1993; 
Maier, Lichtermann et al. 1994; Battaglia, Bernardeschi et al. 1995; Bergman, Silverman 
et al. 2000) generally support familial aggregation with schizophrenia, particularly for the 
affective and interpersonal components (Kremen, Faraone et al. 1998),. However whether 
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schizotypy is a unitary(Jang, Woodward et al. 2005), or like schizophrenia, a 
multidimensional construct (Kendler, McGuire et al. 1995; Vollema and van den Bosch 
1995; Suhr and Spitnagel 2001; Linney, Murray et al. 2003), with attendant aetiologically 
heterogeneity, still remains unclear. 
4.5.6. Additive genetic effects accounted for 13% and dominant genetic effects 53% 
of the variance in schizotypal personality ratings, the results broadly speaking in line with 
studies that have found evidence of both additive and non-additive (dominant) genetic 
influences across a variety of personality domains(Keller, Coventry et al. 2005; Rebollo 
and Boomsma 2006; Rettew, Rebollo-Mesa et al. 2008). While the phenotypic 
correlation for schizotypal personality with schizophrenia was only modest (0.33), this 
nonetheless represented a strong additive genetic correlation ra with schizophrenia of 
0.99, emphasising the genetically linked variance between these two ‘schizophrenia 
spectrum’ disorders, and the lack of any significant unique environmental effects to link 
the two. 
4.5.7. The influence of unique environmental factors on the premorbid markers was 
apparent in our sample, and contributed to developmental divergence. The majority of 
discordant MZ twin studies have reported that the future probands were distinguishable 
pre-morbidly from their genetically identical co-twins by their abnormal personality 
(Arieti 1949; Kringlen 1967; Mosher, Pollin et al. 1971; Fischer and Christen.A 1973), 
social development(Pollin, Stabenau et al. 1966), academic ability (Stabenau and Pollin 
1967) and sub-clinical non-psychotic symptoms (Stabenau and Pollin 1967). Studies in 
unaffected first degree relatives of patients with schizophrenia (Cannon-Spoor, Potkin et 
al. 1982; Foerster, Lewis et al. 1991; MacDonald, Pogue-Geile et al. 2001) strongly 
suggest that similar, if less marked early developmental deficits are present in the 
unaffected relatives, supporting at the very least a familial effect. 
4.5.8. This data suggest that genetically influenced abnormalities in social 
development and personality are linked to the genetic risk for schizophrenia, though that 
unique environmental influences drive up to a third of the variance in developmental and 
personality data in the twins and siblings, both in their social abilities and personality and 
later schizophrenia. Candidate environmental factors for schizophrenia include obstetric 
complications(McNeil, Cantorgraae et al. 1994), childhood trauma(Morgan and Fisher 
2007; McEwen 2008), drug exposure(Arseneault, Cannon et al. 2002; O'Daly, Guillin et 
al. 2005), immigration status(Veiling, Susser et al. 2008) and social inequality(Boydell, 
van Os et al. 2004), each factor’s influence varying with the developmental stage and 
possibly cumulative in effect(Cougnard, Marcelis et al. 2007). Models suggesting how 
these processes operate, through affective(Myin-Germeys, Krabbendam et al. 2003), 
cognitive, stress sensitization(Collip, Myin-Germeys et al. 2008), dopamine 
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sensitization(Laruelle 1998; Laruelle 2000; Featherstone, Kapur et al. 2007) or 
hypothalamic-pituitary-adrenal axis dysfunction(Walker and Diforio 1997; Tarbox and 
Pogue-Geile 2008; Walker, Mittal et al. 2008) however remain speculative. 
4.5.9. Strengths and Limitations 
4.5.9.1. Twin modelling is dependent on the validity of the equal environments 
assumption (Joseph 1998). A finding called into question in our study by the low DZ 
correlations, though other explanations include sibling interaction and genetic 
dominance and epistasis (Loehlin 1986). As has been noted earlier in this thesis (see 
2.3), it is likely that the environmental experiences of MZ twins are more similar than 
DZ twins and siblings, though that this is in fact driven by their shared genotype 
(Plomin and Bergeman 1991). 
4.5.9.2. While the non-psychotic co-twins and siblings in this study were at high 
genetic risk, they were actually at very low risk of ever developing schizophrenia, as all 
the non-psychotic co-twins from discordant pairs had remained free of schizophrenia for 
long enough after their co-twin had become ill (Belmaker, Pollin et al. 1974). Thus we 
can be confident that these findings are not driven by non-psychotic relatives, with an 
excess in the MZ twins, who will later develop schizophrenia. 
4.5.9.3. This study was hampered by its retrospective design, in particular that 
mothers were asked to recall aspects of their children’s development and personality 
from years earlier and after, in some cases one or more of the children had developed 
schizophrenia. The mothers’ reports are subjective and prone to rater error and contrast 
bias. However the mothers of the discordant twins and siblings did not appear to have 
elevated their ‘threshold’ for normality by virtue of having an ‘abnormal’ child who 
later developed schizophrenia, leading to under reporting of abnormalities in the non-
psychotic co-twins. In fact we detected the opposite, with more abnormalities reported 
in the unaffected co-twins and siblings than controls. 
4.5.9.4. The subjects were not drawn from an epidemiological sample and while this 
could introduce a selection bias and inflate the genetic estimates with schizophrenia, this 
effect was minimised as the subjects were referred nationally by NHS psychiatrists. The 
NHS is comprehensive, free at the point of delivery service, it is socially inclusive and 
cares for the majority of patients with schizophrenia in the UK, making it a highly 
representative recruitment source. 
4.5.9.5. As before both our control sample and well co-twins and siblings from 
discordant pairs, contained subjects with other lifetime axis I disorders. In order to 
maintain diagnostic consistency between all the non-schizophrenic subjects (discordant 
MZ and DZ/siblings and control MZ and DZ/siblings), I applied the same psychiatric 
exclusion criteria to all. Consequently these groups contained subjects with lifetime 
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histories of other axis I disorders though none were symptomatic at the time of testing. I 
considered that to introduce additional exclusion criteria for the controls, specifically 
that of any axis I pathology, would artificially inflate differences with the controls. 
4.5.9.6. Strengths of this study include that this sample represents the largest national 
examination of premorbid developmental traits in twins and siblings with schizophrenia, 
and the only to include both MZ and DZ discordant pairs with known zygosity and 
clinically assessed. Genetic model fitting in a combined twin and family sample 
increased the power to detect genetic and environmental effects (Posthuma, de Geus et 
al. 2000; Boomsma, Busjahn et al. 2002), rigorous structured assessment criteria were 
used and improved statistical methods capitalised on the strengths of the twin/sibling 
model avoiding issues of independence. 
4.5.10. This study supports the view that heritable, genetically determined premorbid 
abnormalities of social adjustment and personality are found in schizophrenia. These 
deficits are detectable in those who will later develop schizophrenia and their non-








5.1.1. Background: Reductions in the total whole brain, grey, and to a lesser extent 
white matter volumes are now recognised as robust features of schizophrenia. However, 
it remains unclear to what extent these abnormalities are determined by genetic or 
environmental risk for the disorder. In this study I investigated the influence of these risk 
factors on brain volumes in monozygotic (MZ) twin pairs concordant and discordant for 
schizophrenia as well as healthy control twins. 
5.1.2. Methods: Total whole brain, grey and white matter volumes were calculated 
from structural magnetic resonance images using an automated alogorithm implemented 
in SPM2 from 63 MZ twins pairs, comprising of 21 MZ pairs concordant for 
schizophrenia, 17 MZ pairs discordant for schizophrenia, and 25 healthy MZ twin pairs.  
5.1.3. Results: Whole brain, grey and white matter volumes were all smaller in 
probands with schizophrenia, while there were no significant differences between 
probands with schizophrenia whether they came from concordant or discordant pairs. 
Well co-twins from discordant pairs differed significantly on all three volumes compared 
to the healthy controls, though these findings did not survive correction for multiple 
testing. The ill and well co-twins from discordant pairs did not differ from each other in 
any of the three volumes. There was a negative association for all three volumes with 
abnormal childhood developmental markers. 
5.1.4. Conclusions: Gross cerebral volume reduction in schizophrenia, across white 
and grey matter, is determined primarily by the familial, and indeed probably the genetic 
risk for disorder rather than by unique environmental effects. 
 
5.2. Introduction 
5.2.1. Structural neuroimaging studies of schizophrenia have robustly shown that 
the illness is associated with reductions in total cerebral and grey matter volumes 
(Wright, Rabe-Hesketh et al. 2000{Shenton, 2001 #49; Shenton, Dickey et al. 2001; 
Honea, Crow et al. 2005), with more limited and indeed variable evidence of white 
matter volume changes (Cannon, van Erp et al. 1998; Lawrie and Abukmeil 1998; 
Hulshoff Pol, Schnack et al. 2002; Honea, Crow et al. 2005). 
5.2.2. The pathophysiological significance of these volumetric deficits remains 
contentious. For instance, whether they represent static markers of early abnormal 
neurodevelopment, facets of later neurodegeneration, or a combination of the two 
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(Woods 1998; Lieberman 1999; Lieberman 1999) is unresolved. Furthermore it is 
possible that other factors related to the illness, for instance its treatment with 
antipsychotic medication, may have additional effects on these tissue volumes 
(Lieberman, Tollefson et al. 2005). Finally, from a causative perspective, given 
schizophrenia’s aetiological complexity (Picchioni and Murray 2007; van Os and Kapur 
2009), the extent to which these structural abnormalities are driven by the genetic 
liability (Sullivan, Kendler et al. 2003) as opposed to environmental factors (van Os, 
Kenis et al. 2010), is poorly understood. 
5.2.3. The presence of qualitatively similar volumetric deficits in patents with 
schizotypal personality disorder (Dickey, McCarley et al. 2001; Dickey, McCarley et al. 
2007; Goldman, Pezawas et al. 2009; Goldstein, Hazlett et al. 2009) and patients’ non-
psychotic relatives, including parents, siblings and offspring, has suggested that at least 
some of these abnormalities are related to the familial, and by implication the genetic risk 
for the disorder (Keshavan, Montrose et al. 1997; Sharma, Lancaster et al. 1998; Staal, 
Pol et al. 2000; Keshavan, Dick et al. 2002; Whalley, Whyte et al. 2005). However 
contradicting this, a recent large study of over 200 siblings of schizophrenia patients, 
found no significant differences in grey matter volume and density, compared to controls. 
The authors concluded that the structural brain changes seen in schizophrenia were 
unlikely to be due to genetic factors (Goldman, Pezawas et al. 2008; Honea, Meyer-
Lindenberg et al. 2008). 
5.2.4. Family studies alone cannot discriminate between competing genetic and 
shared environmental factors. Studies of monozygotic (MZ) twins, concordant and 
discordant for schizophrenia, are one means of addressing some of the uncertainty around 
the genetic influence on brain structure in schizophrenia (Reveley, Reveley et al. 1982; 
Suddath, Christison et al. 1990; Bartley, Jones et al. 1997; Sharma, Lancaster et al. 1998; 
Baare, van Oel et al. 2001; Cannon, Thompson et al. 2002; Hulshoff Pol, Brans et al. 
2004; van Erp, Saleh et al. 2004; van Haren, Picchioni et al. 2004; Rijsdijk, Van Haren et 
al. 2005; Hulshoff Pol, Schnack et al. 2006; Ettinger, Picchioni et al. 2007; Koolschijn, 
van Haren et al. 2008; Ettinger, Schmechtig et al. 2010). 
5.2.5. However, to date, the findings from volumetric studies of such twin pairs 
have in some respects been inconsistent. The majority of studies have adopted a region of 
interest approach and found that twins with schizophrenia have larger lateral ventricles 
(Reveley, Reveley et al. 1982; Reveley, Reveley et al. 1984), and smaller total grey 
matter volume than their non-psychotic co-twins. They have also found smaller 
hippocampal and hypothalamic volumes (Suddath, Christison et al. 1990; Baare, van Oel 
et al. 2001; Hulshoff Pol, Brans et al. 2004; Koolschijn, van Haren et al. 2008) and 
smaller thalamic and frontal volumes (Ettinger, Picchioni et al. 2007; Ettinger, 
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Schmechtig et al. 2010). Taken together these findings tend to implicate unique 
environmental effects driving these volume reductions, with variable evidence of 
genetically determined deficits in the well co-twins. 
5.2.6. There are three studies that adopted a whole brain approach to map regional 
grey matter volume differences in discordant twins (Cannon, Thompson et al. 2002; 
Hulshoff Pol, Schnack et al. 2006; Borgwardt, Picchioni et al. 2010). Unfortunately each 
adopted a different analytical approach, and their results are inconsistent, with a mixture 
of familial (shared environment and genetic), genetic, and unique environmental deficits 
implicated principally in deficits in the frontal and temporal lobes. 
5.2.7. This is the first study to examine whole brain, grey and white matter volumes 
to include an MZ concordant twin sample. Hypothetically such twin pairs might carry a 
greater genetic load for schizophrenia than those from discordant pairs (see 2.4.4.2). 
There is some early evidence that twins with schizophrenia from concordant compared to 
discordant pairs exhibit greater deficits in thalamic and some frontal volumes (Ettinger, 
Picchioni et al. 2007; Ettinger, Schmechtig et al. 2010). 
5.2.8. In this study I used an automated technique to compare subjects’ whole brain, 
total grey and total white matter volumes, allowing the entire brain to be examined in an 
objective manner without observer bias. On the basis of previous studies in schizophrenia 
I hypothesised that: 
5.2.8.1. twins with schizophrenia would show reduced total, grey and white matter 
volumes relative to controls  
5.2.8.2. that twins from concordant pairs would be more severely effected, with 
greater loss of cerebral volume 
5.2.8.3. that the well co-twins from discordant pairs would occupy an intermediate 
position, reflecting the influence of familial effects but spared unique environmental 
effects 
5.2.8.4. that the volumetric differences observed would correlate with abnormal 
childhood social development and premorbid schizotypal traits, neurodevelopmental 





5.3.1.1. Probands, unaffected co-twins and healthy controls were recruited as 
described in 3.3.1. 
5.3.1.2. Exclusion criteria for all subjects were as described in 3.3.1 but include a 
history of neurological illness or of systemic illness with known neurological 
 94 
complication, a history of head injury with loss of consciousness of more than 1 minute, 
any current substance misuse or dependence, including alcohol and any 
contraindications to MR scanning. 
5.3.1.3. Local and Multi-Centre ethical approval was granted. After a complete verbal 
and written description of the study all subjects gave written informed consent. 
 
5.3.2. Clinical Assessment 
5.3.2.1. All of the subjects were clinically assessed as described in 3.3.2. In summary 
clinical diagnoses were established using the Schedule for Affective Disorders and 
Schizophrenia—Lifetime Version augmented with further clinical information to make 
DSM-IV diagnoses (Spitzer, Endicott et al. 1978). Psychotic symptoms were assessed 
with the Scales for the Assessment of Positive (SAPS) and Negative (SANS) Symptoms 
(Andreasen 1983), while premorbid developmental markers were assessed using the 
Premorbid Social Scale (Cannon-Spoor, Potkin et al. 1982) and the Pre-morbid 
Assessment of Schizoid and Schizotypal Traits (Foerster, Lewis et al. 1991) from the 
volunteers’ mothers where possible. Handedness was determined using the Annett scale 
(Annett 1970). Probands’ medication status was recorded at assessment and converted 
to chlorpromazine (CPZ) equivalents (Rey, Schulz et al. 1989; Bezchlibnyk-Butler, 
Jeffries et al. 1994; Woods 2003; Bazire 2007; Taylor, Paton et al. 2009). 
 
5.3.3. Participants 
5.3.3.1. Structural magnetic resonance images of 126 MZ twins were obtained: 21 
MZ pairs concordant for schizophrenia, 17 MZ pairs discordant for schizophrenia, and 
25 healthy MZ twin pairs 
5.3.3.2. The minimum time since schizophrenia onset in the probands from the 
discordant pairs was 4 years. Thus the probability that any of the discordant pairs would 
become concordant in the future was low (Belmaker, Pollin et al. 1974). 
5.3.3.3. Some of the non-psychotic co-twins from the discordant pairs had a personal 
history of psychiatric disorders other than psychosis or schizophrenia spectrum 
disorders. Controls were free of any personal or family history of any psychotic illness 
or any schizophrenia spectrum disorder, but were still included if they had a personal 
history of other axis I pathology. I chose to apply the same inclusion/exclusion criteria 
to the controls as the non-psychotic co-twins so as not to artificially increase the 
differences between these two groups. 
5.3.3.4. All subjects were clinically stable at the time of assessment, with no recent 
changes in their medications. 
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5.3.4. Magnetic Resonance Imaging 
5.3.4.1. Participants had a structural MRI scan on a General Electric Signa Advantage 
scanner at 1.5 Tesla. We collected a 3-dimensional T1-weighted, coronal, spoiled 
gradient (SPGR) of the whole head (TE=5ms, TR=35ms, flip angle=30°, NEX=1, 
FOV=200x200mm, voxel dimensions = 1x1x1.5mm), yielding 124 contiguous slices 
1.5mm thick. Imaging took place on identical scanners with identical protocols at either 
one of two sites (St Georges Hospital, London, or The Maudsley Hospital, London). 
Both members of every pair were scanned at the same site. 
5.3.4.2. Nine twin pairs were scanned at both sites to allow comparison between sites, 
four MZ Concordant, three MZ Discordant and two MZ Control pairs. 
5.3.4.3. Image pre-processing 
5.3.4.3.1. Images were first evaluated by a Consultant Neuroradiologist to exclude 
clinically relevant pathology. All images were visually inspected for movement 
artefacts and converted to ANALYZE format (Robb et al., 1990). Optimised VBM 
pre-processing was performed with Statistical Parametric Mapping software (SPM2, 
http://www.fil.ion.ucl.ac.uk/spm/software/spm2/). The image processing steps have 
been described in detail by the developers and I will describe them only briefly here 
(Ashburner and Friston 2000; Good, Johnsrude et al. 2001). 
5.3.4.3.2. The segmentation algorithm implemented in SPM incorporates an a 
priori knowledge of the likely spatial distribution of tissue types in the brain with prior 
probability tissue maps derived from a large number of subjects. To ensure accurate 
segmentation and to avoid bias during the registration step that could favour one of 
the groups, we created study-specific customized prior probability maps based on all 
subjects (Shen, Szameitat et al. 2007). 
5.3.4.3.3. The pre-processing stages were as follows: 1) scans were segmented 
into probabilistic maps of grey and white matter and cerebrospinal fluid with a 
modified mixture model clustering algorithm; 2) the segmented grey matter map was 
mapped to the study specific grey matter template, and the derived warping 
parameters applied to the original T1-weighted image to map it into standard space; 3) 
the registered image was then re-segmented as the a priori knowledge incorporated 
into the SPM2 segmentation algorithm means that it works optimally in standard 
space. Inhomogeneity correction was performed with SPM2's bias correction 
algorithm. The segmented maps were then modulated through multiplying voxel 
values by the Jacobian determinants from the spatial normalisation to correct for 
volume changes. Finally, all normalised, segmented, modulated tissue maps were 
smoothed with an 8 mm full width at half maximum (FWHM) Gaussian filter. This 
smoothing kernel made the data conform to the Gaussian field model underlying the 
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statistical inferences implemented in SPM2 (Ashburner and Friston 2000). Also, 
according to the matched filter theorem, the width of the smoothing kernel determines 
the scale for which volumetric abnormalities will be most sensitively detected (White, 
O'Leary et al. 2001). Segmentation and warping accuracy was assessed by visually 
inspecting axial slices of each subject’s GM image. 
5.3.4.4. Statistical Analysis of Total, Grey and White Matter Volumes 
5.3.4.4.1. Total raw grey and white matter volumes were calculated using the 
algorithms implemented in SPM (http://dbm.neuro.uni-jena.de/vbm/vbm2-for-
spm2/calculate-raw-volumes). The volumes were corrected for size changes induced 
by spatial normalisation and summed to produce an estimate of the total brain volume. 
 
5.3.5. Statistical analysis 
5.3.5.1. Two Site MRI Data  
5.3.5.1.1. In order to determine the presence of and address any systematic 
differences in the MR volumetric data between the two scanner sites I first calculated 
intra class correlation coefficients, then estimated the inter-site bias (Bland and 
Altman 1986) for each brain volume. The method identifies one site, the Maudsley, as 
the reference site and estimates inter-site bias, and thus the inter-site correction factor, 
as the mean difference between the two sites for each volume from the eighteen 
subjects scanned at both sites. 
5.3.5.1.2. The site-specific correction factor for each volume was then applied to 
data from the second site, St George’s Hospital.  
 
5.3.5.2. Twin Analysis 
5.3.5.2.1. As described in 3.3.5.2 the genetic relatedness of twin pairs and the 
within-family correlations violate the assumption of independent observations made in 
analysis of variance. Therefore, differences between groups were analysed with 
regression models that allowed for correlations within twin clusters and departures 
from normality using the robust sandwich estimator to estimate standard errors 
implemented in Stata 10 (Stata Corporation, College Station, TX). 
5.3.5.2.2. Group differences in age, height, parental social class, years of 
education, premorbid schizotypy and premorbid social development, were examined 
using linear regression models with robust standard errors. Group differences in 
gender, handedness and ethnicity were examined by logistic regression with robust 
standard errors of the respective binary dependent variables. 
5.3.5.2.3. To explore for differences in clinical data, the two proband groups 
(concordant and discordant ill) were compared on age at first contact with psychiatric 
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services, total positive (SAPS) and negative (SANS) score at time of scanning, and 
chlorpromazine equivalents using regression models with robust standard errors, and 
on type of antipsychotic medication (first or second generation) using logistic 
regression with robust standard errors. All groups were compared on the premorbid 
schizotypal and social development scores using the same statistical model. 
5.3.5.2.4. For the three brain volumes, intra-class correlation co-efficients were 
calculated separately for each twin type (concordant, discordant and control). 
5.3.5.2.5. For group comparisons of total cerebral, grey and white matter volumes, 
the level of significance for the analysis of the three ROIs was adjusted using the 
Bonferroni method (p=0.05/3=0.017). If a group comparison for a given ROI was 
statistically significant at this level it was followed by four planned pairwise post-hoc 
comparisons determined by my experimental hypotheses using a Bonferroni 
correction (p=0.05/4=0.0125). In order to adopt a parsimonious approach, all contrasts 
were adjusted for age, gender, and scanner as covariates in the models. 
5.3.5.2.6. Finally clinical correlates of the brain volumes were investigated using 
a regression model with robust standard errors predicting brain volume in separate 
analyses from childhood and adolescent social development and schizotypal ratings in 
all subjects, and SAPS, SANS in the patients, using the same covariates. For each 




5.4.1. Demographic and clinical variables 
5.4.1.1. Comparable numbers of twins were scanned at each site (χ2=1.59, df=3, 
p=0.66). There was no significant difference in group membership, i.e. whether MZ 
twins were from concordant, discordant or control pairs, between the two scanner sites 
(χ2 =3.91 (3) p=0.27).  
5.4.1.2. The demographic and clinical variables are summarised in Tables 5.1 and 5.2. 
There were no significant effects of group on age, gender, handedness, ethnicity, height, 
parental social class, or years of education. Among the non-psychotic members of the 
discordant pairs, eleven met criteria for a previous DSM-IV Axis I disorder: depression 
(n=3); depression and alcohol abuse (n=1); depression and simple phobia (n=1); 
obsessive-compulsive disorder, depression and alcohol abuse (n=1); panic disorder, 
depression and mania (n=1); simple phobia (n=1); simple phobia, panic disorder and 
depression (n=1); generalised anxiety disorder and panic disorder (n=1); and generalised 
anxiety disorder, panic disorder and depression (n=1). Eight of the control twins met 
criteria for a previous DSM-IV Axis I diagnosis: depression (n=3), mania (n=1), 
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depression and drug and alcohol abuse (n=2), drug abuse (n=1), and specific phobia, 
agoraphobia and drug abuse (n=1). The frequency of psychiatric diagnoses was 
significantly higher in the discordant unaffected group than in the controls (χ2=9.36, 
df=1, p=0.002). None of the non-schizophrenic twins were unwell at the time of 
assessment nor were any taking any psychotropic medication. 
5.4.1.3.  Table 5.2 summarises the clinical variables. In this sample, patients from 
concordant and discordant pairs did not differ on the proxy measures of illness severity, 
age at first contact with psychiatric services, or positive (SAPS) and negative (SANS) 
psychotic symptom scores at the time of assessment. They also did not differ in the type 
or total daily dose of antipsychotics, though there was a trend for the discordant ill 
group to be more likely to be prescribed a second generation drug. As anticipated the 
four groups differed on premorbid schizotypal traits and difficulties in social adjustment 
during childhood and adolescence, the patients had experienced more problems. 
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Table 5.1 
Demographics of Experimental Groups 









F or Χ2  (df) p 
Number of 
Subjects (Pairs) 42 (21) 17 (17) 17 (17) 50 (25) 
  
Age 34.6 (8.4) 31.4 (13.3) 31.5 (12.0) 36.1 (10.0) 0.68 (3,64) 0.57 
Gender 
% Female 
21 35 41 32 3.36 (3) 0.34 
Handedness 
% Right 
81 81 81 82 0.03 (3) 0.99 
Ethnicity 
% Caucasian 
95 88 88 100 1.06 (2,63) 0.37 
Height 
cm  
174.5 (8.0) 175.6 (9.3) 172.1 (8.6) 174.0 8.7) 0.81 (3,61) 0.49 
Social Class 
Parents 
2.5 2.4 2.4 2.7 0.75 (3,62) 0.53 
Education Years 13.7 (2.8) 12.6 (3.0) 12.7 (2.4) 14.0 (2.7) 1.36 (3,64) 0.26 
Legend Table 5.1 
Data reflect mean (and standard deviation) unless otherwise stated.
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Table 5.2 
Clinical Ratings of Experimental Groups 





MZ Control Analysis F or Χ2  (df) p 
Age at First Contact 21.8 (6.0) 21.3 (6.0) n/a n/a 0.13 (1, 35) 0.72 
SAPS 6.0 (3.6) 6.1 (3.9) n/a n/a 1.35 (1,34) 0.25 
SANS 9.3 (3.9) 8.00 (6.0) n/a n/a 1.35 (1,34) 0.25 
Type of Medication 
N Second/First Generation/na 
17/16/9 9/3/5 n/a n/a 3.55 (1) 0.06 
Medication 
CPZ Equivalence 
630 (477) 500 (371) n/a n/a 0.22 (1,37) 0.64 
Schizotypy 1.7 (0.5) 1.4 (0.4) 1.4 (0.4) 1.0 (0.1) 10.4 (3,33) 0.0001 
Childhood Social Adjustment 2.5 (0.8) 2.4 (0.5) 2.2 (0.6) 1.4 (0.3) 12.4 (3,29) <0.0001 
Adolescent Social 
Adjustment 2.6 (0.7) 2.9 (0.6) 2.5 (0.7) 1.4 (0.3) 27.8 (3,29) <0.0001 
 
Legend Table 5.2 
Data reflect mean (and standard deviation) unless otherwise stated. SAPS=Scale for the Assessment of Positive Symptoms; SANS=Scale for 
the Assessment of Negative Symptoms; CPZ=chlorpromazine; n/a = not available 
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5.4.2. Between Scanner Site Comparison 
Table 5.3 
Intra Class Correlations for Whole Brain, Grey and White Matter Volume 
Brain Volume 
Intra Class Correlation 
n=18 
Whole Brain 0.958 
Grey Matter 0.929 
White Matter 0.846 
 
5.4.2.1. For the eighteen subjects scanned at both sites there were strong relationships 
between the sites for the estimates of each of the three cerebral volumes. Intraclass 
correlations for whole brain, grey and white matter were 0.96, 0.93 and 0.85 
respectively (Figures 5.1 and 5.2). Figure 5.3 shows the Bland Altman plots for each 
volume. The graphs plot the difference between each site’s estimate against their mean, 
giving an index of any systematic intersite bias (Bland and Altman 1986). The bias, 
defined as the mean difference were estimated for each volume and subtracted from the 
second site estimates. The bias estimates were: for whole brain volume = -16.7mls, for 
grey matter = -2.5mls and for white matter = -14.2mls. 
Figure 5.1 
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Plot of Grey and White Matter Volumes St George’s against The Maudsley Sites 
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Bland-Altman Plots of Whole Brain, Grey & White Matter Volumes St George’s against 
The Maudsley Sites 
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5.4.3. Brain Volumes 
5.4.3.1. The adjusted mean brain volumes and their standard deviations are shown in 



























Adjusted Brain Volumes by Group  
Group 
Volume 







Whole Brain 1150.4 (96.4) 1147.2 (156.1) 1146.3 (151.8) 1207.5 (92.7) 
Grey 700.2 (58.7) 711.2 (100.2) 718.0 (90.4) 750.0 (55.5) 
White 450.3 (45.5) 435.9 (67.2) 428.3 (66.6) 457.6 (47.2) 
 
Legend Table 5.4 
Note: Data reflect mean (and standard deviation) of adjusted brain volumes in ml by 













































































Mean Adjusted Grey Matter Volume
 
Figure 5.6 


































Mean Adjusted White Matter Volume
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5.4.3.2. Group Differences in Whole Brain, Grey and White Matter Volumes 
5.4.3.2.1. Table 5.5 shows the results of the statistical contrasts between groups. 
There were significant overall effects of group on the whole brain (F[7,64]=2153.2, 
p<0.0001), grey (F[7,64]=2183.4, p=0.001) and white matter volumes (F[7,64]= 
1611.8, p<0.0001. Subsequent post-hoc comparisons revealed a similar pattern of 
deficits for each of the three volumes. 
5.4.3.2.2. For whole brain volume, I found that patients as a whole (t=-3.21, 
p=0.002), and when subdivided into concordant (t=-3.24, p=0.002) and discordant (t=-
2.44, p=0.017) groups, had smaller volumes than the healthy controls. Patients from 
concordant and discordant pairs did not differ from each other (t=-0.02; p=0.99). 
Discordant schizophrenic twins (t=-2.43, p=0.018) and their non-schizophrenic co-
twins (t=-2.39, p=0.02) both differed from healthy control twins, though neither 
contrast survived stringent multiple testing correction. Finally within the MZ 
discordant pairs the patients did not differ significantly from their well co-twins (t=-
0.77; p=0.45). 
5.4.3.2.3. For grey matter, patients from concordant and discordant pairs did not 
differ (t=-0.66; p=0.51). Patients as a whole (t=-3.44, p=0.001), and when subdivided 
into those from concordant (t=-3.79; p<0.001) and from discordant pairs (t=-2.37; 
p=0.021) and their unaffected co-twins (t=-2.18; p=0.033) had smaller grey matter 
volumes than healthy controls, though neither of the last two contrasts survived 
multiple testing correction. The within discordant pair contrast was again not 
significant (t=-1.23, p=0.23). 
5.4.3.2.4. For white matter, patients from concordant and discordant pairs did not 
differ (t=0.77; p=0.44). Patients as a whole (t=-2.31, p=0.024) differed from controls, 
but did not survive correction. Patients from discordant pairs (t=-2.02; p=0.048) and 
their unaffected co-twins (t=-2.30; p=0.025) had smaller white matter volumes than 
healthy controls, though neither contrast survived multiple testing correction. The 
contrast between the patients and unaffected co-twins within discordant pairs was 
again not significant (t=0.34, p=0.73). 
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Table 5.5 Between Group Tests 
MZ Group Comparison 
Covariates: 
Age, Gender & Scanner MZ Conc vs MZ Disc 
Ill 
All MZ Patients vs 
MZ Control 
MZ Disc Ill vs MZ 
Disc Well 
MZ Disc Well vs 
MZ Control 













Effect Size (95% CI) 
-0.49 
-58.6 to 57.6 
-78.0 
-1126.6 to -29.4 
-7.4 
-26.8 to 11.9 
-70.3 
-129.1 to-11.5 










Effect Size (95% CI) 
-11.8 
-47.7 to 24.1 
-53.0 
-83.8 to -22.2 
-9.6 
-25.2 to 6.0 
-37.5 
-71.9 to -3.1 










Effect Size (95% CI) 
11.3 
-17.8 to 40.4 
-25.0 
-46.7 to -3.4 
2.1 
-10.4 to 14.7 
-32.8 
-61.4 to -4.3 
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Legend Table 5.5 
MZ Conc = MZ Concordant; MZ Disc Ill = MZ Discordant Ill; MZ Disc Well= MZ 
Discordant well. Whole Brain = whole brain volume; Grey = grey matter volume; White = 
white matter volume. *p<0.05, ** p<0.017, *** p<0.0125 corrected for multiple 
comparisons. 
 
5.4.3.3. Intra Twin Class Correlations of ROI Volumes 
5.4.3.3.1. The ICCs for the concordant, discordant and control twins for each of 
the three cerebral volumes are shown in Table 5.6. The ICCs were high ranging from 
0.76 to 0.97. While the ICC estimates were lowest within the concordant twins and 
highest for the discordant twins, the confidence limits of all three groups overlapped 
considerably, suggesting that there were no systematic differences in their magnitude. 
 
Table 5.6 
Intraclass Correlations (ICC) by Twin Category 
Group 
Volume 
MZ Concordant MZ Discordant MZ Control 
Whole Brain 0.79 (0.63/0.96) 0.97 (0.95/0.99) 0.93 (0.88/0.99) 
Grey 0.80 (0.64/0.96) 0.96 (0.91/0.99) 0.88 (0.78/0.97) 
White 0.76 (0.59/0.95) 0.94 (0.88/1.00) 0.90 (0.82/0.97) 
 
Legend Table 5.6 
Intraclass correlations (ICC) coefficients (and 95% confidence interval) by twin category. 
Whole Brain = whole brain volume; Grey = grey matter volume; White = white matter 
volume.  
 
5.4.3.3.2. Clinical Correlates of Brain Volume 
5.4.3.3.2.1. Across the four groups of subjects there were significant 
associations of total cerebral, grey and white matter volumes with childhood (all 
p<0.0019) and adolescent (all p<0.0033) social development problems. 
Furthermore there were significant associations between all three volumes and the 
premorbid schizotypal ratings (all p<0.0001). All contrasts survived correction. On 
each occasion, a greater severity of developmental abnormality in childhood or 
adolescence was associated with smaller brain volumes in adulthood. 
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5.4.3.3.2.2. Within the patients there were no significant associations 
between any of the three brain volumes, total, grey and white matter, and positive 
or negative psychotic symptoms at the time of scanning (all p>0.08). Similarly 
there was no relationship between any of the three brain volumes and antipsychotic 
dose at the time of scanning (all p>0.62). 
 
5.5. Discussion 
5.5.1. In this study I compared unbiased estimates of total brain, grey and white 
matter volumes in MZ twins who varied in their concordance for schizophrenia. The aim 
was to identify the influence of familial, genetic and unique environmental factors on any 
brain volume deficits detected. 
5.5.2. I extended the findings of our own earlier structural studies in twins with 
schizophrenia (van Haren, Picchioni et al. 2004; Rijsdijk, Van Haren et al. 2005; 
Ettinger, Picchioni et al. 2007; Borgwardt, Picchioni et al. 2010; Ettinger, Schmechtig et 
al. 2010), by using an objective technique to the entire brain and expanding the sample 
size. This was also the first study to quantify whole brain, grey and white matter volumes 
over the entire brain that included an MZ concordant sample. 
5.5.3. I found evidence of deficits in whole brain, grey and white matter volume in 
the patients as well as the unaffected co-twins from discordant pairs, though the latter did 
not survive stringent correction for multiple testing. 
5.5.4. I did not find any evidence of significant volumetric differences between 
members of discordant pairs, and found high correlations within twin pairs of all types 
for all of the tissue volumes. 
5.5.5. Finally across the experimental groups there was evidence of an association 
between lower brain volume and developmental markers of the genetic risk for 
schizophrenia. There was no relationship with ‘current’ symptomatology or treatment in 
the patients. 
 
5.5.6. Structural Deficits in Schizophrenia 
5.5.6.1. Numerous structural imaging studies (Mathalon, Sullivan et al. 2001; 
Shenton, Dickey et al. 2001; Wood, Velakoulis et al. 2001; Kubicki, Shenton et al. 
2002; Niznikiewicz, Kubicki et al. 2003), including meta analyses (Wright, Rabe-
Hesketh et al. 2000; Arnone, Cavanagh et al. 2009), have shown robust evidence of 
volumetric differences between patients with schizophrenia and healthy controls. These 
deficits have been most reliably demonstrated in frontal and temporal lobe grey matter 
(Honea, Crow et al. 2005). Studies of white matter, whether assessing its volume and 
density using structural MRI, or its integrity using diffusion tensor imaging (DTI), have 
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tended to produce more mixed results (Kanaan, Kim et al. 2005; Kubicki, McCarley et 
al. 2007). 
5.5.6.2. Data from this study, comparing the twins with schizophrenia and the healthy 
twins produced results that were entirely consistent with the established structural 
imaging findings, including work in twins (Hulshoff Pol, Brans et al. 2004; van Haren, 
Picchioni et al. 2004; Rijsdijk, van Haren et al. 2005). 
 
5.5.7. Familial Risk Effects in Schizophrenia 
5.5.7.1. Both twins with schizophrenia and their genetically identical but non-
psychotic co-twins showed reductions in whole brain, grey and white matter volumes 
relative to healthy twins, though this did not survive stringent multiple testing 
correction. If accepted, this result is consistent with a familial effect, mediated through 
genetic and shared environmental factors. Three further lines of evidence support the 
conclusion that these represent genuine deficits, principally mediated by genetic effects. 
5.5.7.1.1. Firstly there were no significant differences between the twins with 
schizophrenia and their unaffected co-twins from discordant pairs for any of the three 
volumes. 
5.5.7.1.2. Secondly there were high correlations across all three cerebral volumes 
within each of the three twin groups, MZ concordant, MZ discordant and MZ control. 
Imaging studies in healthy twins have estimated the heritability of whole brain volume 
(Tramo, Loftus et al. 1995; Bartley, Jones et al. 1997; Bonan, Argenti et al. 1998; 
Carmelli, DeCarli et al. 1998; Pennington, Filipek et al. 2000; Eckert, Leonard et al. 
2002; Geschwind, Miller et al. 2002; White, Andreasen et al. 2002) to be between 
0.66 (Wright, Sham et al. 2002) and 0.97 (Pennington, Filipek et al. 2000). They agree 
that cortical surface area (Tramo, Loftus et al. 1995), total grey, (Pennington, Filipek 
et al. 2000; van Oel, Baare et al. 2001; Geschwind, Miller et al. 2002; White, 
Andreasen et al. 2002), and total white matter volumes (van Oel, Baare et al. 2001; 
White, Andreasen et al. 2002), as well as grey matter density (Thompson, Cannon et 
al. 2002), and individual lobe volumes (Geschwind, Miller et al. 2002; White, 
Andreasen et al. 2002) are all highly heritable. In the most sophisticated analysis 
applied to date, Thompson et al (Thompson, Cannon et al. 2002), produced a cortical 
map of quantified regional correlations, within MZ pairs across the brain, noting the 
highest regional heritabilities ofaround 90%, in a broad strip of cortex running from 
the frontal lobe to the parietal cortex. In contrast lateral ventricular volume exhibits 
the lowest heritability, and thus the greatest sensitivity to environmental effects, (van 
Oel, Baare et al. 2001; White, Andreasen et al. 2002; Wright, Sham et al. 2002). Gyral 
and sulcal architecture are also less genetically influenced with lower heritability 
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estimates and model fitting unable to reject a unique environmental model (Bartley, 
Jones et al. 1997; Eckert, Leonard et al. 2002; White, Andreasen et al. 2002). 
However one study (Lohmann, von Cramon et al. 1999), used a novel image analysis 
technique and concluded that the genetic influence varied with sulcal depth. The 
deepest, and ontogenetically most primitive sulci, were the most highly genetically 
determined. 
5.5.7.1.3. Thirdly I found a significant statistical relationship between the three 
brain volumes and three developmental markers aligned to the genetic risk for 
schizophrenia, namely childhood and adolescent social development and premorbid 
schizotypal traits. These markers were identified in Chapter 4 as phenotypically and 
genotypically correlated with schizophrenia. Thus they share genetic risk with the 
disorder, and potentially can act as proxy markers of that genetic risk. 
5.5.7.2. The conclusion that the volumetric deficits are primarily genetic in origin 
appears initially at odds with the only other similar study in discordant twins. Hulshoff 
Pol et al (Hulshoff Pol, Brans et al. 2004) reported reduced whole brain and grey matter 
volumes but only in twins with schizophrenia, and not the non-psychotic co-twins 
compared to healthy controls. They interpreted these findings as evidence of 
environmental, or illness specific effects. However that result was the product of an 
interaction test across all groups, and was not supported by a specific significant post 
hoc contrast between the patients and their well co-twins from discordant pairs. 
Furthermore the same group (Hulshoff Pol, Schnack et al. 2006), in a subsequent voxel 
based analysis of the same twins detected grey matter density reductions both in the 
patients and the unaffected relatives compared to controls. Finally, in a longitudinal 5-
year follow-up MRI study of a subgroup of the same twins Brans et al (Brans, van 
Haren et al. 2008) reported evidence of genetically determined progressive reductions in 
grey matter volume both in the patients and also their unaffected co-twins, over and 
above changes in healthy controls. 
5.5.7.3. Grey matter volume reductions have also been described in other subjects at 
heightened risk of schizophrenia, whether identified on clinical, familial or genetic 
grounds. These include people with prodromal clinical signs of schizophrenia (Pantelis, 
Velakoulis et al. 2003; Borgwardt, Riecher-Rossler et al. 2007), people with schizotypal 
personality disorder (Dickey, McCarley et al. 2001; Koo, Dickey et al. 2006; Dickey, 
McCarley et al. 2007), the unaffected relatives of patients (Lawrie, Whalley et al. 2001; 
McDonald, Grech et al. 2002; McDonald, Bullmore et al. 2004; Lawrie, McIntosh et al. 
2008), also supported by meta analysis data (Boos, Aleman et al. 2007), and finally in 
healthy carriers of genetic polymorphisms implicated in schizophrenia (Stern, 
Savostyanova et al. 2008). 
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5.5.7.4. The white matter deficits in both the patients and their co-twins, though that 
did not survive multiple testing correction, is a replication of Hulshoff Pol et al’s 2004 
finding (Hulshoff Pol, Brans et al. 2004), interpreted as evidence of genetically 
determined white matter abnormalities in schizophrenia. These could underpin 
anatomical and functional dysconnectivity in the disorder (Stephan, Baldeweg et al. 
2006; Konrad and Winterer 2008; Stephan, Friston et al. 2009). Diffusion tensor 
imaging (DTI) has now superseded structural imaging as the ideal method of assessing 
white matter integrity in psychiatric disorders (Assaf and Pasternak 2008). 
Unfortunately the results from a dozen and a half DTI studies in schizophrenia thus far 
remain inconsistent (Kanaan, Kim et al. 2005). Increasingly however they suggest that 
white matter tracts are disrupted in schizophrenia. This finding is replicated to certain 
extent in the small number of studies in unaffected relatives of patients with 
schizophrenia. They have reported lowered Fractional Anisotropy (an index of white 
matter integrity) in the inferior frontal, posterior cingulate and internal capsule, but 
increased FA in the anterior cingulate (Hoptman, Nierenberg et al. 2008; Munoz 
Maniega, Lymer et al. 2008; Camchong, Lim et al. 2009). An attempt to synthesise 
these potentially discrepant findings might be to suggest that white matter deficits 
reflect underlying non specific genetic risk to schizophrenia and psychosis (McDonald, 
Bullmore et al. 2004; McDonald, Bullmore et al. 2005), which underlie genetically 
mediated dysconnectivty as part of the fundamental vulnerability to psychosis (Whalley, 
Simonotto et al. 2004). 
 
5.5.8. Specific Correlates of Schizophrenia-Unique Environmental Effects 
5.5.8.1. Comparing the psychotic and non-psychotic members of MZ twins 
discordant for schizophrenia provides a powerful means of identifying the correlates of 
unique environmental factors, including factors that specifically relate to the disorder, 
such as treatment. 
5.5.8.2. Previous MRI region of interest studies of discordant MZ twin pairs have 
detected disorder-specific volume deficits in frontal (Ettinger, Schmechtig et al. 2010), 
thalamic (Ettinger, Picchioni et al. 2007), hippocampal (Suddath, Christison et al. 1990; 
van Erp, Saleh et al. 2004) and lateral ventricular volumes (Baare, van Oel et al. 2001). 
Similarly cortical surface mapping has revealed environmentally driven within-pair 
differences in gray matter density between patients with schizophrenia and their 
unaffected MZ co-twins in the dorsolateral prefrontal cortex, superior temporal gyrus 
and superior parietal lobule (Cannon, Thompson et al. 2002). 
5.5.8.3. My results were not consistent with these data, with no evidence, at the level 
of whole brain, total grey or total white matter of illness specific differences in this 
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cohort. This could have been due to a lack of power, and several factors in this study 
could come into play to increase the chance of this. 
5.5.8.4. Firstly the measures selected for this analysis, whole brain volume, total grey 
and total white matter volumes were estimated across the entire cerebrum and lacked 
anatomical sensitivity. While schizophrenia is associated with widespread cortical 
deficits, there is evidence that the frontal and temporal lobes are most vulnerable 
(Shenton, Dickey et al. 2001; Goldman, Pezawas et al. 2009). 
5.5.8.5. Secondly all three measures are highly heritable and, by restricting the 
analysis to MZ twin pairs, the high correlation of these volumes within pairs of twins, 
even those discordant for schizophrenia, reduced inter-individual differences that might 
otherwise have been detected. Indeed, in our own voxel based analysis of a sub-sample 
of this cohort, more subtle regionally specific deficits in the insula, superior/medial 
frontal, post central, cingulate and superior temporal gyri were detected(Borgwardt, 
Picchioni et al. 2010). Furthermore longitudinal volume changes in very similar 
temporal regions have been detected in individuals scanned both before and after they 
develop schizophrenia (Pantelis, Velakoulis et al. 2003; Job, Whalley et al. 2005; 
Koutsouleris, Meisenzahl et al. 2009), emphasising the specificity of these more 
localised deficits to schizophrenia. 
5.5.8.6. There was no evidence of significant effects of antipsychotic medication in 
the patients, though several of these contrasts approached a trend level of significance. 
While antipsychotic drugs can induce cerebral structural changes (Moncrieff and Leo ; 
Dazzan, Morgan et al. 2005; Lieberman, Tollefson et al. 2005; Navari and Dazzan 2009; 
Smieskova, Fusar-Poli et al. 2009), there is emerging evidence that there may be some 
anatomical specificity to their site of greatest effect. First generation drugs have been 
associated with increases in the basal ganglia and cingulate cortex, while second 
generation agents have been linked to volume increases in the thalamus and temporal 
cortex (Chakos, Lieberman et al. 1994; Scheepers, de Wied et al. 2001; Dazzan, Morgan 
et al. 2005; Lieberman, Tollefson et al. 2005; Thompson, Bartzokis et al. 2009). It is 
possible that in this relatively small sample of patients, fifty-nine in total, prescribed a 
mixture of first and second generation drugs, that the study was underpowered to detect 
a this heterogeneous effect. 
5.5.8.7. While they differed from controls, the patients did not differ whether they 
came from MZ discordant or concordant pairs. The two samples of patients were well 
matched on demographic variables and did not differ clinically. This finding does not 
support the second hypothesis and is at variance with our own earlier ROI studies in 
these twins (Ettinger, Picchioni et al. 2007; Ettinger, Schmechtig et al. 2010), in which 
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we detected subtle regionally specific volumetric differences between these two groups 
of patients, in the thalamus and parts of the frontal lobes. 
 
5.5.9. Strengths and Limitations 
5.5.9.1. In the present study I examined total, grey and white matter volumes using a 
whole brain approach. By surveying the whole brain in an unbiased fashion the results 
should provide a reliable, objective estimate of brain volume changes in schizophrenia 
and in those at familial risk of the disorder. 
5.5.9.2. I used the ‘optimized’ VBM method (Good, Johnsrude et al. 2001) to 
minimise the potentially confounding effects of errors in stereotactic normalization 
(Ashburner and Friston 2000). The method is also potentially more sensitive to 
between-group differences (Good, Johnsrude et al. 2001). 
5.5.9.3. We collected structural MR data at two centres, but using the same 
acquisition sequence on ‘identical scanners’ from the same manufacturer. This could 
have introduced a significant source of variance into the data, and a variety of 
approaches have been deployed in the past to address this (Schnack, van Haren et al. 
2004; Ettinger, Picchioni et al. 2007; Ashton 2009; Moorhead, Gountouna et al. 2009). I 
adopted a parsimonious approach and guarded against this as a source of bias using a 
number of techniques. Firstly there was no systematic difference in the subjects scanned 
between the two sites and both members of each twin were always scanned at the same 
site. While there was a systematic bias between the two centres I was able to incorporate 
a correction factor to address this and also co-varied for scanner site in the final 
analyses. 
5.5.9.4. Although the total sample was relatively large, the individual groups were 
only modest in size. As a result there remains the possibility that the study lacked 
statistical power. This may have particularly relevant to the comparison within 
discordant pairs. 
5.5.9.5. As eleven of the non-psychotic co-twins in this sample met lifetime criteria 
for other axis I pathology, principally anxiety and affective disorders, it is possible that 
the volume deficits in that group could have been related to their past history of other 
psychiatric disorders, as opposed to their genetic risk per se. However all of them were 
clinically well and medication-free at the time of scanning, and the groups were 
otherwise well matched. 
 
5.5.10. Conclusion 
5.5.10.1. To conclude, similar volumetric abnormalities occur in patients with 
schizophrenia whether they come from pairs that are concordant or discordant for 
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schizophrenia. There was no evidence of additional differences between patients with 
schizophrenia and their unaffected co-twins from MZ discordant pairs, while both 
groups differed from healthy controls, but only if multiple testing criteria were relaxed. 
There was a significant association between the brain volumes and three developmental 
markers of the genetic risk for schizophrenia. These findings highlight the substantial 




6. Genetic and environmental influences on brain function in schizophrenia. An fMRI 
study of in the Maudsley Twin and Family cohorts. 
 
6.1. Abstract 
6.1.1. Altered neurocognition in schizophrenia could reflect the influence of both 
genetic and environmental factors. The aim of this study was to assess the influence of 
these factors on regional brain function during a task of executive function, using a case 
control twin-sibling study and verbal fluency as a cognitive endophenotype probe. 
6.1.2. 206 subjects; 163 twins, varying in their zygosity and concordance for 
schizophrenia, and 43 singletons from sibling clusters, varying in their concordance for 
schizophrenia. The groups were matched for handedness, parental socio-economic status, 
and ethnicity. The groups were assessed on their behavioural performance and regional 
brain activation measured using functional magnetic resonance imaging, during a 
phonological verbal fluency task. 
6.1.3. Relative to the healthy control group, patients with schizophrenia and the 
non-psychotic co-twins from monozygotic discordant twin pairs produced fewer correct 
responses. Across all groups, there was a linear trend for differential activation in fronto-
temporal areas. The greater the genetic and environmental risk, the greater the activation 
in the left inferior frontal and left superior temporal gyri, and the greater the deactivation 
in the left hippocampal and middle temporal gyri bilaterally. Thus, these features were 
maximally evident in twins with schizophrenia, and least evident in healthy controls. 
When the analysis was restricted to subjects who did not have schizophrenia (and had 
never been treated), a similar linear trend was evident, with the non-psychotic co-twins 
and siblings of patients showing greater inferior frontal and left superior temporal 
activation, but less right parahippocampal and superior temporal activation than healthy 
controls. Comparison within the monozygotic twin pairs discordant for schizophrenia 
revealed greater activation in the medial frontal gyri and the right middle and superior 
frontal gyri in the affected than the non-affected twins. Full genetic modelling indicated a 
modest phenotypic correlation between schizophrenia and increased activity in the 
inferior frontal gyrus and reduced activity in the left middle temporal gyrus and left 
hippocampus, that was principally due to shared genetic effects. 
6.1.4. Both schizophrenia and its familial vulnerability were associated with 
impaired performance and altered frontal, parahippocampal and temporal activation 




6.2.1. Behaviourally impaired verbal fluency performance satisfies many of the 
criteria for an endophenotype for schizophrenia. It is a robust feature of the 
disorder(Gourovitch, Goldberg et al. 1996; Vinogradov, Kirkland et al. 2003; Woodward, 
Ruff et al. 2003; van Beilen, Pijnenborg et al. 2004), and is evident in patients’ 
unaffected relatives (Chen, Chen et al. 2000; Laurent, Biloa-Tang et al. 2000; Gilvarry, 
Russell et al. 2001; Gilvarry, Russell et al. 2001; Appels, Sitskoorn et al. 2003) and in 
those with schizotypal traits(Cannon, Zorrilla et al. 1994; Gilvarry, Russell et al. 2001). 
Moreover, twin studies show that non-psychotic twins from discordant pairs display 
qualitatively similar verbal fluency deficits to their ill co-twins(Goldberg, Torrey et al. 
1995; Cannon, Huttunen et al. 2000), while we have found that common genetic effects 
link phonological verbal fluency deficits and schizophrenia(Owens, Rijsdijk et al. 2010). 
6.2.2. Functional neuroimaging studies of verbal fluency in schizophrenia have 
reported greater activation in patients than controls in the lateral temporal cortex, with 
similar increases seen in patients’ non-psychotic co-twins or siblings, reflecting familial 
effects(Spence, Liddle et al. 2000; Sommer, Ramsey et al. 2004). Findings in the 
prefrontal cortex are more variable(Frith, Friston et al. 1995; YurgelunTodd, Waternaux 
et al. 1996; Curtis, Bullmore et al. 1998; Curtis, Bullmore et al. 1999; Sommer, Ramsey 
et al. 2001; Sommer, Ramsey et al. 2003; Weiss, Hofer et al. 2004; Fu, Suckling et al. 
2005; Spaniel, Tintera et al. 2007), with some studies describing attenuated prefrontal 
activation in schizophrenia(Curtis, Bullmore et al. 1998),(Andreasen, Rezai et al. 1992; 
Ebmeier, Blackwood et al. 1993; Gur and Gur 1995) , but others have either failed to 
replicate this(Frith, Friston et al. 1995; Weiss, Hofer et al. 2004; Fu, Suckling et al. 
2005), or reported greater prefrontal activation in patients(Mechelli, Prata et al. 2008) and 
those at genetic risk(Prata, Mechelli et al. 2008) compared to controls. This inconsistency 
may partly reflect the potentially confounding effect of group performance differences, 
which have been controlled in some studies, but not in others. 
6.2.3. As well as differential regional activation, several studies have also described 
altered functional connectivity between prefrontal and both lateral and medial temporal 
cortices in schizophrenia and in non-psychotic subjects at increased risk of the disorder. 
These studies have been a significant source of evidence to support the long-held notion 
that a dis-integration of regional function is fundamental to schizophrenia (Wernicke; 
Bleuler; Firston & Frith, 1995; McGuire & Frith 1996). 
6.2.4. The aim of this study was to assess the influence of genetic, common and 
unique environmental influences on regional brain function in schizophrenia, using 
verbal fluency as a functional endophenotype probe. I compared monozygotic (MZ) and 
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dizygotic (DZ) twins and sibling clusters that varied in their concordance for 
schizophrenia. 
6.2.5. In this study we wanted to establish the genetic and environmental influences 
on regional brain function in the context of a verbal fluency task, and then quantify the 
genetic relationship between regional brain function and schizophrenia. As in Chapter 4 I 
used a combined twin and sibling sample in the design. This offers the advantages of 
increasing experimental sample size, reducing sample variance and offering a better 
approximation of the ‘true’ population. In this design sibling pairs can model for 
dizygotic (DZ) twin pairs as they share the same degree of genetic similarity (Picchioni, 
Walshe et al. 2010). 
6.2.6. I used functional Magnetic Resonance Imaging (fMRI) to measure regional 
brain function during a phonological verbal fluency task in which subjects generated 
words in response to letter cues. Activation in patients with schizophrenia can vary with 
the level of behavioural performance(Frith, Friston et al. 1995). I therefore used a 
paradigm that incorporated a clustered acquisition sequence that allowed us to measure 
task performance on-line(Amaro, Williams et al. 2002), then I restricted the analysis to 
images associated with correct responses, to minimize the potentially confounding effects 
of differences in behavioural performance. 
6.2.7. My hypotheses were: 
6.2.7.1.  That across the entire sample, schizophrenia and its risk would be associated 
with altered activation in prefrontal and temporal cortices. 
6.2.7.2.  That qualitatively similar differences would be associated with thedegree of 
familial risk across non-psychotic subjects, and with the unique environmental risk that 
distinguishes MZ twins with schizophrenia from their non-psychotic co-twins within 
discordant pairs. 
6.2.7.3. Finally that model fitting would detect a phenotypic correlation between 
schizophrenia and regional brain activity elicited by verbal fluency, and that shared 




6.3.1.1. The subjects participated in the Maudsley Twin(Picchioni, Walshe et al. 
2010) and Family (McDonald, Marshall et al. 2006) Studies of Schizophrenia and 
Psychosis. 
6.3.1.2. A total of 206 individuals contributed to this part of the study after Research 
Ethics Committee approval had been granted. 
6.3.1.3. Recruitment was as described in 3.3.1.2. 
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6.3.1.4. Exclusion criteria applied to all groups were as in 3.3.1.3 and 4.3.1.4. 
6.3.1.5. All subjects gave written informed consent after a detailed description of the 
study aims and method. 
 
6.3.2. Clinical Assessment 
6.3.2.1. All subjects were assessed using the methodology described in 3.3.2.1. 
Though to highlight current psychotic symptoms in the patients were assessed in the 
twins using the Scales for the Assessment of Positive (SAPS) and Negative Symptoms 
(SANS)(Andreasen 1983; Andreasen 1983) and for the Family Study patients using the 
Positive and Negative Symptom Scale (PANSS)(Kay, Opler et al. 1989). In order to 
compare symptomatology between the two, lifetime psychotic symptoms were then 
rated from all the available information with the Operational Criteria Checklist 
(OPCRIT)(McGuffin, Farmer et al. 1991) for all patients in the two studies with MRI 
data (n=153), then subject to factor analysis, yielding scores for reality distortion, 
negative and disorganized dimensions of psychosis. In addition if a suitable parental 
informant was available, all subjects were rated for premorbid adolescent shizotypal 
personality traits (Picchioni, Walshe et al. 2010). Furthermore intelligence was assessed 
by means of the WAIS-III (Wechsler Adult Intelligence Scale-III), the WAIS-R 
(Wechsler Adult Intelligence Scale-R), or the WASI-FSIQ-4 (Wechsler Abbreviated 
Scale of Intelligence). Results were converted to standardized scores (z-scores) based on 
the mean and standard deviation of the respective controls group. 
6.3.2.2. As before in concordant twin pairs both members, and in discordant pairs one 
member (the proband), met DSM-IV criteria for schizophrenia or schizoaffective 
disorder, while their co-twin or sibling was free of any psychotic illness. Controls were 
free of personal or family history of psychosis or any schizophrenia spectrum disorder. 
Non-psychotic co-twins, siblings and controls were still included even if they met 
lifetime criteria for non-schizophrenia spectrum axis I pathology, and were clinically 
well at assessment. 
 
6.3.3. Participants 
6.3.3.1. The total sample comprised 79 twin pairs, 13 monozygotic (MZ) pairs 
concordant for schizophrenia, 14 MZ pairs discordant for schizophrenia in which the co-
twin was free of any psychotic illness, 8 DZ pairs discordant for schizophrenia and 30 
MZ and 19 DZ healthy control twin pairs (with no personal or family history of a 
psychotic or schizophrenia spectrum disorder) and 34 single generation sibling family 
clusters, 14 patients with schizophrenia, 9 of their discordant (free of any psychotic 
illness) siblings, and 20 healthy control siblings from unaffected families. 
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6.3.3.2. The probability that any of the discordant pairs would become concordant for 
schizophrenia in the future was low, as an average of 8.86 (SD=7.64) years in the MZ 
and 17.05 (10.17) years in the DZ pairs and sibling pairs had elapsed since the onset of 
illness in the probands(Belmaker, Pollin et al. 1974). All schizophrenia probands were 
clinically stable at the time of assessment, with no recent changes to their medication. 
6.3.3.3. Amongst the non-schizophrenic members of the discordant twin and sibling 
pairs, 5 met criteria for a DSM-IV Axis I diagnosis at some point in their lives: 
depression and simple phobia (n=1), depression and obsessive compulsive disorder 
(n=1), panic disorder and depression (n=1), panic disorder, generalised anxiety disorder 
and depression (n=1), and generalised anxiety disorder and panic disorder (n=1). Three 
of the controls met diagnostic criteria for a previous DSM-IV Axis I diagnosis: 
depression (n=1), hypomania (n=1) and agoraphobia and drug abuse (n=1) at some 
point in their lifetime. None of the control twins or unaffected members of discordant 
pairs were unwell at the time of assessment or taking any psychotropic medication. 
 
6.3.4. Verbal Fluency Task. 
6.3.4.1. Task Description 
6.3.4.1.1. We used a version of the task designed for functional MRI studies that 
has been described in detail previously(Fu, Morgan et al. 2001; Fu, Suckling et al. 
2005). Briefly, subjects performed an overt phonological verbal fluency paradigm 
involving two conditions, word generation and word repetition. In the generation 
condition, subjects were visually presented, using Visual Basic (Microsoft Corp., 
Redmond, USA), with a series of cue letters (height: 7 cm, subtending a 0.5° field of 
view) in yellow font, on a back projected blue screen, viewed through a mirror. 
6.3.4.1.2. Subjects were instructed to respond to each cue letter presentation by 
generating a single word that started with that letter. They were told to avoid using 
repetitions, grammatical variations or derivatives (e.g. run, running, runway) of an 
earlier response. In the word repetition condition, subjects were required to read out 
loud the word “REST” presented visually. 
6.3.4.1.3. A blocked design was used, with the cue letters and “REST” presented 
in alternating blocks of seven, in an ABAB design with an inter trial interval of 4000 
msec. Functional MRI data were acquired during two separate acquisition runs, each 
including 5 blocks of active word generation alternating with 5 blocks of baseline. 
This resulted in a total of 70 letter stimuli and 70 baseline trials for each subject. 
Verbal responses were recorded using an MRI compatible microphone onto a personal 
computer running Cool Edit 2000 software (Syntrillium Software Corp., [Adobe 
Systems Inc., San Jose, Calif.]) and later transcribed. "Incorrect" trials were collapsed 
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into a single error condition for the purpose of time series analysis, defined as those 
trials in which the subject either did not generate any response, said ‘pass’ or 
generated repetitions, derivatives or grammatical variations of an earlier response. All 
subjects were trained on the task before entering the MRI scanner, and reminded of 
the instructions once inside the scanner. 
 
6.3.5. Behavioural Data Analysis 
6.3.5.1. The percentage error responses were binomially distributed, so between 
group differences (MZ concordant schizophrenic, MZ and DZ/sibling discordant 
schizophrenic, MZ and DZ/sibling discordant non-schizophrenic, MZ and DZ and 
singleton control) were analysed with regression models that allowed for correlations 
within family clusters, and departures from normality by using the robust sandwich 
estimator to estimate standard errors(Binder 1983), implemented in Stata 10 (Stata 
Corporation, College Station, TX) as before. The significance level was set at 5%. 
 
6.3.6. Image Acquisition. 
6.3.6.1. Seventy-four T2*-weighted gradient-echo single-shot echo-planar images 
were acquired for each of the two four minute fifty-six second runs, on a 1.5 Tesla 
neuro-optimized IGE LX System (General Electric, Milwaukee) at the Maudsley 
Hospital, London, United Kingdom. Twelve contiguous axial planes (7mm thickness, 
slice skip: 0.7mm, in plane resolution = 3.75 x 3.75mm, 64x64 in plane matrix) parallel 
to the anterior commissure-posterior commissure line were collected in a “clustered” 
acquisition (TE=40 msec, flip angle=70°). 
6.3.6.2. Each cue was presented visually for 750 msec and an overt verbal response 
could be made in the silent period of 2900 msec; an image was then acquired over 1100 
msec resulting in a total repetition time (TR) of 4000 msec. This clustered or 
compressed acquisition sequence capitalizes on the delay of the haemodynamic 
response, which reaches its peak 3-5 seconds after stimulus onset34 and allowed fMRI 
data to be collected after the subject had spoken thereby minimising the influence of 
movement artefact(Amaro, Williams et al. 2002). 
6.3.6.3. A structural scan was also collected for each subject with the following 
acquisition parameters: TE 40 ms, TR 3 s, 43 slices, in-plane resolution 3 mm, interslice 
gap 0.3 mm. 
 
6.3.7. Image Processing & Analysis. 
6.3.7.1. Data were analyzed with XBAM v3.4 (Institute of Psychiatry, London, UK.) 
on a Sun Workstation (Sun Microsystems Inc. Santa Clara, USA). 
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6.3.7.2. Individual Analysis 
6.3.7.2.1. The initial five images from each time series were discarded while the 
MR signal reached steady state and acted as the trigger for the stimuli presentation 
software. Images were first examined for excessive motion (> 5mm) then 
aligned(Bullmore, Brammer et al. 1999) to the average image over the whole time 
series to minimise motion related artefacts and smoothed using a Gaussian filter with 
a FWHM of 9mm. Responses to the experimental paradigms were detected by time-
series analysis using gamma variate functions (peak responses weighted between 4 
and 8 seconds) to model the blood oxygen level-dependent response. 
6.3.7.2.2. The experimental condition of interest was correct word articulation, 
contrasted with word repetition (the baseline). In order to exclude colinearity for 
covariation associated with “incorrect” trials, the design model explicitly incorporated 
these as a separate third condition as part of the linear model in the first level analysis. 
First, each experimental condition was convolved separately with the 4 and 8 sec 
gamma functions to yield two models of the expected haemodynamic response to that 
condition. The weighted sum of these that gave the best fit to the time series at each 
voxel was then computed. In order to constrain the possible range of fits to 
physiologically plausible blood oxygen level-dependent responses, the constrained 
fitting procedure suggested by Friman et al(Friman, Borga et al. 2003) was adopted. 
Following this a goodness of fit statistic, the SSQ ratio (akin to a t-map), a measure of 
the mean power of neural response, was computed at each voxel. This was the ratio of 
the sum of squares of deviations from the mean intensity value due to the model 
(fitted time series) divided by the sum of squares due to the residuals (original time 
series minus model time series). The percentage BOLD signal change at each voxel 
was also calculated. This was ((fitmax–fitmin)/mean signal intensity)*100, where 
fitmax and fitmin were the maximum and minimum values of the fitted response for 
the time series in question. 
6.3.7.2.3. In order to sample the distribution of the SSQ ratio under the null 
hypothesis that observed values of the SSQ ratio were not determined by the 
experimental design (with minimal assumptions), the time series at each voxel was 
permuted using a wavelet-based resampling method (Bullmore, Fadili et al. 2003; 
Breakspear, Brammer et al. 2004). This was repeated 20 times at each voxel and the 
data combined over all voxels, preserving the spatial correlational structure in the 
data, resulting in 20 permuted parametric maps of SSQ ratio for each subject. 
Combining the randomised data over all voxels yields the distribution of SSQ ratio 
under the null hypothesis. A test that any given voxel is activated at any required type 
I error can then be carried out by obtaining the appropriate critical value of SSQ ratio 
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from the null distribution. We have shown that this permutation method gives very 
good type I error control with minimal distributional assumptions for continuously 
and clustered acquisition sequences(Bullmore, Long et al. 2001; Breakspear, 
Brammer et al. 2003). 
6.3.7.3. Activation during Verbal Fluency; Group Mapping 
6.3.7.3.1. In order to extend inference for the condition of interest to the group 
level, the observed and randomised SSQ ratio maps for each subject were transformed 
into standard space involving first a rigid body transformation of the fMRI data into 
the gradient echo image of the same subject, followed by an affine transformation 
onto a Talairach template (Brammer, Bullmore et al. 1997). By applying the two 
spatial transformations for each subject to the statistical maps from the observed and 
wavelet-randomised data, a generic brain activation map was produced for each 
experimental condition. In order to allow both members of each control and 
concordant twin or sibling pair to contribute data to the group level analysis, and 
allowing for intra-pair correlations, a pair median map was first calculated for each 
such pair. Thus pair level maps acted as the input for the concordant and control group 
twin maps. The median observed SSQ ratio over all subjects at each voxel (median 
values were used to minimise outlier effects) was then tested at each intracerebral 
voxel in standard space (Talairach, Tournoux et al. 1988; Schmahmann, Doyon et al. 
1999) against a critical value of the permutation distribution for median SSQ ratio, 
ascertained from the spatially transformed wavelet-permuted data (Brammer, 
Bullmore et al. 1997). In order to increase sensitivity and reduce the multiple 
comparison problem, hypothesis testing was carried out at the cluster level, using the 
method developed by Bullmore et al (Bullmore, Suckling et al. 1999), that gives 
excellent cluster-wise type I error control. We set the image-wise expectation for the 
number of false positive clusters under the null hypothesis at less than one. 
6.3.7.4. Main Effect of Group (Analysis of Variance) 
6.3.7.4.1.1. In order to conduct a second level analysis (ANOVA) to 
examine the data for a main effect of group on activation, we performed an analysis 
across the six experimental groups; MZ concordant for schizophrenia, MZ 
discordant with schizophrenia, DZ and siblings discordant with schizophrenia, MZ 
discordant non-psychotic, DZ and siblings discordant non-psychotic, all the healthy 
control subjects, with task and twin pair as repeated measures, and group 
categorical, using the Jonckheere-Terpstra test (J-T test) for ordered differences 
between classes. The value of the statistic (J) obtained from the observed data was 
tested against a null distribution formed by randomly permuting class labels and 
recalculating the statistic(Lehmann 1975). We adopted a parsimonious approach 
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and co-varied for age and intelligence, as these are known to influence verbal 
fluency performance. Analysis of variance was carried out on the effect size maps 
(akin to the beta-value) representing % change in BOLD response, as these were 
unbiased by the subject’s performance, i.e. number of correct responses. This was 
done by first computing the difference in median effect size ratio between groups at 
each voxel. Subsequent inference of the probability of this difference under the null 
hypothesis was made by reference to the null distribution obtained by repeated 
random permutation of group membership and recomputation of the difference in 
median effect size ratios between the two groups. Cluster-level maps were then 
obtained, as described above, with a total number of false positive clusters for each 
analysis set at less than one over the entire brain. Corrections for multiple 
comparisons were not required, as the threshold was set on an image-wide basis. 
6.3.7.5. Between Group Differences (Analysis of Variance): Post Hoc Contrasts 
6.3.7.5.1. In order to more precisely identify the relationship between the 
experimental groups and neural activity, once an effect of group was established, 
specific planned post-hoc comparisons were made between respective groups. We 
planned the following contrasts; firstly to explore the effects of familial risk, genes 
and shared environment, a contrast across the three unaffected groups, MZ discordant 
non-psychotic, DZ and siblings discordant non-psychotic and all the healthy control 
subjects, was performed. Secondly in order to explore unique environmental effects 
we compared between the members of the MZ discordant pairs. Analysis of variance 
was again carried out on the effect size maps in standard space as above, co-varied for 
age and intelligence and cluster level maps were again set to less than one false 
positive cluster over the entire map. 
 
6.3.8. Genetic Modelling 
6.3.8.1. Model Fitting Analysis 
6.3.8.1.1. I carried out full genetic modeling in Mx on each of the regions 
identified from the main effect of group analysis. I focused on those regions identified 
a priori, the inferior frontal gyrus, the middle and superior temporal gyrus and the 
medial temporal lobe. 
6.3.8.2. The Twin Model 
6.3.8.2.1. The twin model was as described in 4.3.5.1. 
6.3.8.3. Bivariate Modelling and Polychoric Correlations 
6.3.8.3.1. Bivariate modeling was as described in 4.3.5.2 but applied to partition 
the covariation between schizophrenia and on this occasion regional brain activity 
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measures, into genetic, shared and unique environmental sources of covariation. 
Polychoric correlations were as described in 4.3.5.4. 
6.3.8.3.2. Continuous neural activity data were ordinalized into five equal classes. 
All correlations between schizophrenia and regional brain activity both within and 
across individuals, were derived from the entire sample. 
 
6.4. Results. 
6.4.1. Demographic features 
6.4.1.1. There were no significant differences between the groups in handedness, 
ethnicity, or parental socio-economic status, but there were differences in age, IQ and 
the severity of psychotic symptoms at the time of scanning (Table 6.1). 
6.4.2. Behavioural Data 
6.4.2.1. There was a main effect of group on performance with, as anticipated, the 
healthy control subjects and the non-psychotic siblings and co-twins of patients making 
the fewest errors (Table 6.1). 
6.4.3. fMRI Data 
6.4.3.1. Activation within each group 
6.4.3.1.1. The pattern of regional activation during word generation relative to 
repetition was qualitatively similar across the six groups. In MZ twins concordant for 
schizophrenia, activation was evident in left inferior frontal gyrus and left precentral 
gyrus. The MZ discordant twins with schizophrenia activated the left inferior frontal 
gyrus, the middle frontal gyrus bilaterally, the right striatum and the right thalamus, 
while the DZ discordant twins and siblings with schizophrenia showed significant 
activation in the left inferior/middle frontal gyrus and left insula. The MZ discordant 
non-psychotic twins developed activation in the same areas, and also in the lingual 
gyrus and cuneus bilaterally. Finally, the DZ twins and siblings discordant non-
psychotic and healthy controls activated the left inferior and middle frontal gyri and 
left insula.
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Table 6.1 Demographics of Twins & Siblings 
 
  GROUP    Group Comparison Test 
 
MZ Cc Scz 
(n=25) 
MZ Dc Scz 
(n=14) 
DZ Dc & 















Age (years) 35.92 (10.12) 30.02 (9.56) 40.61 (12.02) 28.41 (7.72) 41.86 (14.84) 39.11 (13.43) F[5,120]=4.07 p=0.002 
N Male/Female 21/4 9/5 17/4 8/5 9/8 45/71 χ2=18.49, df=5 p=0.002 
Handedness 
(right/left/mixed) 19/6/0 11/3/0 20/1/0 12/1/0 13/4/0 102/9/5 
χ2=8.51, df=5 
p=0.13 
IQ (z-scoring)∗ -2.57 (1.03) -1.99 (1.53) -0.87 (0.81) -1.36 (1.24) -0.41 (0.99) 0.01 (0.98) F[5,114]=18.20 p<0.0001 
Parental socio-economic 
status 2.24 (0.88) 2.14 (0.77) 2.29 (0.90) 2.15 (0.80) 2.00 (0.79) 2.58 (1.56) 
F[5,119]=2.41 
p=0.06 
Ethnicity (% Caucasian) 96% 100% 100% 100% 100% 94.8% F[2,120]=1.63 p=0.20 
Reality distortion  -0.17 (0.83) 0.51 (0.83) -0.08 (1.19) NA NA NA F[2,40]=2.82 p=0.07 
Negative 0.02 (0.85) 0.27 (1.24) -0.36 (0.95) NA NA NA F[2,40]=1.25 p=0.30 
Disorganization -0.55 (0.87) 0.078 (0.90) 0.47 (1.09) NA NA NA F[2,40]=2.60 p=0.09 
Type of Antipsychotic 
(N 
typical/atypical/both/none) 
2/10/0/3 2/8/1/3 5/14/0/0 NA NA NA χ2=0.69, df=2 p=0.71 




(874.05) NA NA NA 
F=[3,119]=21.9 
P<0.001 
Number of errors 15.44 (10.77) 15.93 (7.70) 12.05 (6.68) 17.00 (5.39) 9.82 (7.48) 10.72 (8.47) F[5,120]=3.40 p=0.007 
Legend Table 6.1 Abbreviations: Cc, concordant; Dc, discordant; MZ, monozygotic; DZ, dizygotic ; Scz schizophrenia  
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6.4.3.2. Main Effect of Group 
6.4.3.2.1. There was a significant main effect of group, with a linear pattern of 
differential activation across the six groups, in specific prefrontal and temporal areas 
(Table 6.2). 
6.4.3.2.2. In the left inferior frontal gyrus, insula and superior temporal gyrus, the 
groups including patients with schizophrenia showed more activation than the non-
psychotic co-twins/siblings, while the latter showed greater activation than the healthy 
controls, (Figure 6.1, 6.2). 
 
Table 6.2 
Main Effect Across 6 Groups: Verbal Fluency vs. Baseline 
Size Tal(x) Tal(y) Tal(z) Side Cerebral Region 
MZ Cc Scz ≥ MZ Dc Scz ≥ DZ Dc & Sibling Dc Scz ≥ 
MZ Dc Non-psychotic ≥ DZ Dc & Sibling Dc Non-psychotic ≥ Healthy Controls 
16 -40 15 -18 L Superior Temporal Gyrus 
41 -43 15 -2 L Inferior Frontal Gyrus 
45 -47 4 4 L Precentral Gyrus 
48 -43 4 15 L Insula 
MZ Cc Scz ≤ MZ Dc Scz ≤ DZ Dc & Sibling Dc Scz ≤ 
MZ Dc Non-psychotic ≤ DZ Dc & Sibling Dc Non-psychotic ≤ Healthy Controls 
87 -4 -56 -13 L Cerebellum 
8 51 -56 -13 R Inferior Temporal Gyrus 
68 51 -56 -2 R Middle Temporal Gyrus 
25 -29 -52 -2 L Hippocampal Gyrus 
58 32 -78 4 R Middle Occipital Gyrus 
40 -29 -59 4 L Lingual Gyrus 
15 29 -78 15 R Precuneus 
10 47 -52 15 R Superior Temporal Gyrus 
65 -25 -52 20 L Middle Temporal Gyrus 
13 0 -78 26 L Cuneus 
 
Legend Table 6.2 
Abbreviations: MZ, monozygotic, DZ, dizygotic, Cc, concordant, Dc, discordant, Scz, 
schizophrenia, L, left, R, right. All clusters reported at voxel p=0.05 and cluster p=0.05 for the 
former and p=0.02 for latter contrast, yielding less than one false positive cluster respectively. 
Only the cluster with the largest number of voxels in each region is reported, and is limited to 
clusters of more than five voxels. Talairach coordinates refer to the voxel with the largest sum 
of squares ratio, a measure of power of neural response, in each cluster. 
 
6.4.3.2.3. In the right superior temporal gyrus, the hippocampal/parahippocampal 
gyrus, and in the middle temporal gyrus and cuneus/precuneus bilaterally, this linear 
pattern across the groups was reversed, with controls showing the most activation, 
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patients the least, and the non-psychotic co-twins and siblings at an intermediate 
level. Extracting the mean power of activation (effect size) revealed that in the left 
hippocampal/parahippocampal gyrus and middle temporal gyri, this reflected 
‘deactivation’ in patients with schizophrenia, less marked deactivation in their 





Main Effect of Group - Across 6 Groups: MZ Concordant Schizophrenia ≥ MZ Discordant 
Schizophrenia ≥ DZ Twin & Sibling Discordant Schizophrenia ≥ MZ Discordant Non-
psychotic ≥ DZ Twin & Sibling Discordant Non-psychotic ≥ Healthy Controls. Coronal, 




Extracted Signal Intensity (Mean Cluster SSQ Response) across the 6 Groups at the Left 
Inferior Frontal Gyrus. Coordinates: Tal(x)=-43, Tal(y)=15, Tal(z)=-2. 





Extracted Signal Intensity (Mean Cluster SSQ Response) across the 6 Groups at the Left 
Hippocampal/Parahippocampal Gyrus. Coordinates: Tal(x)=-29, Tal(y)=-52, Tal(z)=-2. 
Abbreviations: MZ, monozygotic, DZ, dizygotic, Cc, concordant, Dc, discordant, Scz, 
schizophrenia. 
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6.4.3.3. Differences between Non-psychotic Groups 
6.4.3.3.1. In order to identify regions specifically related to the familial (genetic 
plus shared environmental risk) of schizophrenia, in the absence of potentially 
confounding effects of illness and treatment, I restricted the above analysis to the 
three non-psychotic groups: non-psychotic MZ co-twins of patients, non-psychotic 
DZ co-twins and siblings of patients, and healthy controls. 
 
Table 6.3 Effect Across Unaffected Subjects: Verbal Fluency vs. Baseline 
Size Tal(x) Tal(y) Tal(z) Side Cerebral Region 
MZ Dc Non-psychotic ≥ DZ Dc & Sibling Dc Non-psychotic ≥ Healthy Controls  
15 -40 15 -13 L Inferior Frontal Gyrus 
30 -47 7 -2 L Insula 
41 51 26 4 R Inferior Frontal Gyrus 
5 -54 -33 4 L Middle Temporal Gyrus 
41 -43 4 9 L Precentral Gyrus 
33 54 0 9 R Precentral Gyrus 
18 -54 -22 15 L Postcentral Gyrus 
16 -58 -41 20 L Superior Temporal Gyrus 
MZ Dc Non-psychotic ≤ DZ Dc & Sibling Dc Non-psychotic ≤ Healthy Controls 
12 51 -52 -13 R Inferior Temporal Gyrus 
56 40 -44 -2 R Hippocampal/Fusiform Gyrus 
9 32 -74 -2 R Inferior Occipital Gyrus 
44 40 -41 4 R Superior/middle Temporal Gyrus 
52 32 -78 9 R Middle Occipital Gyrus 
22 25 -59 20 R Posterior Cigulate Gyrus 
18 43 -37 26 R Inferior Parietal Lobule 
6 25 -59 26 R Precuneus 
 
Legend Table 6.3 
Abbreviations: MZ, monozygotic, DZ, dizygotic, Cc, concordant, Dc, discordant, Scz, 
schizophrenia, L, left, R, right. All clusters reported at voxel p=0.05 and cluster p=0.02, 
yielding less than one false positive cluster. Only the cluster with the largest number of voxels 
in each region is reported, and is limited to clusters with more than five voxels. Talairach 
coordinates refer to the voxel with the largest sum of squares ratio, a measure of power of 
neural response, in each cluster. 
 
6.4.3.3.2. In the inferior frontal gyri, and the left insula and middle/superior temporal 
gyri, there was a linear pattern of differential activation, with greatest activation in the 
MZ co-twins, less activation in the DZ co-twins and siblings, and least in the healthy 
controls (Figure 6.4). The left inferior frontal cluster overlapped with that identified in the 
analysis of all six groups (above), and extended more posteriorly. 
6.4.3.3.3. In the right hippocampal and middle/superior temporal gyrus, this linear 
pattern was reversed, with most activation in the controls, least in the MZ co-twins, and 
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an intermediate level of activation in the DZ co-twins and siblings. Extracting the mean 
power of activation (effect size) from these regions revealed that this reflected relatively 




Extracted Signal Intensity (Mean Cluster SSQ Response) across the unaffected Subjects in the 
Left Superior Temporal Gyrus. Coordinates: Tal(x)=-58, Tal(y)=-11, Tal(z)=4. Abbreviations: 





Extracted Signal Intensity (Mean Cluster SSQ Response) across the unaffected Subjects in the 
Right Middle Temporal Gyrus. Coordinates: Tal(x)=29, Tal(y)=-52, Tal(z)=15. Abbreviations: 
MZ, monozygotic, DZ, dizygotic, Dc, discordant. 
6.4.3.4. Differences Within MZ Discordant Pairs 
6.4.3.4.1. The twins with schizophrenia showed greater activation than their non-
psychotic co-twins in the right middle and superior frontal gyrus, and in the anterior 
cingulate/medial frontal gyrus bilaterally. There were no areas where the non-psychotic 
twins showed relatively greater activation than their co-twins with schizophrenia. 
 
Table 6.4 MZ Discordant Schizophrenia > MZ Discordant Non-psychotic. Verbal Fluency vs. 
Baseline 
Size Tal(x) Tal(y) Tal(z) Side Cerebral Region 
MZ Dc Scz > MZ Dc Non-psychotic 
12 0 33 20 R 
Anterior Cingulate/Medial 
Frontal Gyrus 
8 22 44 20 R Superior Frontal Gyrus 
40 32 41 26 R Middle Frontal Gyrus 
48 -4 26 31 L Cingulate Gyrus 
 
Legend Table 6.4 
Abbreviations: MZ, monozygotic, DZ, dizygotic, L, left, R right. All clusters reported at voxel 
p=0.05 and cluster p=0.01, yielding less than one false positive cluster. Only the cluster with 
the largest number of voxels in each region is reported, and is limited to clusters with more 
than five voxels. Talairach coordinates refer to the voxel with the largest sum of squares ratio, 
a measure of power of neural response, in each cluster. 
 
6.4.4. Genetic Modelling 
6.4.4.1. On the basis of my original a priori hypotheses, I restricted the genetic modeling 
of signal intensity to the frontal and temporal lobe clusters identified in the main effect of 
group contrast described in 6.4.3.2. 
6.4.4.2. Many of the cross-twin within trait confidence intervals were wide and included 
zero in the estimates (Table 6.5). However the majority of the cross-twin/sibling cross-trait 
correlations were significant. Univariate modeling indicated low and non-significant 
heritability h2 (Table 6.6). The greatest were in the left hippocampus h2= 0.40 (0.00/0.62) 
and the right middle temporal gyrus h2=0.32 (0.00/0.56). However h2 and c2 (common 
environment) could not be dropped simultaneously from the model for any region without a 
significant decline in fit, though either could be dropped independently. This suggested a 
familial effect on regional activation. 
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6.4.4.3. Bivariate modeling (Table 6.7) revealed evidence of significant phenotypic 
correlations between schizophrenia and regional activation in each of the regions examined. 
The strongest positive correlation was in the left inferior frontal cortex (rph= 0.27), while the 
strongest negative correlations were in the left middle temporal gyrus (rph=-0.31) and left 
hippocampal gyrus (rph=-0.24). Breaking these correlations down showed that they was 
mainly attributable to common genetic factors, shared between each of these regions with 
schizophrenia (rpha=0.24, rpha=-0.22 and rpha=-0.14, respectively). Again both the genetic and 
the common environmental components could be dropped alone, but not simultaneously, 
from the model, without a significant decline in fit. 
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Table 6.5. Cross-twin/sibling Within Trait and Cross-twin/sibling Cross-trait Correlations (r & 95% CI) 
 
Abbreviations: MZ, monozygotic; DZ, dizygotic 
Note: The schizophrenia cross-twin correlation (SZtw1–SZtw2) is constrained to be .92 in MZ twins and .515 in DZ twins/siblings based on the point estimates 
of meta-analysis results, and the thresholds on the liabilities are fixed to a prevalence of 1%. 
Intervals including 0 indicate non-significance.  
Cross-twin/sibling Within-trait Correlations Cross-twin/sibling Cross-trait Correlations  Within-twin/sibling 
Cross-trait 
Correlations MZ DZ & Siblings MZ DZ & Siblings 
 
     

































































































































Abbreviations: MZ, monozygotic; DZ, dizygotic 
Note: h2,c2, and e2: heritability, shared and non-shared environmental. Confidence intervals including zero indicate non-significance. 
Parameters for schizophrenia are fixed based on a prevalence of 1% and the following genetic model: h2=.81, c2=.11, e2=.08
 h2 c2 e2 
 
   
Left Insula 0.05 (0.00/0.32) 0.32 (0.02/0.53) 0.67 (0.47/0.89) 
Left Inferior Frontal Gyrus 0.07 (0.00/0.42) 0.09 (0.00/0.35) 0.84 (0.58/0.97) 
Left Superior Temporal Gyrus 0.02 (0.00/0.32) 0.04 (0.00/0.27) 0.94 (0.68/1.00) 
Left Precentral Gyrus 0.10 (0.00/0.43) 0.17 (0.00/0.43) 0.73 (0.51/0.95) 
 
   
Right Middle Temporal Gyrus 0.32 (0.00/0.56) 0.01 (0.00/0.45) 0.68 (0.44/0.95) 
Left Middle Temporal Gyrus 0.06 (0.00/0.39) 0.09 (0.00/0.34) 0.85 (0.61/0.98) 
Right Middle Occipital Gyrus 0.10 (0.00/0.48) 0.21 (0.00/0.46) 0.69 (0.48/0.94) 
Right Superior Temporal Gyrus 0.06 (0.00/0.46) 0.12 (0.00/0.39) 0.82 (0.54/1.00) 
Left Hippocampus 0.40 (0.00/0.62) 0.01 (0.00/0.45) 0.59 (0.38/0.85) 
 136 
 
Table 6.7. The phenotypic correlations between schizophrenia and regional brain activity (rph), the decomposed sources of the correlations (rph-a, rph-c, 
rph-e) predicted by the ACE models. 
 
 rph-a rph-c rph-e rph 
 
    
Left Insula 0.07 0.20 0.02 0.27 (0.14/0.39) 
Left Inferior Frontal 
Gyrus 0.24 0.06 -0.03 
0.27 
(0.14/0.39) 
Left Superior Temporal 
Gyrus 0.13 0.06 0.01 
0.20 
(0.07/0.32) 
Left Precentral Gyrus 0.29 -0.02 -0.03 0.25 (0.11/0.37) 
 
    
Right Middle Temporal 
Gyrus -0.18 0.03 -0.04 
-0.20 
(-0.32/-0.07) 
Left Middle Temporal 
Gyrus -0.22 -0.04 -0.05 
-0.31 
(-0.42/-0.19) 
Right Middle Occipital 
Gyrus -0.28 0.08 0.03 
-0.17 
(-0.30/-0.04) 
Right Superior Temporal 
Gyrus -0.08 -0.01 0.03 
-0.07 
(-0.19/0.06) 
Left Hippocampus -0.09 -0.03 -0.04 -0.16 (-0.29/-0.03) 
 
Note: rph: total phenotypic correlation; rph-a, rph-c, rph-e, phenotypic correlation due to additive genetic, shared environmental and specific environmental 
influence. 
Confidence intervals including zero indicate non-significance.
 




6.5.1. Task Performance 
6.5.1.1. There was a linear pattern of verbal fluency performance across the six groups: in 
general, patients made more errors than controls, with their co-twins and siblings 
performing at an intermediate level, in line with hypothetical variation in risk load across 
the groups. 
6.5.1.2. This finding is consistent with previous phonological and semantic verbal 
fluency studies in patients(Pihlajamaki, Tanila et al. 2000; Bokat and Goldberg 2003; 
Vinogradov, Kirkland et al. 2003; Woodward, Ruff et al. 2003; van Beilen, Pijnenborg et al. 
2004), unaffected relatives(Gourovitch, Goldberg et al. 1996; Laurent, Biloa-Tang et al. 
2000; Gilvarry, Russell et al. 2001; Gilvarry, Russell et al. 2001; Vinogradov, Kirkland et 
al. 2003; Woodward, Ruff et al. 2003; van Beilen, Pijnenborg et al. 2004) and 
twins(Goldberg, Torrey et al. 1995; Cannon, Huttunen et al. 2000), which have reported 
performance deficits in non-psychotic relatives a level intermediate between that in patients 
and controls. 
6.5.1.3. The only group whose performance did not fit this model comprised the MZ non-
psychotic co-twins, whose performance was as impaired as in their schizophrenic co-twins 
and in the MZ twins concordant for schizophrenia (Table 6.1). Three of this group met 
lifetime criteria for affective or anxiety disorders, and their impaired performance could 
have been related to these disorders, as opposed to their risk for schizophrenia. However the 
majority of the non-psychotic co-twins had no psychiatric history, and all of them were 
clinically well and medication-free at the time of assessment. It is also unlikely that their 
poor performance reflected the presence of subjects who will subsequently develop 
schizophrenia, as the mean duration of discordance in these MZ twins at the time of testing 
was 9.25 years(Belmaker, Pollin et al. 1974). 
6.5.1.4. The study was powered to detect differences at a neurophsyiological level, and 
genetic modelling across groups. Specific subgroups were relatively small for post hoc 
behavioural contrasts. 
 
6.5.2. Functional MRI Results 
6.5.2.1. Lesion and functional imaging studies of verbal fluency in healthy volunteers 
have consistently implicated a distributed network involving the prefrontal, cingulate, 
lateral and medial temporal regions engaged in this study(Damasio, Grabowski et al. 1996; 
Warburton, Wise et al. 1996; Phelps, Hyder et al. 1997; Schlosser, Hutchinson et al. 1998; 
Pihlajamaki, Tanila et al. 2000; Buchsbaum, Hickok et al. 2001; Fu, Morgan et al. 2001; 
Gurd, Amunts et al. 2002; Abrahams, Goldstein et al. 2003; Amunts, Weiss et al. 2004). 
Proficient verbal fluency performance requires the integrity of both verbal working and 
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long-term memory(Allen, Liddle et al. 1993; Warburton, Wise et al. 1996), and the 
integration of  semantic knowledge and verbal search strategies, mediated by the temporal 
and prefrontal cortices(Gleissner and Elger 2001). Poor verbal fluency performance in 
schizophrenia has been attributed to impaired psychomotor speed(Woodward, Ruff et al. 
2003; van Beilen, Pijnenborg et al. 2004), lexical retrieval(Elvevag, Weinstock et al. 2001; 
Vinogradov, Kirkland et al. 2003), memory organization(Vinogradov, Kirkland et al. 2003), 
word generation or recovery(Allen, Liddle et al. 1993) and compromised 
intelligence(Elvevag, Weinstock et al. 2001; Gilvarry, Russell et al. 2001). However the 
fluency deficits are more marked than those predicted by verbal intelligence 
alone(Crawford, Obonsawin et al. 1993; Joyce, Collinson et al. 1996) and may lie at the 
core of genetically transmitted cognitive effects in schizophrenia(Toulopoulou, Picchioni et 
al. 2007). 
6.5.2.2. Verbal fluency normally engages the left inferior frontal cortex, which plays a 
central role in language production. Functional imaging studies have identified robust 
differences in activation between patients with schizophrenia and controls in this 
region(Curtis, Bullmore et al. 1998; Sommer, Ramsey et al. 2001; Boksman, Theberge et al. 
2005; Fu, Suckling et al. 2005; Weiss, Hofer et al. 2006), with similar functional 
abnormalities in unaffected relatives(Spence, Liddle et al. 2000; Sommer, Ramsey et al. 
2004; Whyte, Whalley et al. 2006). However, some studies have described attenuated left 
middle(Andreasen, Rezai et al. 1992; Ebmeier, Blackwood et al. 1993; Gur and Gur 1995) 
and inferior(Curtis, Bullmore et al. 1998) frontal activation in schizophrenia, while 
investigations that have used paced paradigms, that minimise group differences in 
performance, have either failed to replicate this(Frith, Friston et al. 1995; Weiss, Hofer et al. 
2004; Fu, Suckling et al. 2005), or have reported greater prefrontal activation in 
patients(Mechelli, Prata et al. 2008) and those at genetic risk(Prata, Mechelli et al. 2008). In 
the present study, we used a paced paradigm, and further minimized the potential for effects 
of differential task performance on activation by restricting the analysis to images 
associated with correct responses. Consistent with other studies that have used this 
approach, we found that increased risk was associated with greater, rather than less 
prefrontal activation. Callicott has suggested that patients and their relatives require greater 
prefrontal activation than controls to maintain normal task performance(Callicott, Egan et 
al. 2003) to compensate for prefrontal ‘inefficiency’(Callicott, Mattay et al. 2003). 
6.5.2.3. Relatively increased prefrontal activation in patients with schizophrenia and their 
unaffected relatives has also been reported in the context of other cognitive tasks (Sommer, 
Ramsey et al. 2001; Sommer, Ramsey et al. 2004; Weiss, Hofer et al. 2006) (Whyte, 
Whalley et al. 2006). 
6.5.2.4. In this study, I detected evidence of a phenotypic correlation between increased 
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left prefrontal activation and risk for schizophrenia. Furthermore, qualitatively similar 
increases were present in the non-psychotic co-twins and siblings of patients, attributable to 
the familial risk for the disorder, and independent of potentially confounding effects of 
illness and treatment. Although I was underpowered to definitively discriminate between 
genetic and common environmental effects, there was evidence that this increase was in 
part driven by shared genetic factors with schizophrenia. These observations are also 
consistent with independent evidence from molecular genetic (as opposed to familial) 
studies that genetic risk for schizophrenia influences prefrontal function(Bertolino, Caforio 
et al. 2004; Bertolino, Caforio et al. 2006; Bertolino, Di Giorgio et al. 2008; Mechelli, Prata 
et al. 2008; Prata, Mechelli et al. 2008; Costafreda, Fu et al. 2009; Prata, Mechelli et al. 
2009; Prata, Mechelli et al. 2009; Prata, Mechelli et al. 2009). 
6.5.2.5. In contrast to the inferior frontal cortex, in the middle temporal and 
parahippocampal cortex, increased risk for schizophrenia was associated with relatively 
greater deactivation, with most deactivation in patients, less in non-psychotic relatives, and 
least in the controls. This is consistent with previous functional imaging studies of verbal 
fluency and other tasks in schizophrenia (Frith, Friston et al. 1995; Fletcher, McKenna et al. 
1998), while other have not found this pattern (Spence, Liddle et al. 2000). 
6.5.2.6. Reductions in medial and lateral temporal grey matter volume are among the 
most consistent volumetric findings in schizophrenia(Pearlson 1997; Gur, Turetsky et al. 
2000; Hulshoff Pol, Schnack et al. 2001; Davatzikos, Shen et al. 2005), while qualitatively 
similar but less marked deficits are present in unaffected relatives(Rajarethinam, Sahni et al. 
2004; Job, Whalley et al. 2005) (Honea, Meyer-Lindenberg et al. 2008). Volumetric studies 
in subjects with prodromal symptoms of psychosis(Borgwardt, Radue et al. 2006; 
Borgwardt, McGuire et al. 2007) have also detected reductions in these regions, with some 
evidence that reductions at presentation predict subsequent transition into psychosis. 
Electrophysiological studies, including data from the subjects in this(Hall, Rijsdijk et al. 
2007), and another discordant twin study(Ahveninen, Jaaskelainen et al. 2006), have 
reported converging evidence for both genetic and illness-related abnormalities in temporal 
cortical processing of auditory stimuli in schizophrenia. 
6.5.2.7. I detected reduced activation in the hippocampal/parahippocampal gyrus in 
patients with schizophrenia and their non-psychotic co-twins, findings that reflected 
relatively greater deactivation in this region. Genetic modelling suggested that, in the 
context of the verbal fluency task used here, the phenotypic correlation of hippocampal 
activity with schizophrenia was relatively low, -0.16, though again that the largest variance 
component was shared genetic risk with schizophrenia. As these differences were evident 
on exclusively correct trials, and our fMRI analytical method was unbiased by the number 
of observations, they cannot be simply attributed to impaired behavioural performance, and 
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are consistent with reports of reduced activation in the hippocampus in the siblings of 
patients with schizophrenia during a verbal working memory task(Callicott, Egan et al. 
2003). 
6.5.2.8. Structural neuroimaging abnormalities in the hippocampus are robust, if not 
unequivocal, findings in schizophrenia(Harrison and Eastwood 2001) (Gur, Turetsky et al. 
2000; Wright, Rabe-Hesketh et al. 2000; Hulshoff Pol, Schnack et al. 2001; Davatzikos, 
Shen et al. 2005), and contemporary models of schizophrenia propose that primary 
pathology occurs at this site(Lodge and Grace 2007). However the findings from structural 
imaging studies in non-psychotic high risk groups, such as unaffected relatives or subjects 
with prodromal symptoms are more variable, with some reports of volume reductions (van 
Erp, Saleh et al. 2001; Seidman, Faraone et al. 2002; Tepest, Wang et al. 2003; Boos, 
Aleman et al. 2007; Honea, Meyer-Lindenberg et al. 2008) but others finding no 
differences(Schulze, McDonald et al. 2003; McDonald, Marshall et al. 2006; Goldman, 
Pezawas et al. 2008). Family and twin studies suggest that reduced hippocampal(Goldman, 
Pezawas et al. 2008) and temporal lobe(Brans, van Haren et al. 2008) volume in 
schizophrenia(Reveley, Reveley et al. 1982; Suddath, Christison et al. 1990; Baare, van Oel 
et al. 2001) is heritable, but influenced by environmental factors(van Erp, Saleh et al. 2004). 
Longitudinal MRI studies in clinically defined high risk groups also suggest that there may 
be a progressive loss of medial temporal volume during the transition from the high risk 
mental state to frank psychosis(Pantelis, Velakoulis et al. 2003; Job, Whalley et al. 2005). 
Our results suggest that in people with a genetic vulnerability to schizophrenia, the balance 
of aetiological factors between the frontal and temporal lobes and the hippocampus may 
vary(Heckers, Rauch et al. 1998; Meyer-Lindenberg, Poline et al. 2001). 
 
6.5.3. Limitations 
6.5.3.1. The analysis of functional MR data in this study was limited by the lack of a fully 
optimised analysis method to address the twin nature of the data. As has been noted in this 
thesis, twins by virtue of their genetic relationship violate the assumptions of independence 
of ANOVA. This inflates the possibility of a type I error when contrasting the controls with 
the other experimental groups, and increases the tendency to type II error when testing 
within twin pairs. I tried to guard against this through a number of steps. I matched for other 
potential confounders, optimised the paradigm design, produced first a pair level map for 
each concordant and control pair, as the input to the group level analysis, and paired the 
contrast between members of each twin pair. 
6.5.3.2. Task performance varied significantly between the groups. I minimised the 
impact of this in several methodological ways. I used a clustered acquisition sequence that 
allowed me to measure performance while minimising head motion, using a clustered 
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acquisition sequence. I used a mixed blocked design that allowed me to isolate trials within 
each block on the basis of performance, and model out the incorrect trials. I analysed ‘effect 
size’ maps in XBAM, that are less prone to differences in observation numbers between 
conditions. Finally by way of reassurance, the group differences did not exclusively reflect 
under activity in the patients. 
6.5.3.3. As the patients in the present study were the only group receiving medication, 
this could have contributed to between group differences, although not those between the 
non-psychotic co-twins/siblings and the healthy twins. We addressed this issue in our 
analysis that was restricted to the non-psychotic co-twins and siblings and the controls. 
Consistent with our prediction, the findings in both prefrontal and temporal cortex were 
qualitatively similar to those in the sample as a whole. This suggests that the effect of 
familial risk alone is qualitatively similar to that of familial plus unique environmental risk, 
and that the results are unlikely to be related to effects of psychotic illness or its treatment. 
6.5.3.4. It is noteworthy that the contrast within MZ discordant twin pairs 6.4.3.4, yielded 
increased activation in the patients with schizophrenia only in the frontal and prefrontal 
cortex, with no differences in the temporal lobe. This is at odds with our original hypothesis 
that had predicted unique environmental differences in the temporal cortex. Indeed evidence 
from structural imaging studies, using a variety of methods, suggest that the temporal lobe 
is sensitive to environmental factors in schizophrenia both in lateral and medial regions. It is 
possible that the failure to detect this in this study is a genuine finding. Alternatively it may 
be a function of the choice of verbal fluency as the activation paradigm, that is more 
typically associated with frontal activity. It might also be a consequence of the analysis 
method, effectively excluding between group differences in performance. 
6.5.3.5. Relative strengths of this study are that it represents only the second and certainly 
the largest functional imaging study of twins and unaffected siblings in schizophrenia to 
date. It used a robust and stable activation paradigm, chosen on the basis of off line testing 
to be phenotypically linked to schizophrenia and that it allowed the first genetic modelling 
of the link between fMRI activity and schizophrenia and thus the first quantification of 
fMRI activitity as an endophenotype marker for schizophrenia. 
 
6.6. Conclusions 
6.6.1. Both the familial risk for schizophrenia and the disorder itself are associated with 
significant functional alterations in the prefrontal, medial and lateral temporal cortices. 
6.6.2. Genetic and environmental factors, aetiologically linked to schizophrenia, 
influenced this regional brain activity and could serve as profitable endophenotype markers 
for future genetic studies. 
6.6.3. Future imaging studies in schizophrenia, that classify their groups on the basis of 
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risk genes should consider focusing on tasks that implicate these regions. 
6.6.4. The extent to which these findings could reflect changes in the integration of 
function between these areas needs be clarified through further investigation of their 







7.1.1. In this thesis I examined and evaluated four putative endophenotype markers for 
schizophrenia. I examined a twin (and family) cohort that varied in its concordance, and 
zygosity, for schizophrenia. I applied increasingly sophisticated assessment and analytical 
techniques to establish and validate the ability of these markers to meet endophenotype 
criteria. 
7.1.2. Perhaps the least ‘satisfactory’ study was the structural magnetic resonance 
imaging dataset in Chapter 5. The sample included only MZ twins and can also be criticised 
for using MR data from two sites. I attempted to deal with this potential source of noise and 
confound in the MR data through a variety of methodological and analytical techniques. I 
was able to show that by adopting these techniques it is possible to collect such data reliably. 
While I successfully collected structural MR data on a sample of DZ discordant and DZ 
control twin subgroups, it was not possible to include this data in the analysis for this thesis, 
given the time constraints of the PhD. By virtue of the sample composition and size I was 
only able to apply regression models to the data analysis. These however demonstrated that 
the selected brain volumes were compromised in schizophrenia. They did not differ between 
patient groups, whether they were from MZ concordant or discordant pairs and were 
independent of state effects, measured as psychotic symptoms and antipsychotic treatment, at 
the time of scanning. The volume deficits were present in the unaffected co-twins from MZ 
discordant pairs more than the controls. The volumes were highly correlated within twin 
pairs, suggesting familial effects, but I was not able to estimate their heritability due to lack 
of a DZ sample. However the volume deficits were related to developmental traits, that I was 
able to show in Chapter 4, can act as proxy markers of the genetic risk for schizophrenia. On 
the basis of this evidence, the brain structural measures met endophenotype criteria on the 
criteria that it was possible to assess them, in this limited dataset. 
7.1.3. The neurological abnormalities (Chapter 3) fulfilled all but one of the original 
Gottesman and Gould endophenotype criteria (Gottesman and Gould 2003). However once 
again I was unable to estimate their heritability due to lack of power within the sample. I was 
able to show that neurological abnormalities can be reliably measured at clinical examination 
and are associated with schizophrenia. They were correlated in families, more so in MZ than 
DZ pairs, strongly suggesting genetic effects, and they accumulated in the unaffected 
relatives of patients more so than controls. However I was unable to detect a further 
significant difference between the two hypothetical genetic risk groups of unaffected co-
twins. While the neurological abnormalities were not influenced by the ‘state’ of 
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schizophrenia, in terms of psychotic symptoms, there was evidence that they were sensitive 
to, or could be influenced by antipsychotic medication. On the basis of this evidence the 
neurologiocal abnormalities met many endophenotype criteria, though their demonstrable 
sensitivity to antipsychotic treatment may limit their usefulness to some extent. 
7.1.4. The regression and genetic modelling analyses applied to the child and 
adolescent developmental traits (Chapter 4) and neural activity associated with verbal 
fluency (Chapter 6) allowed a more detailed analysis of their respective endophenotype 
credentials. The results showed that the developmental markers were associated with 
schizophrenia and were also elevated in the unaffected family members in a manner that 
strongly suggested genetic effects. The modelling analysis was able to quantify both their 
heritability and their phenotypic correlation with schizophrenia, and finally estimate that 
additive genetic effects were responsible for that phenotypic relationship due to shared 
genetic risk. 
7.1.5. Turning to verbal fluency performance and its associated neural activity, this was 
also compromised in schizophrenia and segregated in families, following the hypothetical 
pattern of genetic risk. The cross twin-within trait and heritability estimates were however 
non significant. However I was able to show a significant phenotypic correlation between 
schizophrenia and increased neural activity in the inferior frontal gyrus and reduced activity 
in the left middle temporal gyrus and left hippocampus. These phenotypic correlations were 
principally due to shared genetic effects with schizophrenia. 
 
7.2. On balance the evidence in this thesis is most conclusive for the developmental and 
verbal fluency markers, supporting their role as endophenotype markers. However, in 
comparative terms, this may relate more to sample size and methodological factors, than their 
own inherent properties, compared to the other candidates. Given their selection on the basis 
of past work, all of the markers chosen for inclusion in this thesis have demonstrated that they 
meet many endophenotype criteria. 
 
7.3. Critical Analysis of the Endophenotype Concept and Suggestions for Future 
Directions 
7.3.1. Endophenotypes have risen to prominence in mental illness research because of 
our poor grasp of the aetiological and pathophysiological complexity of these disorders and 
as a consequence our inability to define the margins of these disorders more distinctly. 
Endophenotypes have evolved conceptually as quanitative traits, sited on the aetiological 
pathway between genotype and phenotype, and closer to the genetic effects, they offer a lure 
of relative simplicity and precision. 
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7.3.2. Endophenotypes are not equivalent to biomarkers. A biomarker is an indicator of 
a normal or pathological processes (Atkinson, Colburn et al. 2001). Biomarkers are disease 
specific and index the presence or severity of their disorder (Ritsner and Gottesman 2009). 
By way of contrast endophenotypes are quantifiable biological variants that are stable trait 
markers of the genetic vulnerability for a disorder (Ritsner and Gottesman 2009) and 
independent of its severity. 
7.3.3. It was highlighted in 2.3 that there is no unanimity as to how endophenotypes 
should be characterised. The two most influential definitions are that an endophenotype 
should be (Gottesman and Gould 2003): 
• associated with the illness in the population 
• state independent 
• heritable 
• co-segregate in families 
• present in unaffected members more than the general population. 
7.3.4. Influenced by these identifiable criteria Preston and Weinberger then suggested 
that an endophenotype should be (Preston and Weinberger 2005): 
• a quantitative biological trait that is reliable and reasonably heritable 
• associated with variant alleles that distinguish patients and their unaffected siblings from 
healthy controls on quantitative measures 
• reflect a less complex genetic architecture than the disorder 
7.3.5. Combining these criteria engenders a series of assumptions about 
endophenotypes that underpins their potential usefulness: 
• that they are genetically less complex than the exophenotype 
• that effect sizes for their genetic effects are larger 
• that they lie on the pathophysiological pathway from genotype to phenotype 
• that they are specific to a disorder. 
7.4. However, as some have pointed out, none of these assumptions can necessarily be shown 
to be true on the basis of the majority of the published literature (Walters and Craddock 2007). 
7.4.1. The principle role of endophenotypes is to support gene discovery and while it is 
not part of the original definition, it is accepted that endophenotypes ideally should be, 
genetically less complex than the original exophenotype. However there is little evidence to 
support this conclusion (Flint and Munafo 2007; Walters and Craddock 2007; Prasad and 
Keshavan 2008). Firstly the vast majority of studies that have attempted to identify either 
directly or indirectly the endophenotypic credentials of candidate markers, have been unable 
to establish their heritability. There is even less evidence to establish their position on the 
aetiological pathway between genes and the disorder, though this point is often inferred from 
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their detection in unaffected relatives and their state independence in patients. However only 
longitudinal study designs can truly establish this type of causal relationship. Furthermore 
what studies have so for been conducted that assess the genetic influences on putative 
endophenotypes have produced mixed results (Paunio, Tuulio-Henriksson et al. 2004; Dick, 
Jones et al. 2006; Flint and Munafo 2007). Indeed the inability of many earlier studies to 
definitively address these questions has lead to the conclusion that many of these markers 




This shows in simplified, schematic terms some of the possible relationships between putative 
endophenotypes, gene and disease. In reality, different combinations of these simplified 
scenarios are likely. G, genes; Enviro, environmental factors; Endo, putative endophenotype; 
P, disease phenotype. 
Reprinted by permission from Macmillan Pulishers Ltd: Molecular Psychiatry. JTR Walters 




7.4.2. Figure 7.1 illustrates some of the possible aetiological models that could link 
genes, an endophenotype and a psychiatric disorder. Model 1 is of a ‘true’ endophenotype, 
and illustrates a mediational model that links genes, the endopheotype and the disorder. It is 
the model that we usually associate with the endophenotype concept. Model 3 is a risk-
liability model and will successfully meet all of Gottesman and Goulds’ endophenotype 
characteristics, but is an epiphenomenon, not an endophenotype. It will share genetic risk, 
but not be causally linked to the illness. The two pathways are contrasted in Fig 7.2. Both 
will allow genes to cause the ‘endophentype’ and the illness, both will appear to be heritable, 
both will lead to elevated rates of the endophenotype in patients’ unaffected relatives. 
However only the mediational model in pathway (b) predicts that the genetically determined 
pathology that drives the endophenotype is then causally related to the psychiatric illness. 
From a clinical perspective it also vitally predicts that a successful intervention against the 
endophenotype, will have a positive impact of the illness. Again only longitudinal study 
designs can address this question satisfactorily and by their very nature the developmental 
markers assessed in Chapter 4, especially in the context of the current expansion of First 
Episode Psychosis and At Risk Mental State services currently, hint at a possible opportunity 




(c) A liability-index model for endophenotypes (EPs). Genetic variance VG influences both 
the EP and psychiatric disorder (PD). These observed variables also have residual variation, 
RVEP and RVPD, due to other sources. 
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(d) A mediational model for EPs. Genetic variance causes variation in the EP, which in turn 
causes variation in PD. EP and PD have residual variance components RVEP and RVPD, 
respectively. 
Reprinted by permission from Macmillan Publishers Ltd: Molecular Psychiatry. KS Kendler 
and MC Neale. Endophenotype: a conceptual analysis (2010). Molecular Psychiatry 15; 789-
797. 
 
7.4.3. A further criticism of endophenotype models is that while they assume that 
causal relationships are one way, this need not be the case. For instance it may be that the 
presence of neurological abnormalities, or impaired social ability increase the risk for 
schizophrenia, but equally it could be that developing schizophrenia increases the risk of 
neurological abnormalities and impaired social opportunity. Once again future prospective 
longitudinal studies are needed to address this issue. 
7.4.4. There is little or no evidence that all of the genetic risk for the illness needs to 
pass through the endophenotype. Indeed it is likely that some of the genetic effects will by-
pass the endophenotype, directly acting on the illness (Fig 7.3). Furthermore there may be 
genes that act on the illness alone, while others act on the endophenotype alone. The 
modelling studies I conducted in this thesis are one of the only analytical models that can 
quantify shared genetic risk and address this problem through estimation of the rg, the genetic 
correlation. Future studies should estimate this for multiple endophenotypes in combination, 
to produce composite or ‘extended endophenotypes’ with the greatest rg, for future genetic 




A nonexclusive mediational model for endophenotypes (EPs) including a direct causal path 
from genes to the psychiatric disorder (aPD) that does not pass through EP. 
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Reprinted by permission from Macmillan Pulishers Ltd: Molecular Psychiatry. KS Kendler 
and MC Neale. Endophenotype: a conceptual analysis (2010). Molecular Psychiatry 15; 789-
797. 
 
7.4.5. The vast majority of research activity in relation to endophenotpyes in the last 
fifteen years has focussed on their relationship with genes and genetic risk, while either 
ignoring the environment, or viewing the environment as a confound. This has in part 
reflected the prevailing focus of academic interest but perhaps also reflected a lack of 
confidence in the tools and instruments to measure the environment. The role and importance 
of the environment in schizophrenia, while perhaps neglected has never gone away. More 
recently interest in the role of the environment and genetics and the interactions and 
correlations between the two has grown. Furthermore while the environment’s influence on 
an endophenotype in the past might have been seen as a nuisance, it now seems clear that 
endophenotypes can perform exactly the same role but as indices of the environmental 
impact on an exophenotype, just as they do for genes. In line with this change in thinking and 
in response to a need to develop more sophisticated aetiological models to discover the risk 
variants that underpin schizophrenia future genetic studies of endophenotypes should 
incorporate measures both of environmental adversity and support. This consideration will 
become increasingly important if we are to develop a better understanding of the link 
between peoples’ lives, at the individual and wider societal levels, and their risk of psychosis, 
and the mechanisms that mediate that risk. Furthermore through a better understanding of the 
effects of the environment and by identifying those people at greatest genetic risk to that 
environmental adversity, and who might benefit most from support, that targeted 
prophylactic strategies could be developed and deployed in the most efficient and effective 
manner possible. 
7.4.6. One further research strategy to address the specific concerns around 
endophenotypes might be to combine multiple endophenotype measures in the population 
being studied, a concept some have called ‘extended endophenotypes’ (Prasad and Keshavan 
2008), though perhaps composite is more accurate. Criteria already proposed for this concept 
include that: 
• each candidate trait should independently meet endophenotype criteria 
• the extended endophenotype should involve at least two levels of markers, e.g. 
physiological and structural 
• those selected should be correlated within individuals and co-segregate in families 
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• those selected should be mechanistically related (given our current knowledge). 
7.4.7. However additional criteria for such an extended endophenotype model should 
be that each of the candidate markers is not only linked to schizophrenia, but that this link is 
mediated by genes (Walters and Craddock 2007) and that the link is shared between the 
markers themselves. Fundamentally this means that they should be phenotypically and 
genotypically correlated both with schizophrenia and each other. Subjects in future will then 
be selected and stratified for genetic linkage and association studies on the basis of their 
status for the extended endophenotype marker. 
7.4.8. By using such strategies our ability to detect the genes responsible for 
schizophrenia, and thereby to understand the pathology of this disorder will improve. 
Through that route we will develop better, safer, more effective individualised treatments and 




(1993). The International Statistical Classification of Diseases and Related Health Problems 
Tenth Revision. Geneva, World Health Organisation. 
Abrahams, S., L. H. Goldstein, et al. (2003). "Functional magnetic resonance imaging of 
verbal fluency and confrontation naming using compressed image acquisition to 
permit overt responses." Human Brain Mapping 20(1): 29-40. 
Addington, J. and D. Addington (2005). "Patterns of premorbid functioning in first 
episode psychosis: relationship to 2-year outcome." Acta Psychiatrica 
Scandinavica 112(1): 40-46. 
Ahveninen, J., I. P. Jaaskelainen, et al. (2006). "Inherited auditory-cortical dysfunction in 
twin pairs discordant for schizophrenia." Biological Psychiatry 60(6): 612-620. 
Allan, C. L., A. G. Cardno, et al. (2009). "Twin study of illness history variables in 
psychosis." Schizophrenia Research 115(2-3): 237-244. 
Allen, H. A., P. F. Liddle, et al. (1993). "Negative features, retrieval-processes and verbal 
fluency in schizophrenia." British Journal of Psychiatry 163: 769-775. 
Allen, M. G. and W. Pollin (1970). "SCHIZOPHRENIA IN TWINS AND DIFFUSE 
EGO BOUNDARY HYPOTHESIS." American Journal of Psychiatry 127(4): 
437-&. 
Amaro, E., S. C. R. Williams, et al. (2002). "Acoustic noise and functional magnetic 
resonance imaging: Current strategies and future prospects." Journal of Magnetic 
Resonance Imaging 16(5): 497-510. 
American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental 
Disorders, Fourth Edition. Washington, DC, American Psychiatric Association. 
Amunts, K., P. H. Weiss, et al. (2004). "Analysis of neural mechanisms underlying verbal 
fluency in cytoarchitectoncially defined stereotaxic space-The roles of Brodmann 
areas 44 and 45." Neuroimage 22: 42-56. 
Andreasen, N. C. (1983). The Scale for the Assessment of Negative Symptoms (SANS). 
Iowa City, IA., Iowa University. 
Andreasen, N. C. (1983). The Scale for the Assessment of Positive Symptoms (SAPS). 
Iowa City, IA., Iowa University. 
Andreasen, N. C., K. Rezai, et al. (1992). "Hypofrontality in neuroleptic-naive patients 
and in patients with chronic schizophrenia. Assessment with xenon 133 single-
photon emission computed tomogrpahy and the Tower of London." Arch Gen 
Psychiatry 49: 943-958. 
Annett, M. (1970). "A classification of hand preference by association analysis." Br J 
Psychol 61(3): 303-321. 
Appels, M. C. M., M. M. Sitskoorn, et al. (2003). "Cognitive dysfunctions in parents of 
schizophrenic patients parallel the deficits found in patients." Schizophrenia 
Research 63(3): 285-293. 
Argyropoulos, S. V., S. Landau, et al. (2008). "Twins discordant for schizophrenia: 
psychopathology of the non-schizophrenic co-twins." Acta Psychiatrica 
Scandinavica 118(3): 214-219. 
Arieti, S. (1949). "An interpretation of the divergent outcome of schizophrenia in 
identical twins. ." Psychiatric Quarterly 18: 587-599. 
Arnone, D., J. Cavanagh, et al. (2009). "Magnetic resonance imaging studies in bipolar 
disorder and schizophrenia: meta-analysis." British Journal of Psychiatry 195(3): 
194-201. 
 152 
Arseneault, L., M. Cannon, et al. (2002). "Cannabis use in adolescence and risk for adult 
psychosis: longitudinal prospective study." British Medical Journal 325(7374): 
1212-1213. 
Ashburner, J. and K. J. Friston (2000). "Voxel-based morphometry - The methods." 
NeuroImage 11(6): 805-821. 
Ashton, E. (2009). "Quantitative MR in Multi-center clinical trials." Journal of Magenetic 
Resonance Imaging 31: 279-288. 
Assaf, Y. and O. Pasternak (2008). "Diffusion tensor imaging (DTI)-based white matter 
mapping in brain research: A review." Journal of Molecular Neuroscience 34(1): 
51-61. 
Atkinson, A. J., W. A. Colburn, et al. (2001). "Biomarkers and surrogate endpoints: 
Preferred definitions and conceptual framework." Clinical Pharmacology & 
Therapeutics 69(3): 89-95. 
Baare, W. F. C., C. J. van Oel, et al. (2001). "Volumes of brain structures in twins 
discordant for schizophrenia." Archives of General Psychiatry 58(1): 33-40. 
Baca-Garcia, E., M. M. Perez-Rodriguez, et al. (2007). "Diagnostic stability of 
psychiatric disorders in clinical practice." British Journal of Psychiatry 190: 210-
216. 
Bachman, P., J. Kim, et al. (2003). "EEG synchronization and spatial working memory in 
schizophrenia patients, their unaffected co-twins, and controls." 
Psychophysiology 40: S24-S24. 
Bachman, P., J. Kim, et al. (2008). "Abnormally high EEG alpha synchrony during 
working memory maintenance in twins discordant for schizophrenia." 
Schizophrenia Research 103(1-3): 293-297. 
Bailer, J., W. Brauer, et al. (1996). "Premorbid adjustment as predictor of outcome in 
schizophrenia: Results of a prospective study." Acta Psychiatrica Scandinavica 
93(5): 368-377. 
Baron, M., R. Gruen, et al. (1985). "A family study of schizophrenic and normal control 
probands: implications for the spectrum concept of schizophrenia." American 
Journal of Psychiatry 142(4): 447-455. 
Bartley, A. J., D. W. Jones, et al. (1997). "Genetic variability of human brain size and 
cortical gyral patterns." Brain 120: 257-269. 
Battaglia, M., L. Bernardeschi, et al. (1995). "A family study of schizotypal disorder." 
Schizophrenia Bulletin 21(1): 33-45. 
Bazire, S. (2007). Psychotropic Drug Directory. Aberdeen, HealthComm UK Limited  
Belmaker, R., W. Pollin, et al. (1974). "Follow-up of Monozygotic Twins Discordant for 
Schizophrenia." Archives of General Psychiatry 30(2): 219-222. 
Bentall, R. P., G. S. Claridge, et al. (1988). "The multidimensional nature of schizotypal 
traits: A factor analytic study with normal subjects." British Journal of Clinical 
Psychology 28: 363-375. 
Bergman, A. J., J. M. Silverman, et al. (2000). "Schizotypal symptoms in the relatives of 
schizophrenia patients: An empirical analysis of the factor structure." 
Schizophrenia Bulletin 26(3): 577-586. 
Berman, K. F., E. F. Torrey, et al. (1992). "REGIONAL CEREBRAL BLOOD-FLOW 
IN MONOZYGOTIC TWINS DISCORDANT AND CONCORDANT FOR 
SCHIZOPHRENIA." Archives of General Psychiatry 49(12): 927-934. 
Bertolino, A., G. Caforio, et al. (2004). "Interaction of COMT Val(108/158) met 
genotype and olanzapine treatment on prefrontal cortical function in patients with 
schizophrenia." American Journal of Psychiatry 161(10): 1798-1805. 
 153 
Bertolino, A., G. Caforio, et al. (2006). "Prefrontal dysfunction in schizophrenia 
controlling for COMT Val(158)Met genotype and working memory 
performance." Psychiatry Research-Neuroimaging 147(2-3): 221-226. 
Bertolino, A., A. Di Giorgio, et al. (2008). "Epistasis between dopamine regulating genes 
identifies a nonlinear response of the human hippocampus during memory tasks." 
Biological Psychiatry 64(3): 226-234. 
Bezchlibnyk-Butler, K. Z., J. J. Jeffries, et al. (1994). "Clinical handbook of psychotropic 
drugs, Fourth edition." Clinical handbook of psychotropic drugs, Fourth edition: 
ii+129p. 
Binder, D. A. (1983). "On the Variances of Asymptotically Normal Estimators from 
Complex Surveys." International Statistical Review 51(3): 279-292. 
Bland, J. M. and D. G. Altman (1986). "Statistical-methods for assessing agreement 
between methods of clinical measurement." Lancet 1(8476): 307-310. 
Bleuler, E. (1911). Dementia Praecox oder die Gruppe der Schizophrenien. Liepzig, 
Deuticke. 
Bokat, C. E. and T. E. Goldberg (2003). "Letter and category fluency in schizophrenic 
patients: a meta-analysis." Schizophrenia Research 64(1): 73-78. 
Boklage, C. E. (1977). "SCHIZOPHRENIA, BRAIN ASYMMETRY DEVELOPMENT, 
AND TWINNING - CELLULAR RELATIONSHIP WITH ETIOLOGICAL 
AND POSSIBLY PROGNOSTIC IMPLICATIONS." Biological Psychiatry 
12(1): 19-35. 
Boksman, K., J. Theberge, et al. (2005). "A 4.0-T fMRI study of brain connectivity 
during word fluency in first-episode schizophrenia." Schizophrenia Research 75: 
247-263. 
Bonan, I., A. M. Argenti, et al. (1998). "Magnetic resonance imaging of cerebral central 
sulci: A study of monozygotic twins." Acta Geneticae Medicae et Gemellologiae 
47(2): 89-100. 
Boomsma, D., A. Busjahn, et al. (2002). "Classical twin studies and beyond." Nature 
Review Genetics 3(11): 872-882. 
Boos, H. B., A. Aleman, et al. (2007). "Brain volumes in relatives of patients with 
schizophrenia." Archives of General Psychiatry 64: 297-304. 
Boos, H. B. M., A. Aleman, et al. (2007). "Brain volumes in relatives of patients with 
schizophrenia - A meta-analysis." Archives of General Psychiatry 64(3): 297-304. 
Borgwardt, S. J., P. K. McGuire, et al. (2007). "Structural brain abnormalities in 
individuals with an at-risk mental state who later develop psychosis." British 
Journal of Psychiatry 191: S69-S75. 
Borgwardt, S. J., M. M. Picchioni, et al. (2010). "Regional Gray Matter Volume in 
Monozygotic Twins Concordant and Discordant for Schizophrenia." Biological 
Psychiatry 67(10): 956-964. 
Borgwardt, S. J., M. M. Picchioni, et al. (In Press). "Regional Gray Matter Volume in 
Monozygotic Twins COncordant and Discordant for Schizophrenia." Biological 
Psychiatry. 
Borgwardt, S. J., E. W. Radue, et al. (2006). "Radiological findings in individuals at high 
risk of psychosis." Journal of Neurology Neurosurgery and Psychiatry 77(2): 229-
233. 
Borgwardt, S. J., A. Riecher-Rossler, et al. (2007). "Regional gray matter volume 
abnormalities in the at risk mental state." Biological Psychiatry 61(10): 1148-
1156. 
 154 
Boydell, J., J. van Os, et al. (2004). "The association of inequality with the incidence of 
schizophrenia - An ecological study." Social Psychiatry and Psychiatric 
Epidemiology 39(8): 597-599. 
Bracha, H. S., E. F. Torrey, et al. (1991). "SUBTLE SIGNS OF PRENATAL 
MALDEVELOPMENT OF THE HAND ECTODERM IN SCHIZOPHRENIA - 
A PRELIMINARY MONOZYGOTIC TWIN STUDY." Biological Psychiatry 
30(7): 719-725. 
Bracha, H. S., E. F. Torrey, et al. (1992). "2ND-TRIMESTER MARKERS OF FETAL 
SIZE IN SCHIZOPHRENIA - A STUDY OF MONOZYGOTIC TWINS." 
American Journal of Psychiatry 149(10): 1355-1361. 
Brammer, M. J., E. T. Bullmore, et al. (1997). "Generic brain activation mapping in 
functional magnetic resonance imaging: A nonparametric approach." Magnetic 
Resonance Imaging 15(7): 763-770. 
Brans, R., N. Van Haren, et al. (2007). "Structural brain changes in twin pairs discordant 
for schizophrenia: A 5-year follow-up MRI study." Schizophrenia Bulletin 33(2): 
329-330. 
Brans, R. G. H., N. E. M. van Haren, et al. (2008). "Heritability of changes in brain 
volume over time in twin pairs discordant for schizophrenia." Arch Gen 
Psychiatry 65(11): 1259-1268. 
Brans, R. G. H., N. E. M. van Haren, et al. (2008). "Heritability of Changes in Brain 
Volume Over Time in Twin Pairs Discordant for Schizophrenia." Archives of 
General Psychiatry 65(11): 1259-1268. 
Bray, N. J., A. Preece, et al. (2005). "Haplotypes at the dystrobrevin binding protein 1 
(DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 
expression." Human Molecular Genetics 14(14): 1947-1954. 
Breakspear, M., M. Brammer, et al. (2003). "Construction of multivariate surrogate sets 
from nonlinear data using the wavelet transform." Physica D-Nonlinear 
Phenomena 182(1-2): 1-22. 
Breakspear, M., M. J. Brammer, et al. (2004). "Spatiotemporal wavelet resampling for 
functional neuroimaging data." Human Brain Mapping 23(1): 1-25. 
Bressers, W. M. A., A. W. Eriksson, et al. (1987). "Increasing tren in monozygotic 
twinning rate." Acta Geneticae Medicae Et Gemellologiae 36(3): 397-408. 
Bridle, N., C. Pantelis, et al. (2002). "Thalamic and caudate volumes in monozygotic 
twins discordant for schizophrenia." Australian and New Zealand Journal of 
Psychiatry 36(3): 347-354. 
Broome, M. R., J. B. Wooley, et al. (2005). "What causes the onset of psychosis?" 
Schizophrenia Research 79: 23-34. 
Buchanan, R. W. and D. W. Heinrichs (1989). "The Neurological Evaluation Scale (Nes) 
- a Structured Instrument for the Assessment of Neurological Signs in 
Schizophrenia." Psychiatry Research 27(3): 335-350. 
Buchsbaum, B. R., G. Hickok, et al. (2001). "Role of left posterior superior temporal 
gyrus in phonological processing for speech perception and production." 
Cognitive Science 25(5): 663-678. 
Bullmore, E., J. Fadili, et al. (2003). "Wavelets and statistical analysis of functional 
magnetic resonance images of the human brain." Statistical Methods in Medical 
Research 12(5): 375-399. 
Bullmore, E. T., M. J. Brammer, et al. (1999). "Methods for diagnosis and treatment of 
stimulus-correlated motion in generic brain activation studies using fMRI." 
Human Brain Mapping 7(1): 38-48. 
 155 
Bullmore, E. T., C. Long, et al. (2001). "Coloured noise and computational inference in 
neurophysiological (fMRI) time series analysis: Resampling methods in time and 
wavelet domains." Human Brain Mapping 12: 61-78. 
Bullmore, E. T., J. Suckling, et al. (1999). "Global, voxel, and cluster tests, by theory and 
permutation, for a difference between two groups of structural MR images of the 
brain." Ieee Transactions on Medical Imaging 18(1): 32-42. 
Callicott, J. H., M. F. Egan, et al. (2003). "Abnormal fMRI response of the dorsolateral 
prefrontal cortex in cognitively intact siblings of patients with schizophrenia." 
American Journal of Psychiatry 160(4): 709-719. 
Callicott, J. H., V. S. Mattay, et al. (2003). "Complexity od prefrontal cortical 
dysfunction in schizophrenia: more than up and down." American Journal of 
Psychiatry 160(12): 2209-2215. 
Camchong, J., K. O. Lim, et al. (2009). "Frontal white matter integrity as an 
endophenotype for schizophrenia: diffusion tensor imaging in monozygotic twins 
and patients' nonpsychotic relatives." Frontiers in Human Neuroscience 3. 
Cannon-Spoor, H. E., S. G. Potkin, et al. (1982). "Measurement of Premorbid Adjustment 
in Chronic-Schizophrenia." Schizophrenia Bulletin 8(3): 470-484. 
Cannon, M., A. Caspi, et al. (2002). "Evidence for early-childhood, pan-developmental 
impairment specific to schizophreniform disorder - Results from a longitudinal 
birth cohort." Archives of General Psychiatry 59(5): 449-456. 
Cannon, M., P. Jones, et al. (1997). "Premorbid social functioning in schizophrenia and 
bipolar disorder: Similarity and differences." American Journal of Psychiatry 
154(11): 1544-1550. 
Cannon, T. D., M. O. Huttunen, et al. (2000). "The inheritance of neuropsychological 
dysfunction in twins discordant for schizophrenia." American Journal of Human 
Genetics 67(2): 369-382. 
Cannon, T. D., J. Kaprio, et al. (1998). "The genetic epidemiology of schizophrenia in a 
Finnish twin cohort - A population-based modeling study." Archives of General 
Psychiatry 55(1): 67-74. 
Cannon, T. D. and M. C. Keller (2006). "Endophenotypes in the genetic analysis of 
mental disorders." Annual Review of Clinical Psychology 2: 267-290. 
Cannon, T. D., P. M. Thompson, et al. (2002). "Cortex mapping reveals regionally 
specific patterns of genetic and disease-specific gray-matter deficits in twins 
discordant for schizophrenia." Proceedings of the National Academy of Sciences 
of the United States of America 99(5): 3228-3233. 
Cannon, T. D., T. G. M. van Erp, et al. (1998). "Regional gray matter, white matter, and 
cerebrospinal fluid distributions in schizophrenic patients, their siblings, and 
controls." Archives of General Psychiatry 55(12): 1084-1091. 
Cannon, T. D., L. E. Zorrilla, et al. (1994). "Neuropsychological functioning in siblings 
discordant for schizoophrenia and healthy-volunteers." Archives of General 
Psychiatry 51(8): 651-661. 
Canon, M., P. B. Jones, et al. (2002). "Obstetric complications and schizophrenia: 
historical and meta-analytic review." American Journal of Psychiatry 159: 1080-
1092. 
Cantor-Graae, E., B. Ismail, et al. (2000). "Are neurological abnormalities in 
schizophrenic patients and their siblings the result of perinatal trauma?" Acta 
Psychiatrica Scandinavica 101(2): 142-147. 
Cantor-Graae, E., T. F. McNeil, et al. (1994). "Are Neurological Abnormalities in Well 
Discordant Monozygotic Co-Twins of Schizophrenic Subjects the Result of 
Perinatal Trauma." American Journal of Psychiatry 151(8): 1194-1199. 
 156 
Cantor-Graae, E., T. F. McNeil, et al. (1994). "Are neurological abnormalities in well 
discordant monozygotic co-twins of schizophrneia subjects the result of perinatal 
tramua." American Journal of Psychiatry 151(8): 1194-1199. 
Cantor-Graae, E., T. F. McNeil, et al. (1994). "Link between pregnancy complications 
and minor physical anomalies in monozygotic twins discordant for 
schizophrenia." American Journal of Psychiatry 151(8): 1188-1193. 
Cantorgraae, E., T. F. McNeil, et al. (1994). "ARE NEUROLOGICAL 
ABNORMALITIES IN WELL DISCORDANT MONOZYGOTIC CO-TWINS 
OF SCHIZOPHRENIC SUBJECTS THE RESULT OF PERINATAL 
TRAUMA." American Journal of Psychiatry 151(8): 1194-1199. 
Cardno, A. G., E. J. Marshall, et al. (1999). "Heritability estimates for psychotic disorders 
- The Maudsley Twin psychosis series." Archives of General Psychiatry 56(2): 
162-168. 
Cardno, A. G., E. J. Marshall, et al. (1999). "Heritability estimates for psychotic 
disorders." Archives of General Psychiatry 56: 162-168. 
Cardno, A. G., F. V. Rijsdijk, et al. (2002). "A twin study of genetic relationships 
between psychotic symptoms." American Journal of Psychiatry 159(4): 539-545. 
Cardno, A. G., P. C. Sham, et al. (2002). "Heritability of Schneider's first-rank 
symptoms." British Journal of Psychiatry 180: 35-38. 
Cardno, A. G., P. C. Sham, et al. (2001). "Twin study of symptom dimensions in 
psychoses." British Journal of Psychiatry 179: 39-45. 
Carmelli, D., C. DeCarli, et al. (1998). "Evidence for genetic variance in white matter 
hyperintensity volume in normal elderly male twins." Stroke 29(6): 1177-1181. 
Casanova, M. F., R. D. Sanders, et al. (1990). "MORPHOMETRY OF THE CORPUS-
CALLOSUM IN MONOZYGOTIC TWINS DISCORDANT FOR 
SCHIZOPHRENIA - A MAGNETIC-RESONANCE-IMAGING STUDY." 
Journal of Neurology Neurosurgery and Psychiatry 53(5): 416-421. 
Caspi, A., T. E. Moffitt, et al. (2005). "Moderation of the effect of adolescent-onset 
cannabis use on adult psychosis by a functional polymorphism in the catechol-O-
methyltransferase gene: Longitudinal evidence of a gene X environment 
interaction." Biological Psychiatry 57(10): 1117-1127. 
Chakos, M. H., J. A. Lieberman, et al. (1994). "INCREASE IN CAUDATE NUCLEI 
VOLUMES OF FIRST-EPISODE SCHIZOPHRENIC-PATIENTS TAKING 
ANTIPSYCHOTIC-DRUGS." American Journal of Psychiatry 151(10): 1430-
1436. 
Chan, R. C. K., T. Xu, et al. (2010). "Neurological Soft Signs in Schizophrenia: A Meta-
analysis." Schizophrenia Bulletin 36(6): 1089-1104. 
Chauhan, S. P., J. A. Scardo, et al. (2010). "Twins: prevalence, problems, and preterm 
births." American Journal of Obstetrics and Gynecology 203(4): 305-315. 
Cheek, F. E. (1964). "THE SCHIZOPHRENOGENIC MOTHER IN WORD AND 
DEED." Family Process 3(1): 155-177. 
Chen, Y. L. R., Y. H. E. Chen, et al. (2000). "Semantic verbal fluency deficit as a familial 
trait marker in schizophrenia." Psychiatry Research 95: 133-148. 
Collip, D., I. Myin-Germeys, et al. (2008). "Does the concept of "sensitization" provide a 
plausible mechanism for the putative link between the environment and 
schizophrenia?" Schizophrenia Bulletin 34(2): 220-225. 
Costafreda, S. G., C. H. Y. Fu, et al. (2009). "Increased Inferior Frontal Activation 
During Word Generation: A Marker of Genetic Risk for Schizophrenia but not 
Bipolar Disorder?" Human Brain Mapping 30(10): 3287-3298. 
 157 
Cougnard, A., M. Marcelis, et al. (2007). "Does normal developmental expression of 
psychosis combine with environmental risk to cause persistence of psychosis? A 
psychosis proneness-persistence model." Psychological Medicine 37(4): 513-527. 
Craddock, N., M. C. O'Donovan, et al. (2007). "Phenotypic and genetic complexity of 
psychosis - Invited commentary on ... Schizophrenia: a common disease caused 
by multiple rare alleles." British Journal of Psychiatry 190: 200-203. 
Crawford, J. R., M. C. Obonsawin, et al. (1993). "Frontal lobe impairment in 
schizophrenia -relationships to intellectual-functioning." Psychological Medicine 
23(3): 787-790. 
Crow, T. J. (1999). "Twin studies of psychosis and the genetics of cerebral asymmetry." 
British Journal of Psychiatry 175: 399-401. 
Crow, T. J. (2000). "Schizophrenia as the price that Homo sapiens pays for language: a 
resolution of the central paradox in the origin of the species." Brain Research 
Reviews 31(2-3): 118-129. 
Curtis, V. A., E. Bullmore, et al. (1998). "Attenuated frontal activation during a verbal 
fluency task in patients wiht schizophrenia." American Journal of Psychiatry 155: 
1056-1063. 
Curtis, V. A., E. T. Bullmore, et al. (1999). "Attenuated frontal activation in 
schizophrenia may be task dependent." Schizophrenia Research 37(1): 35-44. 
Damasio, H., T. J. Grabowski, et al. (1996). "A neural basis for lexical retrieval." Nature 
380(6574): 499-505. 
Davatzikos, C., D. G. Shen, et al. (2005). "Whole-brain morphometric study of 
schizophrenia revealing a spatially complex set of focal abnormalities." Archives 
of General Psychiatry 62(11): 1218-1227. 
Davidson, M., A. Reichenberg, et al. (1999). "Behavioral and intellectual markers for 
schizophrenia in apparently healthy male adolescents." American Journal of 
Psychiatry 156(9): 1328-1335. 
Davis, J. O. and H. S. Bracha (1996). "Prenatal growth markers in schizophrenia: A 
monozygotic co-twin control study." American Journal of Psychiatry 153(9): 
1166-1172. 
Davis, J. O. and J. A. Phelps (1995). "TWINS WITH SCHIZOPHRENIA - GENES OR 
GERMS." Schizophrenia Bulletin 21(1): 13-18. 
Davis, J. O., J. A. Phelps, et al. (1995). "PRENATAL DEVELOPMENT OF 
MONOZYGOTIC TWINS AND CONCORDANCE FOR SCHIZOPHRENIA." 
Schizophrenia Bulletin 21(3): 357-366. 
Dazzan, P., K. D. Morgan, et al. (2005). "Different effects of typical and atypical 
antipsychotics on grey matter in first episode psychosis: the AE SOP study." 
Neuropsychopharmacology 30(4): 765-774. 
Dazzan, P., K. D. Morgan, et al. (2004). "The structural brain correlates of neurological 
soft signs in AE SOP first-episode psychoses study." Brain 127: 143-153. 
Deb-Rinker, P., T. A. Klempan, et al. (1999). "Molecular characterization of a MSRV-
like sequence identified by RDA from monozygotic twin pairs discordant for 
schizophrenia." Genomics 61(2): 133-144. 
Denbow, M. L. and N. M. Fisk (1996). "Chorionicity and twins." Current Obstetrics and 
Gynaecology 6: 212-219. 
Dickey, C. C., R. W. McCarley, et al. (2001). "MRI measures of prefrontal gray and 
white matter in males and females diagnosed with schizotypal personality 
disorder." Schizophrenia Research 49(1-2): 153-153. 
 158 
Dickey, C. C., R. W. McCarley, et al. (2007). "MRI abnormalities of the hippocampus 
and cavum septi pellucidi in females with schizotypal personality disorder." 
Schizophrenia Research 89(1-3): 49-58. 
Dilalla, D. L. and Gottesman, II (1995). "Normal personality-characteristics in identical-
twins discordant for schizophrenia." Journal of Abnormal Psychology 104(3): 
490-499. 
Docherty, N. M. and Gottesman, II (2000). "A twin study of communication disturbances 
in schizophrenia." Journal of Nervous and Mental Disease 188(7): 395-401. 
Done, D. J., T. J. Crow, et al. (1994). "Childhood Antecedents of Schizophrenia and 
Affective-Illness - Social-Adjustment at Ages 7 and 11." British Medical Journal 
309(6956): 699-703. 
Dworkin, R. H., J. A. Lewis, et al. (1994). "Social competence deficits in adolescents at 
risk for schizophrenia." Journal of Nervous and Mental Disease 182(2): 103-108. 
Eaves, L., D. Foley, et al. (2003). "Has the "equal environments" assumption been tested 
in twin studies?" Twin Research 6(6): 486-489. 
Ebmeier, K. P., D. H. R. Blackwood, et al. (1993). "SINGLE-PHOTON EMISSION 
COMPUTED-TOMOGRAPHY WITH TC-99M-EXAMETAZIME IN 
UNMEDICATED SCHIZOPHRENIC-PATIENTS." Biological Psychiatry 33(7): 
487-495. 
Eckert, M. A., C. M. Leonard, et al. (2002). "The epigenesis of planum temporale 
asymmetry in twins." Cerebral Cortex 12(7): 749-755. 
Egan, M. F., T. M. Hyde, et al. (2001). "Relative risk of neurological signs in siblings of 
patients with schizophrenia." American Journal of Psychiatry 158(11): 1827-
1834. 
Elvevag, B., D. M. Weinstock, et al. (2001). "A comparison of verbal fluency tasks in 
schizophrenic patients and normal controls." Schizophrenia Research 51(2-3): 
119-126. 
Endicott, J. and R. L. Spitzer (1978). "A diagnostic interview: the schedule for affective 
disorders and schizophrenia." Arch Gen Psychiatry 35(7): 837-844. 
Ettinger, A. Schmechtig, et al. (2010). "Prefrontal and Striatal Volumes in Monozygotic 
Twins Concordant and Discordant for Schizophrenia " Schizophrenia Bulletin 
first published online June 10, 2010 doi:10.1093/schbul/sbq060. 
Ettinger, U., M. Picchioni, et al. (2006). "Antisaccade performance in monozygotic twins 
discordant for schizophrenia: The Maudsley twin study." American Journal of 
Psychiatry 163(3): 543-545. 
Ettinger, U., M. Picchioni, et al. (2007). "Magnetic resonance imaging of the thalamus 
and adhesio interthalamica in twins with schizophrenia." Archives of General 
Psychiatry 64(4): 401-409. 
Falret, J. (1878). "La folie circulaire ou folie à formes alternes." Archives Génerales de 
Médecine. 
Farmer, A. E., P. McGuffin, et al. (1984). "Searching for the split in schizophrenia - a 
twin study perspective." Psychiatry Research 13(2): 109-118. 
Farmer, A. E., P. McGuffin, et al. (1987). "TWIN CONCORDANCE FOR DSM-III 
SCHIZOPHRENIA - SCRUTINIZING THE VALIDITY OF THE 
DEFINITION." Archives of General Psychiatry 44(7): 634-641. 
Fearon, P., J. B. Kirkbride, et al. (2006). "Incidence of schizophrenia and other psychoses 
in ethnic minority groups: results from the MRC AESOP study." Psychological 
Medicine 36(11): 1541-1550. 
 159 
Featherstone, R. E., S. Kapur, et al. (2007). "The amphetamine-induced sensitized state as 
a model of schizophrenia." Progress in Neuro-Psychopharmacology & Biological 
Psychiatry 31(8): 1556-1571. 
Fischer, M. (1971). "Psychoses in the offspring of schizophrenic monozygotic twins and 
their normal co-twins." British Journal of Psychiatry 118: 43-52. 
Fischer, M. (1973). "Genetic and environmental factors in schizophrenia A study of 
schizophrenic twins and their families." Acta Psychiatrica Scandinavica 
Supplementum 238: 5-152. 
Fischer, M. (1973). "Genetic and environmental factors in schizophrenia. A study of 
schizophrenic twins and their families." Acta Psychiatr Scand Suppl 238: 9-142. 
Fischer, M. and Christen.A (1973). "Genetic and Environmental Factors in Schizophrenia 
- Study of Schizophrenic Twins and Their Families." Acta Psychiatrica 
Scandinavica: 1-158. 
Fletcher, P. C., P. J. McKenna, et al. (1998). "Brain activations in schizophrenia during a 
graded memory task studied with functional neuroimaging." Archives of General 
Psychiatry 55(11): 1001-1008. 
Flint, J. I. and M. R. Munafo (2007). "The endophenotype concept in psychiatric 
genetics." Psychological Medicine 37: 163-180. 
Flyckt, L., O. Sydow, et al. (1999). "Neurological signs and psychomotor performance in 
patients with schizophrenia, their relatives and healthy controls." Psychiatry 
Research 86(2): 113-129. 
Foerster, A., S. Lewis, et al. (1991). "Premorbid Adjustment and Personality in Psychosis 
- Effects of Sex and Diagnosis." British Journal of Psychiatry 158: 171-176. 
Franzek, E. and H. Beckmann (1998). "Different genetic background of schizophrenia 
spectrum psychoses: A twin study." American Journal of Psychiatry 155(1): 76-
83. 
Friedhoff, A. J., J. C. Miller, et al. (1995). "A SUBTRACTED PROBE DERIVED 
FROM LYMPHOCYTES OF TWINS DISCORDANT FOR SCHIZOPHRENIA 
HYBRIDIZES TO SELECTIVE AREAS OF RAT-BRAIN." Biological 
Psychiatry 37(2): 127-131. 
Friman, O., M. Borga, et al. (2003). "Adaptive analysis of fMRI data." Neuroimage 
19(3): 837-845. 
Frith, C. D., K. J. Friston, et al. (1995). "Regional Brain Activity in Chronic-
Schizophrenic Patients During the Performance of a Verbal Fluency Task." 
British Journal of Psychiatry 167: 343-349. 
Frommreichmann, F. (1954). "PSYCHOTHERAPY OF SCHIZOPHRENIA." American 
Journal of Psychiatry 111(6): 410-419. 
Fu, C. H. Y., K. Morgan, et al. (2001). "A functional magnetic resonance imaging study 
of overt letter verbal fluency using a clustered acquisition sequence: Greater 
anterior cingulate activation with increases task demand." Neuroimage 17: 871-
879. 
Fu, C. H. Y., J. Suckling, et al. (2005). "Effects of psychotic state and task demand on 
prefrontal function in schizophrenia: An fMRI study of overt verbal fluency." 
American Journal of Psychiatry 162(3): 485-494. 
Fuller Torry, E., A. E. Bowler, et al. (1994). Schizophrenia and Manic-Depressive 
Disorder, The Biological Roots of Mental Illness as Revealed by the Landmark 
Study of Identical Twins. New York, Basic Books. 
Gatz, M., N. L. Pedersen, et al. (2000). "Defining discordance in twin studies of risk and 
protective factors for late life disorders." Twin Res 3(3): 159-164. 
 160 
Geschwind, D. H., B. L. Miller, et al. (2002). "Heritability of lobar brain volumes in 
twins supports genetic models of cerebral laterality and handedness." Proceedings 
of the National Academy of Sciences of the United States of America 99(5): 
3176-3181. 
Gilmore, J. H., D. O. Perkins, et al. (1996). "Fetal brain development of twins assessed in 
utero by ultrasound: Implications for schizophrenia." Schizophrenia Research 
19(2-3): 141-149. 
Gilvarry, C. M., A. Russell, et al. (2001). "Neuropsychological performance and 
spectrum personality traits in the relatives of patients with schizophrenia and 
affective psychosis." Psychiatry Research 101(2): 89-100. 
Gilvarry, C. M., A. Russell, et al. (2001). "Verbal fluency in patients with schizophrenia 
and affective psychoses and their first-degree realtives." Psychological Medicine 
31: 695-704. 
Gilvarry, C. M., A. Russell, et al. (2001). "Verbal fluency in patients with schizophrenia 
and affective psychoses and their first-degree relatives." Psychological Medicine 
31(4): 695-704. 
Gleissner, U. and C. E. Elger (2001). "The hippocampal contribution to verbal fluency in 
patients with temporal lobe epilepsy." Cortex 37(1): 55-63. 
Goldberg, T. E., J. D. Ragland, et al. (1990). "NEUROPSYCHOLOGICAL 
ASSESSMENT OF MONOZYGOTIC TWINS DISCORDANT FOR 
SCHIZOPHRENIA." Archives of General Psychiatry 47(11): 1066-1072. 
Goldberg, T. E., E. F. Torrey, et al. (1994). "RELATIONS BETWEEN 
NEUROPSYCHOLOGICAL PERFORMANCE AND BRAIN 
MORPHOLOGICAL AND PHYSIOLOGICAL MEASURES IN 
MONOZYGOTIC TWINS DISCORDANT FOR SCHIZOPHRENIA." 
Psychiatry Research-Neuroimaging 55(1): 51-61. 
Goldberg, T. E., E. F. Torrey, et al. (1995). "GENETIC RISK OF 
NEUROPSYCHOLOGICAL IMPAIRMENT IN SCHIZOPHRENIA - A STUDY 
OF MONOZYGOTIC TWINS DISCORDANT AND CONCORDANT FOR 
THE DISORDER." Schizophrenia Research 17(1): 77-84. 
Goldberg, T. E., E. F. Torrey, et al. (1993). "LEARNING AND MEMORY IN 
MONOZYGOTIC TWINS DISCORDANT FOR SCHIZOPHRENIA." 
Psychological Medicine 23(1): 71-85. 
Goldman, A. L., L. Pezawas, et al. (2009). "Widespread Reductions of Cortical Thickness 
in Schizophrenia and Spectrum Disorders and Evidence of Heritability." Archives 
of General Psychiatry 66(5): 467-+. 
Goldman, A. L., L. Pezawas, et al. (2008). "Heritability of brain morphology related to 
schizophrenia: A large-scale automated magnetic resonance imaging 
segmentation study." Biological Psychiatry 63: 475-483. 
Goldman, A. L., L. Pezawas, et al. (2008). "Heritability of brain morphology related to 
schizophrenia: A large-scale automated magnetic resonance imaging 
segmentation study." Biological Psychiatry 63(5): 475-483. 
Goldstein, K. E., E. A. Hazlett, et al. (2009). "Smaller superior temporal gyrus volume 
specificity in schizotypal personality disorder." Schizophrenia Research 112(1-3): 
14-23. 
Good, C. D., I. S. Johnsrude, et al. (2001). "A voxel-based morphometric study of ageing 
in 465 normal adult human brains." NeuroImage 14(1): 21-36. 
Gottesman, II and A. Bertelsen (1989). "Confirming unexpressed genotypes for 
schizophrenia - Risks in the offspring of Fischer's identical and fraternal 
discordant trwins." Archives of General Psychiatry 46(10): 867-872. 
 161 
Gottesman, II and T. D. Gould (2003). "The endophenotype concept in psychiatry: 
Etymology and strategic intentions." American Journal of Psychiatry 160(4): 636-
645. 
Goulding, S. M., A. S. Leiner, et al. (2008). "Family strengths: a potential determinant of 
the duration of untreated psychosis among hospitalized African-American first-
episode patients." Early Intervention in Psychiatry 2(3): 162-168. 
Gourovitch, M. L., T. E. Goldberg, et al. (1996). "Verbal fluency deficits in patients with 
schizophrenia: Semantic fluency is differentially impaired as compared with 
phonologic fluency." Neuropsychology 10(4): 573-577. 
Griffiths, T. D., T. Sigmundsson, et al. (1998). "Neurological abnormalities in familial 
and sporadic schizophrenia." Brain 121: 191-203. 
Gringras, P. and W. Chen (2001). "Mechanisms for differences in monozygous twins." 
Early Human Development 64(2): 105-117. 
Grove, W. M., B. S. Lebow, et al. (1991). "Familial prevalence and coaggregation of 
schizotypy indicators: a multitrait family study 
" Journal of Abnormal Psychology 100(2): 115-121. 
Gupta, S., N. C. Andreasen, et al. (1995). "Neurological Soft Signs in Neuroleptic-Naive 
and Neuroleptic- Treated Schizophrenic-Patients and in Normal Comparison 
Subjects." American Journal of Psychiatry 152(2): 191-196. 
Gupta, S., R. Rajaprabhakaran, et al. (1995). "Premorbid Adjustment as a Predictor of 
Phenomenological and Neurobiological Indexes in Schizophrenia." Schizophrenia 
Research 16(3): 189-197. 
Gur, R. C. and R. E. Gur (1995). "Hypofrontality in schizophrenia: RIP." Lancet 345: 
1383-1384. 
Gur, R. E., B. I. Turetsky, et al. (2000). "Temporolimbic volume reductions in 
schizophrenia." Archives of General Psychiatry 57(8): 769-775. 
Gurd, J. M., K. Amunts, et al. (2002). "Posterior parietal cortex is implicated in 
continuous switching between verbal fluency tasks: an fMRI study with clinical 
implications." Brain 125: 1024-1038. 
Hall, J. G. (1996). "Twinning: Mechanisms and genetic implications." Current Opinion in 
Genetics & Development 6(3): 343-347. 
Hall, M. H., F. Rijsdijk, et al. (2007). "Substantial shared genetic influences on 
schizophrenia and event-related potentials." American Journal of Psychiatry 
164(5): 804-812. 
Hans, S. L., J. G. Auerbach, et al. (2000). "Social adjustment of adolescents at risk for 
schizophrenia: The Jerusalem Infant Development Study." Journal of the 
American Academy of Child and Adolescent Psychiatry 39(11): 1406-1414. 
Hans, S. L., J. G. Auerbach, et al. (2005). "Development from birth to adolescence of 
children at-risk for schizophrenia." Journal of Child and Adolescent 
Psychopharmacology 15(3): 384-394. 
Harrison, P. J. and S. L. Eastwood (2001). "Neuropathological studies of synaptic 
connectivity in the hippocampal formation in schizophrenia." Hippocampus 
11(5): 508-519. 
Hay, D. A., N. G. Martin, et al. (2001). "Phenotypic and genetic analysis of a short 
measure of psychosis-proness in a large-scale Australian twin study." Twin 
Research 4: 30-40. 
Hecker, E. (1871). "Die Henrephrenie." Archiv fur pathologische Anatomie und 
Physiologie und fur kliniche Medizin 25: 394-429. 
Heckers, S., S. L. Rauch, et al. (1998). "Impaired recruitment of the hippocampus during 
conscious recollection in schizophrenia." Nature Neuroscience 1(4): 318-323. 
 162 
Henquet, C., R. Murray, et al. (2005). "The environment and schizophrenia: The role of 
cannabis use." Schizophrenia Bulletin 31(3): 608-612. 
Hettema, J. M., M. C. Neale, et al. (1995). "Physical similarity and the equal-
environments assumption in twin studies of psychiatric-disorders." Behavior 
Genetics 25(4): 327-335. 
Hirvonen, J., T. G. M. van Erp, et al. (2005). "Increased caudate dopamine D-2 receptor 
availability as a genetic marker for schizophrenia." Archives of General 
Psychiatry 62(4): 371-378. 
Hoffer, A. and W. Pollin (1970). "SCHIZOPHRENIA IN NAS-NRC PANEL OF 15,909 
VETERAN TWIN PAIRS." Archives of General Psychiatry 23(5): 469-&. 
Holzman, P. S., E. Kringlen, et al. (1980). "DEVIANT EYE TRACKING IN TWINS 
DISCORDANT FOR PSYCHOSIS - A REPLICATION." Archives of General 
Psychiatry 37(6): 627-631. 
Holzman, P. S., E. Kringlen, et al. (1978). "SMOOTH PURSUIT EYE-MOVEMENTS 
IN TWINS DISCORDANT FOR SCHIZOPHRENIA." Journal of Psychiatric 
Research 14(1-4): 111-120. 
Holzman, P. S., E. Kringlen, et al. (1977). "ABNORMAL-PURSUIT EYE-
MOVEMENTS IN SCHIZOPHRENIA." Archives of General Psychiatry 34(7): 
802-805. 
Holzman, P. S., D. L. Levy, et al. (1997). "Smooth pursuit eye tracking in twins - A 
critical commentary." Archives of General Psychiatry 54(5): 429-431. 
Honea, R., T. J. Crow, et al. (2005). "Regional deficits in brain volume in schizophrenia: 
A meta-analysis of voxel-based morphometry studies." American Journal of 
Psychiatry 162(12): 2233-2245. 
Honea, R. A., A. Meyer-Lindenberg, et al. (2008). "Is gray matter volume an 
intermediate phenotype for schizophrenia? A voxel-based morphometry study of 
patients with schizophrenia and their healthy siblings." Biological Psychiatry 63: 
465-474. 
Honea, R. A., A. Meyer-Lindenberg, et al. (2008). "Is gray matter volume an 
intermediate phenotype for schizophrenia? A voxel-based morphometry study of 
patients with schizophrenia and their healthy siblings." Biological Psychiatry 
63(5): 465-474. 
Hoptman, M. J., J. Nierenberg, et al. (2008). "A DTI study of white matter microstructure 
in individuals at high genetic risk for schizophrenia." Schizophrenia Research 
106(2-3): 115-124. 
Horwitz, A. V., T. M. Videon, et al. (2003). "Rethinking twins and environments: 
Possible social sources for assumed genetic influences in twin research." Journal 
of Health and Social Behavior 44(2): 111-129. 
Howes, O. D., C. McDonald, et al. (2004). "Pathways to schizophrenia: the impact of 
environmental factors." International Journal of Neuropsychopharmacology 
7((Supplement 1)): S7-S13. 
Hui, C. L. M., G. H. Y. Wong, et al. (2009). "Potential Endophenotype for 
Schizophrenia: Neurological Soft Signs." Annals Academy of Medicine 
Singapore 38(5): 408-413. 
Hulshoff Pol, H. E., R. G. H. Brans, et al. (2004). "Gray and white matter volume 
abnormalities in monozygotic and same-gender dizygotic twins discordant for 
schizophrenia." Biological Psychiatry 55(2): 126-130. 
Hulshoff Pol, H. E., H. G. Schnack, et al. (2002). "Volume changes in gray matter in 
patients with schizophrenia." American Journal of Psychiatry 159(2): 244-250. 
 163 
Hulshoff Pol, H. E., H. G. Schnack, et al. (2006). "Gray and white matter density changes 
in monozygotic and same-sex dizygotic twins discordant for schizophrenia using 
voxel-based morphometry." Neuroimage 31(2): 482-488. 
Hulshoff Pol, H. E., H. G. Schnack, et al. (2001). "Focal gray matter density changes in 
schizophrenia." Archives of General Psychiatry 58(12): 1118-1125. 
Imaizumi, Y. (2003). "A comparative study of zygotic twinning and triplet rates in eight 
countries, 1972-1999." Journal of Biosocial Science 35(2): 287-302. 
Ismail, B., E. Cantor-Graae, et al. (1998). "Neurological abnormalities in schizophrenic 
patients and their siblings." American Journal of Psychiatry 155(1): 84-89. 
Jablensky, A. (2000). "Epidemiology of schizophrenia: the global burden of disease and 
disability." European Archives of Psychiatry and Clinical Neuroscience 250(6): 
274-285. 
Jackson, D. D., Ed. (1960). The Etiology of Schizophrenia. New York, Basic Books, Inc. 
Jakobsen, K. D., T. Hansen, et al. (2007). "Diagnostic stability among chronic patients 
with functional psychoses: an epidemiological and clinical study." BMC 
Psychiatry 7. 
Jang, K. L., T. S. Woodward, et al. (2005). "the genetic and environmental basis of the 
relationship between schizotypy and personality." The Journal of Nervous and 
Mental Disease 193(3): 153-159. 
Job, D. E., H. C. Whalley, et al. (2005). "Grey matter changes over time in high risk 
subjects developing schizophrenia." NeuroImage 25(4): 1023-1030. 
Johnson, J. K., M. O. Huttunen, et al. (2003). "The relationship between schizotypal 
symptoms, genetic risk for schizophrenia, and neurocognitive deficits: A twin 
study." Schizophrenia Research 60(1): 82-82. 
Johnson, J. K., A. Tuulio-Henriksson, et al. (2003). "Do schizotypal symptoms mediate 
the relationship between genetic risk for schizophrenia and impaired 
neuropsychological performance in co-twins of schizophrenic patients?" 
Biological Psychiatry 54(11): 1200-1204. 
Johnstone, E. C., K. P. Ebmeier, et al. (2005). "Predicting schizophrenia: findings from 
the Edinburgh high-risk study." British Journal of Psychiatry 186: 18-25. 
Jones, H. E. (1955). "Perceived differences among twins." Eugenics Quarterly 2: 98-102. 
Joseph, J. (1998). "The equal environment assumption of the classical twin method: A 
critical analysis." Journal of Mind and Behavior 19(3): 325-358. 
Joyce, E. M., S. L. Collinson, et al. (1996). "Verbal fluency in schizophrenia: 
Relationship with executive function, semantic memory and clinical alogia." 
Psychological Medicine 26(1): 39-49. 
Kahlbaum, K. L. (1863). Die Gruppierung der psychischen Krankhieten und die 
Einterlung der Seelenstoerungen. Danzig, AW Kafemann. 
Kanaan, R. A. A., J. S. Kim, et al. (2005). "Diffusion tensor imaging in schizophrenia." 
Biological Psychiatry 58(12): 921-929. 
Kaufman, M. H. (2004). "The embryology of conjoined twins." Childs Nervous System 
20: 508-525. 
Kay, S. R., L. A. Opler, et al. (1989). "THE POSITIVE AND NEGATIVE SYNDROME 
SCALE (PANSS) - RATIONALE AND STANDARDIZATION." British Journal 
of Psychiatry, Vol 155, Supp No. 7: 59-65. 
Keller, M. C., W. L. Coventry, et al. (2005). "Widespread evidence for non-additive 
genetic variation in Cloninger's and Eysenck's personality dimensions using a 
twin plus sibling design." Behavior Genetics 35(6): 707-721. 
Kelly, B. D., D. Cotter, et al. (2004). "Neurological soft signs and dermatoglyphic 
anomalies in twins with schizophrenia." European Psychiatry 19(3): 159-163. 
 164 
Kendler, K. S. and S. R. Diehl (1993). "The genetics of schizophrrenia - a current, 
genetic-epidemiologic perspective." Schizophrenia Bulletin 19(2): 261-285. 
Kendler, K. S. and J. Hewitt (1992). "The Structure of Self-Report Schizotypy in Twins." 
Journal of Personality Disorders 6(1): 1-17. 
Kendler, K. S., M. McGuire, et al. (1993). "The Roscommon Family Study I. Methods, 
diagnosis of probands, and risk of schizophrenia in relatives." Arch Gen 
Psychiatry 50: 527-540. 
Kendler, K. S., M. McGuire, et al. (1993). "The Roscommon Family Study .1. Methods, 
Diagnosis of Probands, and Risk of Schizophrenia in Relatives." Archives of 
General Psychiatry 50(7): 527-540. 
Kendler, K. S., M. McGuire, et al. (1995). "Schizotypal symptoms and signs in the 
Roscommon Family Study. Their factor structure and familial relationship with 
psychotic and affective disorders." Arch Gen Psychiatry 52: 296-303. 
Kendler, K. S. and M. C. Neale (2010). "Endophenotype: a conceptual analysis." 
Molecular Psychiatry 15(8): 789-797. 
Kendler, K. S., M. C. Neale, et al. (1993). "A test of the equal-environments assumption 
in twin studies of psychiatric-illness." Behavior Genetics 23(1): 21-27. 
Kendler, K. S., M. C. Neale, et al. (1993). "A test of the equal environments assumption 
in twin studies of psychiatric-illness." Behavior Genetics 23(1): 21-27. 
Kendler, K. S., M. C. Neale, et al. (1994). "Parental treatment and the equal environment 
assumption in twin studies of psychiatric-illness." Psychological Medicine 24(3): 
579-590. 
Kendler, K. S. and C. D. Robinette (1983). "Schizophrenia in the National Academy of 
Sciences- National Research Council Twins Registry- A 16 year update." 
American Journal of Psychiatry 140(12): 1551-1563. 
Keshavan, M. S., E. Dick, et al. (2002). "Decreased left amygdala and hippocampal 
volumes in young offspring at risk for schizophrenia." Schizophrenia Research 
58(2-3): 173-183. 
Keshavan, M. S., D. M. Montrose, et al. (1997). "Magnetic resonance imaging and 
spectroscopy in offspring at risk for schizophrenia: Preliminary studies." Progress 
in Neuro-Psychopharmacology & Biological Psychiatry 21(8): 1285-1295. 
Keshavan, M. S., R. D. Sanders, et al. (2003). "Diagnostic specificity and 
neuroanatomical validity of neurological abnormalities in first-episode 
psychoses." American Journal of Psychiatry 160(7): 1298-1304. 
Kinney, D. K., D. A. Yurgelun Todd, et al. (1991). "Hard Neurologic Signs and 
Psychopathology in Relatives of Schizophrenic-Patients." Psychiatry Research 
39(1): 45-53. 
Klaning, U. (1999). "Greater occurrence of schizophrenia in dizygotic but not 
monozygotic twins - Register-based study." British Journal of Psychiatry 175: 
407-409. 
Klaning, U., P. B. Mortensen, et al. (1996). "Increased occurrence of schizophrenia and 
other psychiatric illnesses among twins." British Journal of Psychiatry 168(6): 
688-692. 
Konrad, A. and G. Winterer (2008). "Disturbed structural connectivity in schizophrenia - 
Primary factor in pathology or epiphenomenon?" Schizophrenia Bulletin 34(1): 
72-92. 
Koo, M. S., C. C. Dickey, et al. (2006). "Smaller neocortical gray matter and larger sulcal 
cerebrospinal fluid volumes in neuroleptic-naive women with schizotypal 
personality disorder." Archives of General Psychiatry 63(10): 1090-1100. 
 165 
Koolschijn, P., N. E. M. van Haren, et al. (2008). "Hypothalamus volume in twin pairs 
discordant for schizophrenia." European Neuropsychopharmacology 18(4): 312-
315. 
Kopala, L. C., K. P. Good, et al. (1998). "Olfactory function in monozygotic twins 
discordant for schizophrenia." American Journal of Psychiatry 155(1): 134-136. 
Koutsouleris, N., E. M. Meisenzahl, et al. (2009). "Use of Neuroanatomical Pattern 
Classification to Identify Subjects in At-Risk Mental States of Psychosis and 
Predict Disease Transition." Archives of General Psychiatry 66(7): 700-712. 
Kraepelin, E. (1899). Psychiatrie. Ein Lehrbuch fur Studirende und Aertze. Leipzig, 
Barth. 
Kraepelin, E. (1913). Dementia Praecox. Edinburgh, E and S Livingstone. 
Kraepelin, E. (1919). Dementia Praecox. Edinburgh, Livingstone. 
Kremen, W. S., S. V. Faraone, et al. (1998). "Sex differences in self-reported schizotypal 
traits in relatives of schizophrenic probands." Schizophrenia Research 34(1-2): 
27-37. 
Kringlen, E. (1967). Heredity and environment in the functional psychoses. Oslo, 
Universitetsforlaget. 
Kringlen, E. (1967). Heredity and the environment in the functional psychoses. London, 
William Heinmann. 
Kringlen, E. and G. Cramer (1989). "Offspring of monozygotic twins discordant for 
schizophrenia." Archives of General Psychiatry 46(10): 873-877. 
Kruyer, H., M. Mila, et al. (1994). "FRAGILE X SYNDROME AND THE (CGG)(N) 
MUTATION - 2 FAMILIES WITH DISCORDANT MZ TWINS." American 
Journal of Human Genetics 54(3): 437-442. 
Kubicki, M., R. McCarley, et al. (2007). "A review of diffusion tensor imaging studies in 
schizophrenia." Journal of Psychiatric Research 41(1-2): 15-30. 
Kubicki, M., M. E. Shenton, et al. (2002). "Voxel-based morphornetric analysis of gray 
matter in first episode schizophrenia." NeuroImage 17(4): 1711-1719. 
Kulkarni, M. L., C. Sureshkumar, et al. (1994). "Conjoined twins." Indian Pediatr 31(8): 
1017-1024. 
Kunugi, H., M. Tsukue, et al. (1999). "A case of a monozygotic twin pair discordant for 
schizophrenia a possible link between prenatal hypoxia and neurodevelopmental 
impairment." Schizophrenia Research 36(1-3): 91-91. 
Kunugi, H., T. Urushibara, et al. (2003). "Prenatal underdevelopment and schizophrenia: 
A case report of monozygotic twins." Psychiatry and Clinical Neurosciences 
57(3): 271-274. 
Laing, R. D. (1964). "What is schizophrenia." New Left Review(28): 63-68. 
Laing, R. D. (1983). The Politics of Experience. Harmondsworth, Penguin. 
Laruelle, M. (1998). The role of endogenous sensitization in the pathophysiology of 
schizophrenia: implications from recent brain imaging studies. Nobel Symposium 
111: Schizophrenia - Pathophysiological Mechanisms, Stockholm, Sweden, 
Elsevier Science Bv. 
Laruelle, M. (2000). "The role of endogenous sensitization in the pathophysiology of 
schizophrenia: implications from recent brain imaging studies." Brain Research 
Reviews 31(2-3): 371-384. 
Laurent, A., M. Biloa-Tang, et al. (2000). "Executive/attentional performance and 
measures of schizotypy in patients with schizophrenia and in their nonpsychotic 
first-degree relatives." Schizophrenia Research 46(2-3): 269-283. 
 166 
Lavrentieva, I., N. E. Broude, et al. (1999). "High polymorphism level of genomic 
sequences flanking insertion sites of human endogenous retroviral long terminal 
repeats." Febs Letters 443(3): 341-347. 
Lawrie, S. M. and S. S. Abukmeil (1998). "Brain abnormality in schizophrenia - A 
systematic and quantitative review of volumetric magnetic resonance imaging 
studies." British Journal of Psychiatry 172: 110-120. 
Lawrie, S. M., A. M. McIntosh, et al. (2008). "Brain structure and function changes 
during the development of schizophrenia: The evidence from studies of subjects 
at increased genetic risk." Schizophrenia Bulletin 34(2): 330-340. 
Lawrie, S. M., H. C. Whalley, et al. (2001). "Brain structure, genetic liability, and 
psychotic symptoms in subjects at high risk of developing schizophrenia." 
Biological Psychiatry 49(10): 811-823. 
Leask, S. J., D. J. Done, et al. (2002). "Adult psychosis, common childhood infections 
and neurological soft signs in a national birth cohort." British Journal of 
Psychiatry 181: 387-392. 
Lehmann, E. L. (1975). Nonparametrics: Statistical methods based on ranks. San 
Francisco, Holden-Day, Inc. 
Lewine, R. R., N. F. Watt, et al. (1980). "Childhood social competence in functionally 
disordered psychiatric patients and in normals." Journal of Abnormal Psychology 
89(2): 132-138. 
Lewis, S. (1996). "Schizophrenia in twins." British Journal of Psychiatry 169(4): 522-
523. 
Lewis, S. W., B. Chitkara, et al. (1989). "HAND PREFERENCE IN PSYCHOTIC 
TWINS." Biological Psychiatry 25(2): 215-221. 
Lewis, S. W., B. Chitkara, et al. (1987). "FAMILY HISTORY AND BIRTH-WEIGHT 
IN MONOZYGOTIC TWINS CONCORDANT AND DISCORDANT FOR 
PSYCHOSIS." Acta Geneticae Medicae Et Gemellologiae 36(2): 267-273. 
Liddle, P. F. (1987). "The symptoms of chronic schizophrenia: A re-examination of the 
positive-negative dichotomy." British Journal of Psychiatry 151: 145-151. 
Liddle, P. F. and T. R. E. Barnes (1990). "Syndromes of chronic schizophrenia." British 
Journal of Psychiatry 157: 558-561. 
Lidz, T., S. Schafer, et al. (1962). "EGO DIFFERENTIATION AND SCHIZOPHRENIC 
SYMPTOM FORMATION IN IDENTICAL-TWINS." Journal of the American 
Psychoanalytic Association 10(1): 74-90. 
Lieberman, J. A. (1999). "Is schizophrenia a neurodegenerative disorder? A clinical and 
neurobiological perspective." Biological Psychiatry 46(6): 729-739. 
Lieberman, J. A. (1999). "Searching for the neuropathology of schizophrenia: 
Neuroimaging strategies and findings." American Journal of Psychiatry 156(8): 
1133-1136. 
Lieberman, J. A., G. D. Tollefson, et al. (2005). "Antipsychotic drug effects on brain 
morphology in first-episode psychosis." Archives of General Psychiatry 62(4): 
361-370. 
Linney, Y. M., R. M. Murray, et al. (2003). "A quantitative genetic analysis of 
schizotypal personality traits." Psychological Medicine 33(5): 803-816. 
Litman, R. E., E. F. Torrey, et al. (1997). "A quantitative analysis of smooth pursuit eye 
tracking in monozygotic twins discordant for schizophrenia." Archives of General 
Psychiatry 54(5): 417-426. 
Lodge, D. J. and A. A. Grace (2007). "Aberrant hippocampal activity underlies the 
dopamine dysregulation in an animal model of schizophrenia." The Journal of 
Neuroscience 27(42): 11424-11430. 
 167 
Loehlin, J. (1986). "Heredity, Environment, and the Thurstone Temperament Schedule." 
Behavioral Genetics 16: 61-73. 
Lohmann, G., D. Y. von Cramon, et al. (1999). "Sulcal variability of twins." Cerebral 
Cortex 9(7): 754-763. 
Luchins, D., W. Pollin, et al. (1980). "LATERALITY IN MONOZYGOTIC 
SCHIZOPHRENIC TWINS - ALTERNATIVE HYPOTHESIS." Biological 
Psychiatry 15(1): 87-93. 
Lutkenhoff, E. S., T. G. van Erp, et al. (2010). "Proton MRS in twin pairs discordant for 
schizophrenia." Molecular Psychiatry 15(3): 308-318. 
Luxenburger, H. (1940). Zwillingsforschung als Methode der Erbforschung beim 
Menschen. Hanbuch der Erbbiologie der Menschen, Vol II, Methodik Genetik der 
Gesamptperson. G. Just, K. H. Baner and E. Hanhart. Berlin, Springer: 213-248. 
Lykken, D. T., M. McGue, et al. (1990). "Does contact lead to similarity or similarlity 
lead to contact." Behavior Genetics 20(5): 547-561. 
Lyons, M. J., J. L. Bar, et al. (2002). "Nicotine and familial vulnerability to 
schizophrenia: A discordant twin study." Journal of Abnormal Psychology 
111(4): 687-693. 
Lyons, M. J., R. Toomey, et al. (1997). "Psychopathology in twin pairs discordant for 
schizophrenia." American Journal of Medical Genetics 74(6): 562-562. 
Lytton, H. (1977). "DO PARENTS CREATE, OR RESPOND TO, DIFFERENCES IN 
TWINS." Developmental Psychology 13(5): 456-459. 
MacDonald, A. W., M. F. Pogue-Geile, et al. (2001). "Genetic and environmental 
influences on schizotypy: A community based twin study." Schizophrenia 
Bulletin 27(1): 47-58. 
Machin, G., K. Still, et al. (1996). "Correlations of placental vascular anatomy and 
clinical outcomes in 69 monochorionic twin pregnancies." American Journal of 
Medical Genetics 61(3): 229-236. 
Machin, G. A. (1996). "Placental vascular anatomy and twin transfusion syndrome." 
American Journal of Obstetrics and Gynecology 174(2): 799-800. 
Machin, G. A. (1996). "Some causes of genotypic and phenotypic discordance in 
monozygotic twin pairs." American Journal of Medical Genetics 61(3): 216-228. 
Mahy, G. E., R. Mallett, et al. (1999). "First-contact incidence rate of schizophrenia on 
Barbados." British Journal of Psychiatry 175: 28-33. 
Maier, W., D. Lichtermann, et al. (1994). "Personality disorders among the relatives of 
schizophrenia patients." Schizophrenia Bulletin 20(3): 481-493. 
Malaspina, D., S. Harlap, et al. (2001). "Advancing paternal age and the risk of 
schizophrenia." Archives of General Psychiatry 58(4): 361-367. 
Malmberg, A., G. Lewis, et al. (1998). "Premorbid adjustment and personality in people 
with schizophrenia." British Journal of Psychiatry 172: 308-313. 
Marcus, J., S. L. Hans, et al. (1985). "Neurological Dysfunctioning in Offspring of 
Schizophrenics in Israel and Denmark - a Replication Analysis." Archives of 
General Psychiatry 42(8): 753-761. 
Mata, I., C. M. Gilvarry, et al. (2003). "Schizotypal personality traits in nonpsychotic 
relatives are associated with positive symptoms in psychotic probands." 
Schizophrenia Bulletin 29(2): 273-283. 
Mata, I., M. J. Madoz, et al. (2001). "Olanzapine: concordant response in monozygotic 
twins with schizophrenia." British Journal of Psychiatry 178: 86. 
Mathalon, D. H., E. V. Sullivan, et al. (2001). "Progressive brain volume changes and the 
clinical course of schizophrenia in men - A longitudinal magnetic resonance 
imaging study." Archives of General Psychiatry 58(2): 148-157. 
 168 
Matheny, A. P., R. S. Wilson, et al. (1976). "RELATIONS BETWEEN TWINS 
SIMILARITY OF APPEARANCE AND BEHAVIORAL SIMILARITY - 
TESTING AN ASSUMPTION." Behavior Genetics 6(3): 343-351. 
Maxwell, M. E. (1992). Family Interview for Genetic Studies (FIGS): Manual for FIGS. 
Bethesda, MD, Clinical Neurogenetics Branch, Intramural Research Programme, 
National Institute of Mental Health. 
McClellan, J. M., E. Susser, et al. (2007). "Schizophrenia: a common disease caused by 
multiple rare alleles." British Journal of Psychiatry 190: 194-199. 
McDonald, C., E. Bullmore, et al. (2005). "Regional volume deviations of brain structure 
in schizophrenia and psychotic bipolar disorder - Computational morphometry 
study." British Journal of Psychiatry 186: 369-377. 
McDonald, C., E. T. Bullmore, et al. (2004). "Association of Genetic Risks for 
Schizophrenia and Bipolar Disorder With Specific and Generic Brain Structural 
Endophenotypes." Arch Gen Psychiatry 61: 974-984. 
McDonald, C., E. T. Bullmore, et al. (2004). "Association of genetic risks for 
schizophrenia and bipolar disorder with specific and generic brain structural 
endophenotypes." Archives of General Psychiatry 61(10): 974-984. 
McDonald, C., A. Grech, et al. (2002). "Brain volumes in familial and non-familial 
schizophrenic probands and their unaffected relatives." American Journal of 
Medical Genetics 114(6): 616-625. 
McDonald, C., N. Marshall, et al. (2006). "Regional Brain Morphometry in Patients With 
Schizophrenia or Bipolar Disorder and Their Unaffected Relatives." American 
Journal of Psychiatry 163(3): 478-487. 
McDonald, C., N. Marshall, et al. (2006). "Regional brain morphometry in patients with 
schizophrenia or bipolar disorder and their unaffected relatives." American 
Journal of Psychiatry 163(3): 478-487. 
McDonald, P., M. Lewis, et al. (2003). "Appraisal of genetic and epigenetic congruity of 
a monozygotic twin pair discordant for schizophrenia." J Med Genet 40(2): E16. 
McEwen, B. S. (2008). "Understanding the potency of stressful early life experiences on 
brain and body function." Metabolism Clinical and Experimental 57(Suppl 2): 
S11-S15. 
McGrath, J. J. (2006). "Variations in the incidence of schizophrenia: Data versus dogma." 
Schizophrenia Bulletin 32(1): 195-197. 
McGrath, J. J., S. Saha, et al. (2004). "A systematic review of the incidence of 
schizophrenia: The distribution of rate items and the influence of methodology, 
urbanicity, sex and migrant status." Schizophrenia Research 67(1): 65-66. 
McGuffin, P., P. Asherson, et al. (1994). "The strength of the genetic 
effect - Is there room for an environmental influence 
in the etiology of schizophrenia." British Journal of Psychiatry 
164: 593-599. 
McGuffin, P., A. Farmer, et al. (1987). "Is there really a split in schizophrenia - the 
genetic evidence." British Journal of Psychiatry 150: 581-592. 
McGuffin, P., A. Farmer, et al. (1991). "A Polydiagnostic application of operational 
criteria in studies of psychotic illness - Development and reliability of the 
OPCRIT system." Archives of General Psychiatry 48(8): 764-770. 
McGuffin, P., A. E. Farmer, et al. (1984). "Twin concordance for operationally defined 
schizophrenia - confirmation of familality and heritability." Archives of General 
Psychiatry 41(6): 541-545. 
 169 
McNeil, T. F., E. Cantor-Graae, et al. (2000). "Relationship of obstetric complications 
and differences in size of brain structures in monozygotic twin pairs discordant 
for schizophrenia." American Journal of Psychiatry 157(2): 203-212. 
McNeil, T. F., E. Cantorgraae, et al. (1994). "OBSTETRIC COMPLICATIONS AS 
ANTECEDENTS OF SCHIZOPHRENIA - EMPIRICAL EFFECTS OF USING 
DIFFERENT OBSTETRIC COMPLICATION SCALES." Journal of Psychiatric 
Research 28(6): 519-530. 
McNeil, T. F., E. Cantorgraae, et al. (1994). "OBSTETRIC COMPLICATIONS IN 
HISTORIES OF MONOZYGOTIC TWINS DISCORDANT AND 
CONCORDANT FOR SCHIZOPHRENIA." Acta Psychiatrica Scandinavica 
89(3): 196-204. 
Mechelli, A., D. P. Prata, et al. (2008). "The effects of neuregulin1 on brain function in 
controls and patients with schizophrenia and bipolar disorder." Neuroimage 42(2): 
817-826. 
Mechri, A., M.-C. Bourdel, et al. (2009). "Neurological soft signs in patients with 
schizophrenia and their unaffected siblings: frequency and correlates in two ethnic 
and socioeconomic distinct populations." Eur Arch Psychiatry Clin Neurosci 
259(4): 218-226. 
Mechri, A., L. Gassab, et al. (2010). "Neurological soft signs and schizotypal dimensions 
in unaffected siblings of patients with schizophrenia." Psychiatry Research 175(1-
2): 22-26. 
Meyer-Lindenberg, A., J. B. Poline, et al. (2001). "Evidence for abnormal cortical 
functional connectivity during working memory in schizophrenia." American 
Journal of Psychiatry 158(11): 1809-1817. 
Moncrieff, J. and J. Leo "A systematic review of the effects of antipsychotic drugs on 
brain volume." Psychological Medicine 40(9): 1409-1422. 
Moorhead, T. W. J., V. E. Gountouna, et al. (2009). "Prospective multi-centre Voxel 
Based Morphometry study employing scanner specific segmentations: Procedure 
development using CaliBrain structural MRI data." BMC Medical Imaging: 8 (20 
pp.). 
Morel, B. A. (1860). Traite des Maladies Mentales. Paris, Masson. 
Morgan, C. and H. Fisher (2007). "Environment and schizophrenia: Environmental 
factors in schizophrenia: Childhood trauma - A critical review." Schizophrenia 
Bulletin 33(1): 3-10. 
Morris Yates, A., G. Andrews, et al. (1990). "TWINS - A TEST OF THE EQUAL 
ENVIRONMENTS ASSUMPTION." Acta Psychiatrica Scandinavica 81(4): 322-
326. 
Mosher, L. R., W. Pollin, et al. (1970). "Family Studies of Mz Twins Discordant for 
Schizophrenia - Neurological Findings." Acta Geneticae Medicae Et 
Gemellologiae 19(1-2): 305-&. 
Mosher, L. R., W. Pollin, et al. (1971). "FAMILIES WITH IDENTICAL TWINS 
DISCORDANT FOR SCHIZOPHRENIA - SOME RELATIONSHIPS 
BETWEEN IDENTIFICATION, THINKING STYLES, PSYCHOPATHOLOGY 
AND DOMINANCE-SUBMISSIVENESS." British Journal of Psychiatry 
118(542): 29-42. 
Mosher, L. R., W. Pollin, et al. (1971). "IDENTICAL TWINS DISCORDANT FOR 
SCHIZOPHRENIA - NEUROLOGIC FINDINGS." Archives of General 
Psychiatry 24(5): 422-&. 
 170 
Munoz Maniega, S., G. K. S. Lymer, et al. (2008). "A diffusion tensor MRI study of 
white matter integrity in subjects at high genetic risk of schizophrenia." Schizophr 
Res 106(2-3): 132-139. 
Murray, R. M., E. O'Callaghan, et al. (1992). "A Neurodevelopmental Approach to the 
Classification of Schizophrenia." Schizophrenia Bulletin 18(2): 319-332. 
Myin-Germeys, I., L. Krabbendam, et al. (2003). "Do life events have their effect on 
psychosis by influencing the emotional reactivity to daily life events?" 
Psychological Medicine 33: 327-333. 
Narr, K. L., T. D. Cannon, et al. (2002). "Genetic contributions to altered callosal 
morphology in schizophrenia." Journal of Neuroscience 22(9): 3720-3729. 
Narr, K. L., T. G. M. van Erp, et al. (2002). "A twin study of genetic contributions to 
hippocampal morphology in schizophrenia." Neurobiology of Disease 11(1): 83-
95. 
Nathan, M. and R. Guttman (1984). "SIMILARITIES IN TEST-SCORES AND 
PROFILES OF KIBBUTZ TWINS AND SINGLETONS." Acta Geneticae 
Medicae Et Gemellologiae 33(2): 213-218. 
Navari, S. and P. Dazzan (2009). "Do antipsychotic drugs affect brain structure? A 
systematic and critical review of MRI findings." Psychological Medicine 39(11): 
1763-1777. 
Nayani, T. H. and A. S. David (1996). "The auditory hallucination: A phenomenological 
survey." Psychological Medicine 26(1): 177-189. 
Nelson, B., A. R. Yung, et al. (2008). "The phenomenological critique and self-
disturbance: Implications for ultra-high risk ("Prodrome") research." 
Schizophrenia Bulletin 34(2): 381-392. 
Nguyen, G. H., J. Bouchard, et al. (2003). "DNA stability and schizophrenia in twins." 
American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 
120B(1): 1-10. 
Niethammer, R., M. Weisbrod, et al. (2000). "Genetic influence on laterality in 
schizophrenia? A twin study of neurological soft signs." American Journal of 
Psychiatry 157(2): 272-274. 
Nieuwint, A., R. Van Zalen-Sprock, et al. (1999). "'Identical' twins with discordant 
karyotypes." Prenatal Diagnosis 19(1): 72-76. 
Niznikiewicz, M. A., M. Kubicki, et al. (2003). "Recent structural and functional imaging 
findings in schizophrenia." Current Opinion in Psychiatry 16(2): 123-147. 
Noga, J. T., A. J. Bartley, et al. (1996). "Cortical gyral anatomy and gross brain 
dimensions in monozygotic twins discordant for schizophrenia." Schizophrenia 
Research 22(1): 27-40. 
Nordgaard, J., S. M. Arnfred, et al. (2008). "The diagnostic status of first-rank 
symptoms." Schizophrenia Bulletin 34(1): 137-154. 
O'Daly, O. G., O. Guillin, et al. (2005). "Schizophrenia and substance abuse co-
morbidity: a role for dopamine sensitisation?" Journal of Dual Diagnosis 1(2): 11-
40. 
O'Donovan, M. C., N. Craddock, et al. (2008). "Identification of loci associated with 
schizophrenia by genome-wide association and follow-up." Nature Genetics 
40(9): 1053-1055. 
Obladen, M. (2010). "Unequal but monozygous: a history of twin-twin transfusion 
syndrome." Journal of Perinatal Medicine 38(2): 121-128. 
Ohara, K., H. D. Xu, et al. (1998). "Cerebral ventricle-brain ratio in monozygotic twins 
discordant and concordant for schizophrenia." Progress in Neuro-
Psychopharmacology & Biological Psychiatry 22(6): 1043-1050. 
 171 
Olin, S. S. and S. A. Mednick (1996). "Risk facotrs of psychosis: identifying populations 
premorbidly." Schizophrenia Bulletin 22(2): 223-240. 
Onstad, S., I. Skre, et al. (1991). "Subtypes of schizophrenia -  evidence from a twin 
family study." Acta Psychiatrica Scandinavica 84(2): 203-206. 
Onstad, S., I. Skre, et al. (1992). "Birth-weight and obstetric complications in 
schizophrenic twins." Acta Psychiatrica Scandinavica 85(1): 70-73. 
Orstavik, R. E., N. Tommerup, et al. (1995). "NONRANDOM X-CHROMOSOME 
INACTIVATION IN AN AFFECTED TWIN IN A MONOZYGOTIC TWIN 
PAIR DISCORDANT FOR WIEDEMANN-BECKWITH SYNDROME." 
American Journal of Medical Genetics 56(2): 210-214. 
Owens, S. F., F. Rijsdijk, et al. (2010). "Genetic overlap between schizophrenia and 
selective components of executive function." Schizophrenia Research In Press, 
Corrected Proof. 
Owens, S. F., F. Rijsdijk, et al. (In Press). "Genetic overlap between schizophrenia and 
selective components of executive function." Schizophr Res. 
Oyebode, F. (2008). Sims Symptoms in the Mind, 4th Edition, An Introduction to 
Descriptive Psychopathology Saunders Elsevier  
Pantelis, C., D. Velakoulis, et al. (2003). "Neuroanatomical abnormalities before and 
after onset of psychosis: a cross-sectional and longitudinal MRI comparison." 
Lancet 361(9354): 281-288. 
Pantelis, C., D. Velakoulis, et al. (2003). "Neuroanatomical abnormalities before and 
after onset of psychosis: a cross-sectional and longitudinal MRI comparison." The 
Lancet 361(9354): 281-288. 
Pardo, P. J., M. A. Knesevich, et al. (2000). "Genetic and state variables of 
neurocognitive dysfunction in schizophrenia: A twin study." Schizophrenia 
Bulletin 26(2): 459-477. 
Pearlson, G. D. (1997). "Superior temporal gyrus and planum temporale in schizophrenia: 
A selective review." Progress in Neuro-Psychopharmacology & Biological 
Psychiatry 21(8): 1203-1229. 
Pedersen, C. B. and P. B. Mortensen (2001). "Evidence of a dose-response relationship 
between urbanicity during upbringing and schizophrenia risk." Archives of 
General Psychiatry 58(11): 1039-1046. 
Pennington, B. F., P. A. Filipek, et al. (2000). "A twin MRI study of size variations in the 
human brain." Journal of Cognitive Neuroscience 12(1): 223-232. 
Petronis, A. and J. L. Kennedy (1995). "Unstable genes - unstable mind." American 
Journal of Psychiatry 152(2): 164-172. 
Petronis, A., A. D. Paterson, et al. (1999). "Schizophrenia: An epigenetic puzzle?" 
Schizophrenia Bulletin 25(4): 639-655. 
Petronis, A., J. B. Vincent, et al. (1998). "Search for unstable DNA in schizophrenia." 
Schizophrenia Research 29(1-2): 135-135. 
Phelps, E. A., F. Hyder, et al. (1997). "Fmri of the prefrontal cortex during overt verbal 
fluency." Neuroreport 8: 561-565. 
Phillips, D. I. W. (1993). "TWIN STUDIES IN MEDICAL-RESEARCH." Lancet 
342(8862): 52-52. 
Phillips, L. J., A. R. Yung, et al. (2002). "Prediction and prevention of transition to 
psychosis in young people at incipient risk for schizophrenia." American Journal 
of Medical Genetics 114(8): 929-937. 
Picchioni, M. M. and R. M. Murray (2007). "Schizophrenia." British Medical Journal 
335(7610): 91-95. 
 172 
Picchioni, M. M., T. Toulopoulou, et al. (2006). "Neurological Abnormalities in 
Schizophrenic Twins." Biological Psychiatry 59(4): 341-348. 
Picchioni, M. M., M. Walshe, et al. (2010). "Genetic modelling of childhood social 
development and personality in twins and siblings with schizophrenia." 
Psychological Medicine 40(8): 1305-1316. 
Pihlajamaki, M., H. Tanila, et al. (2000). "Verbal fluency activates the left medial 
temporal lobe: A functional magnetic resosnce imaging study." Annals of 
Neurology 47: 470-476. 
Pinborg, A., A. Loft, et al. (2004). "Neurological sequelae in twins born after assisted 
conception: controlled national cohort study." BMJ 329: 311-315. 
Plomin, R. and C. S. Bergeman (1991). "Nature and nurture - authors response." 
Behavioral and Brain Sciences 14(3): 414-428. 
Plomin, R. and C. S. Bergeman (1991). "The Nature of Nurture - Genetic Influence on 
Environmental Measures." Behavioral and Brain Sciences 14(3): 373-385. 
Plomin, R. and C. S. Bergeman (1991). "The nature of nurture - genetics of 
environmental measures." Behavioral and Brain Sciences 14(3): 373-385. 
Plomin, R., J. C. DeFries, et al., Eds. (1997). Behavioural Genetics. New York, W.H. 
Freeman and Company. 
Plomin, R., L. Willerman, et al. (1976). "RESEMBLANCE IN APPEARANCE AND 
EQUAL ENVIRONMENTS ASSUMPTION IN TWIN STUDIES OF 
PERSONALITY-TRAITS." Behavior Genetics 6(1): 43-52. 
Pollin, W., J. R. Stabenau, et al. (1966). "LIFE HISTORY DIFFERENCES IN 
IDENTICAL TWINS DISCORDANT FOR SCHIZOPHRENIA." American 
Journal of Orthopsychiatry 36(3): 492-510. 
Pollin, W., J. R. Stabenau, et al. (1965). "FAMILY STUDIES WITH IDENTICAL-
TWINS DISCORDANT FOR SCHIZOPHRENIA." Psychiatry 28(1): 60-78. 
Poltorak, M., R. Wright, et al. (1997). "Monozygotic twins discordant for schizophrenia 
are discordant for N-CAM and L1 in CSF." Brain Research 751(1): 152-154. 
Polymeropoulos, M. H., H. Xiao, et al. (1993). "SEARCH FOR A GENETIC EVENT IN 
MONOZYGOTIC TWINS DISCORDANT FOR SCHIZOPHRENIA." 
Psychiatry Research 48(1): 27-36. 
Porteous, D. J., P. Thomson, et al. (2006). "The Genetics and Biology of Disc1--An 
Emerging Role in Psychosis and Cognition." Biological Psychiatry 60(2): 123-
131. 
Posthuma, D., E. J. de Geus, et al. (2000). "Multivariate genetic analysis of brain 
structure in an extended twin design." Behaviour Genetics 30(4): 311-319. 
Poulton, R., A. Caspi, et al. (2000). "Children's self-reported psychotic symptoms and 
adult schizophreniform disorder - A 15-year longitudinal study." Archives of 
General Psychiatry 57(11): 1053-1058. 
Prasad, K. M. and M. S. Keshavan (2008). "Structural cerebral variations as useful 
endophenotypes in schizophrenia: Do they help construct "Extended 
Endophenotypes"?" Schizophrenia Bulletin 34(4): 774-790. 
Prasad, K. M., R. Sanders, et al. (2009). "Neurological abnormalities among offspring of 
persons with schizophrenia: Relation to premorbid psychopathology." 
Schizophrenia Research 108(1-3): 163-169. 
Prata, D. P., A. Mechelli, et al. (2009). "Opposite Effects of Catechol-O-
Methyltransferase Val158Met on Cortical Function in Healthy Subjects and 
Patients with Schizophrenia." Biological Psychiatry 65(6): 473-480. 
Prata, D. P., A. Mechelli, et al. (2008). "Effects of disrupted-in-schizophrenia-1 on pre-
frontal cortical function." Molecular Psychiatry 13: 915-917. 
 173 
Prata, D. P., A. Mechelli, et al. (2009). "Epistasis between the DAT 3 ' UTR VNTR and 
the COMT Val158Met SNP on cortical function in healthy subjects and patients 
with schizophrenia." Proceedings of the National Academy of Sciences of the 
United States of America 106(32): 13600-13605. 
Prata, D. P., A. Mechelli, et al. (2009). "Altered Effect of Dopamine Transporter 3 ' UTR 
VNTR Genotype on Prefrontal and Striatal Function in Schizophrenia." Archives 
of General Psychiatry 66(11): 1162-1172. 
Preston, G. A. and D. R. Weinberger (2005). "Intermediate phenotypes in schizophrenia: 
a selective review." Dialogues Clin Neurosci 7(2): 165-179. 
Ragins, N., J. Schachter, et al. (1975). "Infants and children at risk for schizophrenia: 
environmental and developmental observations." American Journal of Child 
Psychiatry 14: 150-177. 
Rajarethinam, R., S. Sahni, et al. (2004). "Reduced superior temporal gyrus volume in 
young offspring of patients with schizophrenia." American Journal of Psychiatry 
161(6): 1121-1124. 
Raschka, L. B. (2000). "Paternal age and schizophrenia in dizygotic twins." British 
Journal of Psychiatry 176: 400-401. 
Rebollo, I. and D. I. Boomsma (2006). "Genetic analysis of anger: Genetic dominance or 
competitive sibling interaction." Behavior Genetics 36(2): 216-228. 
Reichenberg, A. and P. D. Harvey (2007). "Neuropsychological impairments in 
schizophrenia: Integration of performance-based and brain imaging findings." 
Psychological Bulletin 133: 833-858. 
Reichenberg, A., J. Rabinowitz, et al. (2000). "Premorbid functioning in a national 
population of male twins discordant for psychoses." American Journal of 
Psychiatry 157(9): 1514-1516. 
Reichenberg, A., M. Weiser, et al. (1999). "Premorbid personality and 
neuropsychological assessment of male twins discordant for schizophrenia." 
Schizophrenia Research 36(1-3): 151-151. 
Rettew, D. C., I. Rebollo-Mesa, et al. (2008). "Non-additive and additive genetic effects 
on extraversion in 3314 Dutch adolescent twins and their parents." Behavior 
Genetics 38(3): 223-233. 
Reveley, A. M., M. A. Reveley, et al. (1982). "Cerebral ventricle size in twins discordant 
for schizophrenia." Lancet 1: 540-541. 
Reveley, A. M., M. A. Reveley, et al. (1982). "CEREBRAL VENTRICULAR SIZE IN 
TWINS DISCORDANT FOR SCHIZOPHRENIA." Lancet 1(8271): 540-541. 
Reveley, A. M., M. A. Reveley, et al. (1984). "CEREBRAL VENTRICULAR 
ENLARGEMENT IN NON-GENETIC SCHIZOPHRENIA - A CONTROLLED 
TWIN STUDY." British Journal of Psychiatry 144(JAN): 89-93. 
Rey, M. J., P. Schulz, et al. (1989). "GUIDELINES FOR THE DOSAGE OF 
NEUROLEPTICS .1. CHLORPROMAZINE EQUIVALENTS OF ORALLY-
ADMINISTERED NEUROLEPTICS." International Clinical 
Psychopharmacology 4(2): 95-104. 
Rijsdijk, F. V., N. E. M. van Haren, et al. (2005). "Brain MRI Abnormalities in 
Schizophrenia: Same Genes or Same Environment?" Psychological Medicine 
35(10): 1399-1409. 
Rijsdijk, F. V., N. E. M. Van Haren, et al. (2005). "Brain MRI abnormalities in 
schizophrenia: same genes or same environment?" Psychological Medicine 
35(10): 1399-1409. 
Ritsner, M. S. and I. I. Gottesman (2009). "Where Do We Stand in the Quest for 
Neuropsychiatric Biomarkers and Endophenotypes and What Next?" Handbook 
 174 
of Neuropsychiatric Biomarkers, Endophenotypes and Genes, Vol 
1:NEUROPSYCHOLOGICAL ENDOPHENOTYPES AND BIOMARKERS: 3-
21. 
Rogers, J. G., L. Voullaire, et al. (1982). "MONOZYGOTIC TWINS DISCORDANT 
FOR TRISOMY 21." American Journal of Medical Genetics 11(2): 143-146. 
Rogers, W. H. (1993). "Regression standard errors in  clustered samples." Reprinted in 
Stata Technical Bulleting Reprints 3: 88-94. 
Rosa, A., L. Fananas, et al. (2000). "Congenital dermatoglyphic malformations and 
psychosis: A twin study." American Journal of Psychiatry 157(9): 1511-1513. 
Rosenthal, D. (1959). "Some factors associated with concordance and discordance with 
respect to schizophrenia in monozygotoc twins." Journal of Nervous and Mental 
Disease 129(1): 1-10. 
Rosenthal, D. (1960). "Confusion of Identity and the Frequency of Schizophrenia in 
Twins." Archives of General Psychiatry 3(3): 297-304. 
Rosenthal, D. and S. S. Kety, Eds. (1968). The transmission of Schizophrenia. Oxford, 
Pergamon Press. 
Rossi, A., S. Decataldo, et al. (1990). "Neurological Soft Signs in Schizophrenia." British 
Journal of Psychiatry 157: 735-739. 
Sadrzadeh, S., S. A. Treloar, et al. (2001). "Potential bias regarding birth weight in 
historical and contemporary twin data bases." Twin Res 4(5): 332-336. 
Saha, S., D. Chant, et al. (2005). "A systematic review of the prevalence of 
schizophrenia." Plos Medicine 2(5): 413-433. 
Samuels, L. (1978). "Sex- differences in concordance rates for schizophrenia - finding or 
artifact." Schizophrenia Bulletin 4(1): 14-15. 
Samuels, L. (1979). "Sex-differences in schizophrenia - reply." Schizophrenia Bulletin 
5(1): 8-10. 
Sartorius, N., R. Shapiro, et al. (1974). "The International Pilot Study of Schizophrenia." 
Schizophrenia Bulletin 11: 21-34. 
Scarr, S. (1968). "Environmental bias in twin studies." Eugenics Quarterly 15(1): 34-40. 
Scarr, S. (1996). "How people make their own environments: Implications for parents 
and policy makers." Psychology Public Policy and Law 2(2): 204-228. 
Scarr, S. and K. McCartney (1983). "How people make their environments - a theory of 
genotype environment effects." Child Development 54(2): 424-435. 
Scheepers, F. E., C. C. G. de Wied, et al. (2001). "Effect of clozapine on caudate nucleus 
volume in relation to symptoms of schizophrenia." American Journal of 
Psychiatry 158(4): 644-646. 
Schlosser, R., M. Hutchinson, et al. (1998). "Functional magnetic resonance imaging of 
human brain activity in a verbal fluency task." Journal of Neurology 
Neurosurgery and Psychiatry 64: 492-498. 
Schmahmann, J. D., J. Doyon, et al. (1999). "Three-dimensional MRI atlas of the human 
cerebellum in proportional stereotaxic space." Neuroimage 10(3): 233-260. 
Schnack, H. G., N. E. M. van Haren, et al. (2004). "Reliability of brain volumes from 
multicenter MRI acquisition: A calibration study." Human Brain Mapping 22(4): 
312-320. 
Schubert, E. W., E. Cantor-Graae, et al. (2002). "Neurological deviation in offspring of 
women with psychosis: From infancy to adulthood." Schizophrenia Research 
53(3): 232-232. 
Schubert, E. W. and T. F. McNeil (2004). "Prospective study of neurological 
abnormalities in offspring of women with psychosis: Birth to adulthood." 
American Journal of Psychiatry 161(6): 1030-1037. 
 175 
Schulze, K., C. McDonald, et al. (2003). "Hippocampal volume in familial and 
nonfamilial schizophrenic probands and their unaffected relatives." Biological 
Psychiatry 53(7): 562-570. 
Seeman, M. V. (2009). "The Changing Role of Mother of the Mentally Ill: From 
Schizophrenogenic Mother to Multigenerational Caregiver." Psychiatry-
Interpersonal and Biological Processes 72(3): 284-294. 
Seidman, L. J., S. V. Faraone, et al. (2002). "Left hippocampal volume as a vulnerability 
indicator for schizophrenia - A magnetic resonance imaging morphometric study 
of nonpsychotic first-degree relatives." Archives of General Psychiatry 59(9): 
839-849. 
Selten, J. P., J. D. Blom, et al. (2008). "Psychosis risk for parents and siblings of Dutch 
and Moroccan-Dutch patients with non-affective psychotic disorder." 
Schizophrenia Research 104(1-3): 274-278. 
Selten, J. P. and E. Cantor-Graae (2010). "The denial of a psychosis epidemic." Psychol 
Med 40(5): 731-733. 
Shapiro, D. I., S. Marcenco, et al. (2009). "The Premorbid Adjustment Scale as a measure 
of developmental compromise in patients with schizophrenia and their healthy 
siblings." Schizophrenia Research In Press. 
Sharma, T., E. Lancaster, et al. (1998). "Brain changes in schizophrenia - Volumetric 
MRI study of families multiply affected with schizophrenia - The Maudsley 
Family Study 5." British Journal of Psychiatry 173: 132-138. 
Shen, S., A. J. Szameitat, et al. (2007). "VBM lesion detection depends on the 
normalization template: a study using simulated atrophy." Magnetic Resonance 
Imaging 25(10): 1385-1396. 
Shenton, M. E., C. C. Dickey, et al. (2001). "A review of MRI findings in schizophrenia." 
Schizophrenia Research 49(1-2): 1-52. 
Shibre, T., D. Kebede, et al. (2002). "Neurological soft signs (NSS) in 200 treatment-
naive cases with schizophrenia: A community-based study in a rural setting." 
Nordic Journal of Psychiatry 56(6): 425-431. 
Shim, G., D. H. Kang, et al. (2008). "Social functioning deficits in young people at risk 
for schizophrenia." Australian and New Zealand Journal of Psychiatry 42(8): 678-
685. 
Singh, S., B. Murphy, et al. (2002). "Epigenetic contributors to the discordance of 
monozygotic twins." Clinical Genetics 62(2): 97-103. 
Sirugo, G., J. Ashenbrenner, et al. (2004). "No evidence of association between the 
genetic predisposition for dizygotic twinning and schizophrenia in West Africa." 
Schizophrenia Research 70(2-3): 343-344. 
Sklar, P. (2002). "Linkage analysis in psychiatric disorders: the emerging picture." 
Annual Review of Genomics and Human Genetics 25: 1-50. 
Slaghekke, F., W. J. Kist, et al. (2009). "TAPS and TOPS: two distinct forms of feto-fetal 
transfusion in monochorionic twins." Z Geburtshilfe Neonatol 213(6): 248-254. 
Slater, E. (1953). "Psychotic and neurotic illnesses in twins." Spec Rep Ser Med Res 
Counc (G B) 278: 1-385. 
Smieskova, R., P. Fusar-Poli, et al. (2009). "The Effects of Antipsychotics on the Brain: 
What Have We Learnt from Structural Imaging of Schizophrenia? - A Systematic 
Review." Current Pharmaceutical Design 15(22): 2535-2549. 
Sobel, D. (1961). "Children of schizophrenic patients: preliminary observations on early 
development." American Journal of Psychiatry 118: 512-517. 
Sommer, I. E. C., N. F. Ramsey, et al. (2001). "Language lateralization in schizophrenia, 
an fMRI study." Schizophrenia Research 52(1-2): 57-67. 
 176 
Sommer, I. E. C., N. F. Ramsey, et al. (2004). "Language activation in monozygotic 
twins discordant for schizophrneia." British Journal of Psychiatry 184: 128-135. 
Sommer, I. E. C., N. F. Ramsey, et al. (2003). "Language lateralization in female patients 
with schizophrenia: an fMRI study." Schizophrenia Research 60(2-3): 183-190. 
Sommer, I. E. C., N. F. Ramsey, et al. (2004). "Language activation in monozygotic 
twins discordant for schizophrenia." British Journal of Psychiatry 184: 128-135. 
Spaniel, F., T. Hajek, et al. (2003). "Differences in fMRI and MRS in a monozygotic twin 
pair discordant for schizophrenia (case report)." Acta Psychiatrica Scandinavica 
107(2): 155-157. 
Spaniel, F., V. Herynek, et al. (2005). "Magnetic resonance relaxometry in monozygotic 
twins discordant and concordant for schizophrenia." European Psychiatry 20(1): 
41-44. 
Spaniel, F., J. Tintera, et al. (2007). "Language lateralization in monozygotic twins 
discordant and concordant for schizophrenia. A functional MRI pilot study." 
European Psychiatry 22(5): 319-322. 
Spence, S. A., P. F. Liddle, et al. (2000). "Functional anatomy of verbal fluency in people 
with schizophrenia and those at genetic risk - Focal dysfunction and distributed 
disconnectivity reappraised." British Journal of Psychiatry 176: 52-60. 
Spitz, L. (2005). "Conjoined twins." Prenatal Diagnosis 25(9): 814-819. 
Spitzer, R. L., J. Endicott, et al. (1978). "Research diagnostic criteria: rationale and 
reliability." Arch Gen Psychiatry 35(6): 773-782. 
Staal, W. G., H. E. H. Pol, et al. (2000). "Structural brain abnormalities in patients with 
schizophrenia and their healthy siblings." American Journal of Psychiatry 157(3): 
416-421. 
Stabenau, J. R. and W. Pollin (1967). "EARLY CHARACTERISTICS OF 
MONOZYGOTIC TWINS DISCORDANT FOR SCHIZOPHRENIA." Archives 
of General Psychiatry 17(6): 723-&. 
Stabenau, J. R., W. Pollin, et al. (1969). "Study of monozygotic twins discordant for 
schizophrenia - some biologic variables (lactate-pyruvic ratio - 3,4-
dimethoxyphenlethylamine - S19 macroglobulin - antirabbit hemagglutin - protein 
bound iodine)." 
Stassen, H. H., R. Coppola, et al. (1999). "EEG differences in monozygotic twins 
discordant and concordant for schizophrenia." Psychophysiology 36(1): 109-117. 
Stefansson, H., R. A. Ophoff, et al. (2009). "Common variants conferring risk of 
schizophrenia." Nature 460(7256): 744-U799. 
Stefansson, H., E. Sigurdsson, et al. (2002). "Neuregulin 1 and susceptibility to 
schizophrenia." American Journal of Human Genetics 71(4): 877-892. 
Stephan, K. E., T. Baldeweg, et al. (2006). "Synaptic plasticity and dysconnection in 
schizophrenia." Biological Psychiatry 59(10): 929-939. 
Stephan, K. E., K. J. Friston, et al. (2009). "Dysconnection in Schizophrenia: From 
Abnormal Synaptic Plasticity to Failures of Self-monitoring." Schizophrenia 
Bulletin 35(3): 509-527. 
Stern, A. J., A. A. Savostyanova, et al. (2008). "Impact of the Brain-Derived 
Neurotrophic Factor Val66Met Polymorphism on Levels of Hippocampal N-
Acetyl-Aspartate Assessed by Magnetic Resonance Spectroscopic Imaging at 3 
Tesla." Biological Psychiatry 64(10): 856-862. 
Straub, R. E. and D. R. Weinberger (2006). "Schizophrenia Genes - Famine to Feast." 
Biological Psychiatry 60(2): 81-83. 
Styner, M., J. A. Lieberman, et al. (2005). "Morphometric analysis of lateral ventricles in 
schizophrenia and healthy controls regarding genetic and disease-specific 
 177 
factors." Proceedings of the National Academy of Sciences of the United States of 
America 102(13): 4872-4877. 
Suddath, R. L., G. W. Christison, et al. (1990). "ANATOMICAL ABNORMALITIES IN 
THE BRAINS OF MONOZYGOTIC TWINS DISCORDANT FOR 
SCHIZOPHRENIA." New England Journal of Medicine 322(12): 789-794. 
Suddath, R. L., G. W. Christison, et al. (1990). "Anatomical abnormalities in the brains of 
monozygotic twins discordant for schizophrenia." New England Journal of 
Medicine 322: 789-794. 
Suhr, J. A. and M. B. Spitnagel (2001). "Factor versus cluster models of schizotypal 
traits. I: A comparison of unselected and highyl schizotypal samples." 
Schizophrenia Research 52: 231-239. 
Sullivan, P. F., K. S. Kendler, et al. (2003). "Schizophrenia as a complex trait - Evidence 
from a meta- analysis of twin studies." Archives of General Psychiatry 60(12): 
1187-1192. 
Sullivan, P. F., K. S. Kendler, et al. (2003). "Schizophrenia as a complex trait - Evidence 
from a meta-analysis of twin studies." Archives of General Psychiatry 60(12): 
1187-1192. 
Suzuki, S. (2009). "Impact of Perinatal Outcome of the Presence of Fused or Separate 
Placentas in Dichorionic Twins." Fetal Diagnosis and Therapy 26(3): 127-130. 
Szasz, T. (1996). "'Audible thoughts' and 'speech defect' in schizophrenia - A note on 
reading and translating Bleuler." British Journal of Psychiatry 168(5): 533-535. 
Szasz, T. (2008). "Debunking antipsychiatry: Laing, law, and largactil." Current 
Psychology 27(2): 79-101. 
Szasz, T. S. (1976). "Schizophrenia: the sacred symbol of psychiatry." Seishin 
Shinkeigaku Zasshi 78(4): 261-308. 
Talairach, J., P. Tournoux, et al. (1988). "Anatomical Stereotaxic Studies of the Frontal-
Lobe in the Management of the Epilepsies." Epilepsia 29(2): 205-205. 
Tandon, R., M. S. Keshavan, et al. (2008). "Schizophrenia, "Just the Facts" What we 
know in 2008. 2. Epidemiology and etiology." Schizophrenia Research 102(1-3): 
1-18. 
Tarbox, S. I. and M. F. Pogue-Geile (2008). "Development of social functioning in 
preschizophrenia children and adoescents: a systematic review." Psychological 
Bulletin 34(4): 561-583. 
Taylor, D., C. Paton, et al. (2009). The Maudsley Prescribing Guidelines, 10th Edition. 
London, Martin Dunitz. 
Tepest, R., L. Wang, et al. (2003). "Hippocampal deformities in the unaffected siblings of 
schizophrenia subjects." Biological Psychiatry 54(11): 1234-1240. 
Thompson, P., T. D. Cannon, et al. (2002). "Mapping genetic influences on human brain 
structure." Annals of Medicine 34(7-8): 523-536. 
Thompson, P. M., G. Bartzokis, et al. (2009). "Time-Lapse Mapping of Cortical Changes 
in Schizophrenia with Different Treatments." Cerebral Cortex 19(5): 1107-1123. 
Tienari, P. (1963). "PSYCHIATRIC ILLNESSES IN IDENTICAL-TWINS." Acta 
Psychiatrica Scandinavica 39: 9-&. 
Torgersen, S., S. Onstad, et al. (1993). "True schizotypal personality disorder - A study of 
co-twins and relatives of schizophrenic probands." American Journal of 
Psychiatry 150(11): 1661-1667. 
Torrey, E. F. (1990). "Offspring of twins with schizophrenia." Archives of General 
Psychiatry 47(10): 976-977. 
 178 
Torrey, E. F., I. I. Gottesman, et al. (1994). Schizophrenia and Manic Depressive 
Disorder: The Biological Roots of Mental Illness as Revealed by a Landmark 
Study of Identical Twins. New York, Basic Books. 
Toulopoulou, T., T. E. Goldberg, et al. (2010). "Impaired intellect and memory: a missing 
link between genetic risk and schizophrenia?" Arch Gen Psychiatry 67(9): 905-
913. 
Toulopoulou, T., M. Picchioni, et al. (2007). "Substantial genetic overlap between 
neurocognition and schizophrenia - Genetic modeling in twin samples." Archives 
of General Psychiatry 64: 1348-1355. 
Toulopoulou, T., M. Picchioni, et al. (2007). "Substantial genetic overlap between 
neurocognition and schizophrenia: Genetic modeling in twin samples." Archives 
of General Psychiatry 64(12): 1348-1355  
Toulopoulou, T., M. M. Picchioni, et al. (2007). "Substantial Genetic Overlap Between 
Neurocognition and Schizophrenia." Arch Gen Psychiatry 64(12): 1348-1355. 
Tramo, M. J., W. C. Loftus, et al. (1995). "SURFACE-AREA OF HUMAN 
CEREBRAL-CORTEX AND ITS GROSS MORPHOLOGICAL 
SUBDIVISIONS - IN-VIVO MEASUREMENTS IN MONOZYGOTIC TWINS 
SUGGEST DIFFERENTIAL HEMISPHERE EFFECTS OF GENETIC-
FACTORS." Journal of Cognitive Neuroscience 7(2): 292-302. 
Tsujita, T., N. Niikawa, et al. (1998). "Genomic discordance between monozygotic twins 
discordant for schizophrenia." American Journal of Psychiatry 155(3): 422-424. 
Uchida, I. A., D. J. Desa, et al. (1983). "45,X/46,XX MOSAICISM IN DISCORDANT 
MONOZYGOTIC TWINS." Pediatrics 71(3): 413-417. 
Valsky, D. V., E. Eixarch, et al. (2010). "Selective intrauterine growth restriction in 
monochorionic diamniotic twin pregnancies." Prenatal Diagnosis 30(8): 719-726. 
van Beilen, M., M. Pijnenborg, et al. (2004). "What is measured by verbal fluency tests in 
schizophrenia?" Schizophrenia Research 69(2-3): 267-276. 
van Erp, T. G. M., P. A. Saleh, et al. (2004). "Hippocampal volumes in schizophrenic 
twins." Archives of General Psychiatry 61(4): 346-353. 
van Erp, T. G. M., P. A. Saleh, et al. (2001). "Hippocampus volumes in schizophrenic 
patients, their siblings, and controls: Contributions of genes and fetal hypoxia." 
Neuroimage 13(6): S1110-S1110. 
van Haren, N. E. M., M. M. Picchioni, et al. (2004). "A Controlled Study of Brain 
Structure in Monozygotic Twins Concordant and Discordant for Schizophrenia." 
Biological Psychiatry 56(6): 454-461. 
van Haren, N. E. M., M. M. Picchioni, et al. (2004). "A controlled study of brain structure 
in monozygotic twins concordant and discordant for schizophrenia." Biological 
Psychiatry 56(6): 454-461. 
van Oel, C. J., W. F. C. Baare, et al. (2001). "Differentiating between low and high 
susceptibility to schizophrenia in twins: the significance of dermatoglyphic 
indices in relation to other determinants of brain development." Schizophrenia 
Research 52(3): 181-193. 
Van Oel, C. J., W. F. C. Baare, et al. (1999). "Genetic liability versus intrauterine 
environment in twins discordant for schizophrenia." Schizophrenia Research 
36(1-3): 213-214. 
Van Oel, C. J. and R. S. Kahn (1997). "Birth order and low birth weight as predictors for 
schizophrenia in discordant twins." American Journal of Medical Genetics 74(6): 
566-566. 
van Os, J., L. Fananas, et al. (1997). "Dermatoglyphic abnormalities in psychosis: A twin 
study." Biological Psychiatry 41(5): 624-626. 
 179 
van Os, J. and S. Kapur (2009). "Schizophrenia." Lancet 374(9690): 635-645. 
van Os, J., G. Kenis, et al. (2010). "The environment and schizophrenia." Nature 
468(7321): 203-212. 
van Os, J., H. Verdoux, et al. (1999). "Self-reported psychosis-like symptoms and the 
continuum of psychosis." Social Psychiatry and Psychiatric Epidemiology 34(9): 
459-463. 
Vander Putten, D. M., E. Fuller Torry, et al. (1996). "Plasma protein variations in 
monozygotic twins discordant for schizophrenia." Biological Psychiatry 40: 437-
442. 
Veiling, W., E. S. Susser, et al. (2008). "Ethnic density of neighbourhoods and incidence 
of psychotic disorders among immigrants." American Journal of Psychiatry 165: 
66-73. 
Veling, W., J. P. Selten, et al. (2007). "Discrimination and the incidence of psychotic 
disorders among ethnic minorities in The Netherlands." International Journal of 
Epidemiology 36: 761-768. 
Veling, W., E. Susser, et al. (2008). "Ethnic density of Neighborhoods and incidence of 
psychotic disorders among immigrants." American Journal of Psychiatry 165(1): 
66-73. 
Vincent, J. B., G. Kalsi, et al. (1998). "No evidence of expansion of CAG or GAA repeats 
in schizophrenia families and monozygotic twins." Human Genetics 103(1): 41-
47. 
Vinogradov, S., J. Kirkland, et al. (2003). "Both processing speed and semantic memory 
organization predict verbal fluency in schizophrenia." Schizophrenia Research 
59(2-3): 269-275. 
Vojvoda, D., K. Grimmell, et al. (1996). "Monozygotic twins concordant for response to 
clozapine." Lancet 347(8993): 61. 
Vollema, M. G. and R. J. van den Bosch (1995). "The multidimensionality of 
schizotypy." Schizophrenia Bulletin 21: 19-30. 
Vourdas, A., R. Pipe, et al. (2003). "Increased developmental deviance and premorbid 
dysfunction in early onset schizophrenia." Schizophrenia Research 62(1-2): 13-
22. 
Waddington, J. L., A. P. Corvin, et al. (2007). "Functional genomic and schizophrenia: 
endophenotypes and mutant models." Psychiatric Clinics of North America 30(3): 
365-399. 
Walker, E. and D. Diforio (1997). "Schizophrenia: a neural diathesis-stress model." 
Psychological Review 104(4): 667-685. 
Walker, E., V. Mittal, et al. (2008). "Stress and the hypothalamic pituitary adrenal axis in 
the developmental course of schizophrenia." Annual Review of Clinical 
Psychology 4: 189-216. 
Walshe, M., M. Taylor, et al. (2007). "Familial liability to schizophrenia and premorbid 
adjustment." British Journal of Psychiatry 191: 260-261. 
Walters, J. T. R. and N. Craddock (2007). "Endophenotypes in psychiatric genetics." 
Molecular Psychiatry 12: 886-890. 
Warburton, E., R. J. S. Wise, et al. (1996). "Noun and verb retrieval by normal subjects 
studies with PET." Brain 119: 159-179. 
Weinberger, D. R. (1987). "Implications of normal brain development for the 
pathogenesis of schizophrenia." Archives of General Psychiatry 44: 660-669. 
Weinberger, D. R., K. F. Berman, et al. (1992). "EVIDENCE OF DYSFUNCTION OF A 
PREFRONTAL-LIMBIC NETWORK IN SCHIZOPHRENIA - A MAGNETIC-
RESONANCE-IMAGING AND REGIONAL CEREBRAL BLOOD-FLOW 
 180 
STUDY OF DISCORDANT MONOZYGOTIC TWINS." American Journal of 
Psychiatry 149(7): 890-897. 
Weisbrod, M., H. Hill, et al. (1999). "Genetic influence on auditory information 
processing in schizophrenia: P300 in monozygotic twins." Biological Psychiatry 
46(5): 721-725. 
Weisbrod, M., H. Hill, et al. (2004). "Nongenetic Pathologic developments of brain-wave 
patterns in monozygotic twins discordant and concordant for schizophrenia." 
American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 
125B(1): 1-9. 
Weiss, E. M., A. Hofer, et al. (2004). "Brain activation patterns during a verbal fluency 
test - a functional MRI study in healthy volunteers and patients with 
schizophrenia." Schizophrenia Research 70(2-3): 287-291. 
Weiss, E. M., A. Hofer, et al. (2006). "Language lateralization in unmedicated patients 
during an acute episode of schizophrenia: a functional MRI study." Psychiatry 
Research 146: 185-190. 
Whalley, H. C., E. Simonotto, et al. (2004). "FMRI correlates of state and trait effects in 
subjects at genetically enhanced risk of schizophrenia." Brain 127: 478-490. 
Whalley, H. C., M. C. Whyte, et al. (2005). "Neural correlates of enhanced genetic risk 
for schizophrenia." Neuroscientist 11(3): 238-249. 
White, T., N. C. Andreasen, et al. (2002). "Brain volumes and surface morphology in 
monozygotic twins." Cerebral Cortex 12(5): 486-493. 
White, T., D. O'Leary, et al. (2001). "Anatomic and functional variability: The effects of 
filter size in group fMRI data analysis." NeuroImage 13(4): 577-588. 
Whyte, M. C., H. C. Whalley, et al. (2006). "Event-related fmri of word classification and 
successful word recognition in subjects at genetically enhanced risk of 
schizophrenia." Psychological Medicine 36: 1427-1439. 
Williams, N. M., A. Preece, et al. (2004). "Identification in 2 independent samples of a 
novel schizophrenia risk haplotype of the dystrobrevin binding protein gene 
(DTNBP1)." Archives of General Psychiatry 61(4): 336-344. 
Williams, R. L. (2000). "A note on robust variance estimation for cluster-correlated data." 
Biometrics 56(2): 645-646. 
Wojcik, J. D., A. J. Gelenberg, et al. (1980). "Prevalence of tardive dyskinesia in an 
outpatient population." Compr Psychiatry 21(5): 370-380. 
Wolff, A. L. and G. A. O'Driscoll (1999). "Motor deficits and schizophrenia: the 
evidence from neuroleptic-naive patients and populations at risk." Journal of 
Psychiatry & Neuroscience 24(4): 304-314. 
Wood, S. J., D. Velakoulis, et al. (2001). "A longitudinal study of hippocampal volume in 
first episode psychosis and chronic schizophrenia." Schizophrenia Research 52(1-
2): 37-46. 
Woods, B. T. (1998). "Is schizophrenia a progressive neurodevelopmental disorder? 
Toward a unitary pathogenetic mechanism." American Journal of Psychiatry 
155(12): 1661-1670. 
Woods, S. W. (2003). "Chlorpromazine equivalent doses for the newer atypical 
antipsychotics." Journal of Clinical Psychiatry 64(6): 663-667. 
Woodward, T. S., C. C. Ruff, et al. (2003). "Methodological considerations regarding the 
association of Stroop and verbal fluency performance with the symptoms of 
schizophrenia." Schizophrenia Research 61(2-3): 207-214. 
Wright, I. C., S. Rabe-Hesketh, et al. (2000). "Meta-analysis of regional brain volumes in 
schizophrenia." American Journal of Psychiatry 157(1): 16-25. 
 181 
Wright, I. C., P. Sham, et al. (2002). "Genetic contributions to regional variability in 
human brain structure: methods and preliminary analysis." NeuroImage 17: 256-
271. 
Yazici, A. H., B. Demir, et al. (2002). "Neurological soft signs in schizophrenic patients 
and their nonpsychotic siblings." Schizophrenia Research 58(2-3): 241-246. 
Yung, A. R., L. J. Phillips, et al. (1998). "Can we predict the onset of first-episode 
psychosis in a high-risk group?" International Clinical Psychopharmacology 13: 
S23-S30. 
Yung, A. R., L. J. Phillips, et al. (2004). "Risk factors for psychosis in an ultra high-risk 
group: psychopathology and clinical features." Schizophrenia Research 67(2-3): 
131-142. 
YurgelunTodd, D. A., C. M. Waternaux, et al. (1996). "Functional magnetic resonance 
imaging of schizophrenic patients and comparison subjects during word 
production." American Journal of Psychiatry 153(2): 200-205. 
Zandi, T., J. M. Havenaar, et al. (2010). "First contact incidence of psychotic disorders 
among native Dutch and Moroccan immigrants in the Netherlands: Influence of 
diagnostic bias." Schizophrenia Research 119(1-3): 27-33. 
Zumarraga, M., I. Andia, et al. (2004). "Expression in normals and in subjects with 
schizophrenia of a novel gene fragment originally isolated from monozygotic 
twins discordant for schizophrenia." Genetics and Molecular Biology 27(1): 17-
21. 
Zwijnenburg, P. J. G., H. Meijers-Heijboer, et al. (2010). "Identical But Not the Same: 
The Value of Discordant Monozygotic Twins in Genetic Research." American 
Journal of Medical Genetics Part B-Neuropsychiatric Genetics 153B(6): 1134-
1149. 
 
 
